<ead xmlns="urn:isbn:1-931666-22-9" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="urn:isbn:1-931666-22-9 http://www.loc.gov/ead/ead.xsd">
  <eadheader countryencoding="iso3166-1" dateencoding="iso8601" langencoding="iso639-2b" repositoryencoding="iso15511">
    <eadid>FA1103A.xml</eadid>
    <filedesc>
      <titlestmt>
        <titleproper type="filing">Rockefeller University collection of the Medical Letter publication, 1996-2004</titleproper>
        <titleproper>A Guide to the Rockefeller University collection of the Medical Letter publication, 1996-2004 <num>FA1103A</num></titleproper>
      </titlestmt>
      <publicationstmt>
        <publisher>Rockefeller Archive Center</publisher>
        <address>
          <addressline>15 Dayton Avenue</addressline>
          <addressline>Sleepy Hollow 10591</addressline>
          <addressline>archive@rockarch.org</addressline>
          <addressline>URL: <extptr xlink:href="http://www.rockarch.org" xlink:show="new" xlink:title="http://www.rockarch.org" xlink:type="simple"/></addressline>
        </address>
      </publicationstmt>
    </filedesc>
    <profiledesc>
      <creation>This finding aid was produced using ArchivesSpace on <date>2016-11-03 00:03:57 -0400</date>.</creation>
      <descrules>Describing Archives: A Content Standard</descrules>
    </profiledesc>
  </eadheader>
  <archdesc level="collection">
    <did>
      <langmaterial>
        <language langcode="eng">English</language>
      </langmaterial>
      <repository>
        <corpname>Rockefeller Archive Center</corpname>
      </repository>
      <unittitle>Rockefeller University collection of the Medical Letter publication</unittitle>
      <origination label="creator">
        <corpname role="aut" source="lcnaf">Rockefeller University</corpname>
      </origination>
      <origination label="creator">
        <corpname role="aut" source="lcnaf">Medical Letter, Inc</corpname>
      </origination>
      <unitid>FA1103A</unitid>
      <physdesc altrender="whole">
        <extent altrender="materialtype spaceoccupied">122.5 Cubic Feet</extent>
      </physdesc>
      <unitdate normal="1996/2004" type="inclusive">1996-2004</unitdate>
    </did>
    <processinfo id="4f6518ea8bae3b64eb48a7b6e5a4ac82">
      <head>Processing Information</head>
      <p>Minimal processing</p>
    </processinfo>
    <prefercite id="08d6bd5a3343d88ae174562240e1c48c">
      <head>Preferred Citation</head>
      <p>Information regarding the Rockefeller Archive Center's preferred elements and forms of citation can be found at <extref href="http://www.rockarch.org/research/citations.php">http://www.rockarch.org/research/citations.php</extref></p>
    </prefercite>
    <accessrestrict id="8e22992d16c1acad66ec2350a423e469">
      <head>Conditions Governing Access</head>
      <p>Records more than 25 years old are open for research with select materials restricted as noted. Brittle or damaged items are available at the discretion of RAC.</p>
    </accessrestrict>
    <fileplan id="b18026630ad0911a346cf5ce064ebdd5">
      <head>File Plan</head>
      <p>Former Classification: I 891-U</p>
    </fileplan>
    <otherfindaid id="80d67a066600f6ef1d33e75468f27af6">
      <head>Other Finding Aids</head>
      <p>For additional Medical Letter materials open for research see:</p>
      <p>FA241 Rockefeller University collection of the Medical Lettter publication</p>
    </otherfindaid>
    <scopecontent id="96fc3f4b0ecc38c530137eb411f39ada">
      <head>Scope and Contents</head>
      <p>Contents includes: original manuscripts, reprints, advertising and package inserts, sources check, consultatnts drafts, manufacturers replies, and bibliography.</p>
    </scopecontent>
    <bioghist id="6c159867ba2a2151b8b7399752c3890b">
      <head>Biographical / Historical</head>
      <p>The Medical Letter on Drugs and Therapeutics is an independent, non-profit publication providing unbiased critical evaluation of drugs in terms of their effectiveness, adverse effects and possible alternative medications.</p>
    </bioghist>
    <userestrict id="37e428481bbdbecee9f5c722527c7cfc">
      <head>Conditions Governing Use</head>
      <p>Use agreement is required prior to providing access. See RAC Head of Reference for assistance.</p>
    </userestrict>
    <dsc>
      <c id="722d135ab2e6b9a0415068e6118db069" level="file">
        <did>
          <unittitle>TML, 38-9 - Acarbose for diabetes mellitus</unittitle>
          <unitdate type="inclusive">1996 February 2</unitdate>
          <container id="c24ef98ca22b8f5bfbf13193feec5bae" label="Mixed Materials (A0000000075844)" type="box">1</container>
          <container id="b8ac731fcf4f2bf46a7a5f5b67d4db4b" parent="c24ef98ca22b8f5bfbf13193feec5bae" type="folder">1-4</container>
        </did>
        <accessrestrict id="6413d819e0f61297a55139d343bc6b2f">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="8e0dd5900ff39bfca71872aabc11f428" level="file">
        <did>
          <unittitle>TML, 38-55 - Acetaminophen, NSAIDs and Alcohol</unittitle>
          <unitdate type="inclusive">1996 June 21</unitdate>
          <container id="7b02ffd533817b5ec86d042c9f993ea8" label="Mixed Materials (A0000000075844)" type="box">1</container>
          <container id="c8a2e0890f2c1562273ffbaaa7013722" parent="7b02ffd533817b5ec86d042c9f993ea8" type="folder">5-7</container>
        </did>
        <accessrestrict id="656f8049cade326890b44a882a172390">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="92bb9fbbd017dace4f8bbbdfdcec0a7a" level="file">
        <did>
          <unittitle>TML, 38-43 - Acute reactions to Drugs of Abuse</unittitle>
          <unitdate type="inclusive">1996 May 10</unitdate>
          <container id="7afcfdc703bf24688ba309e5a6effd73" label="Mixed Materials (A0000000075844)" type="box">1</container>
          <container id="64026d1c7a7f818bf83991152058705b" parent="7afcfdc703bf24688ba309e5a6effd73" type="folder">8-12</container>
        </did>
        <accessrestrict id="ca3616172a78ef218806617937be4ae3">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="299c68349552c9c16b93a8a4762f739e" level="file">
        <did>
          <unittitle>TML, 38-35 - New drugs for HIV</unittitle>
          <unitdate type="inclusive">1996 April 12</unitdate>
          <container id="44cf7b25306b1a11bf4416050163a5fe" label="Mixed Materials (A0000000075844)" type="box">1</container>
          <container id="c56ab94ffd31095db9378bf794ec2403" parent="44cf7b25306b1a11bf4416050163a5fe" type="folder">13-17</container>
        </did>
        <accessrestrict id="86a00cb09aea1b9f00fe35947afa8c0e">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="c5fa85f3bd2884f1a9dfd36830a4fb4d" level="file">
        <did>
          <unittitle>TML, 38-99 - Alteplase for thrombolysis in acute ischemic stroke</unittitle>
          <unitdate type="inclusive">1996 November 8</unitdate>
          <container id="d37f558d848b4c3504d076af1bafbd19" label="Mixed Materials (A0000000075844)" type="box">1</container>
          <container id="e58dbe7cf239df5205163a435195a38f" parent="d37f558d848b4c3504d076af1bafbd19" type="folder">18</container>
        </did>
        <accessrestrict id="6490910db6cb9773d516babe0e3ba2c3">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="25c672276d8de231f00bfa483bb42cb2" level="file">
        <did>
          <unittitle>TML, 38-99 - Alteplase for thrombolysis in acute ischemic stroke</unittitle>
          <unitdate type="inclusive">1996 November 8</unitdate>
          <container id="c23b6181a8cf0fd6eef008cc5d323011" label="Mixed Materials (A0000000075845)" type="box">2</container>
          <container id="dadb30fae27c620b212da8690544e48f" parent="c23b6181a8cf0fd6eef008cc5d323011" type="folder">1-3</container>
        </did>
        <accessrestrict id="2d841e9b213eca4386b5020a0f960ab2">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="520cba0819f4d1a661ffbae9d84a72d2" level="file">
        <did>
          <unittitle>TML, 38-61 - Anatrozle for metastatic breast cancer</unittitle>
          <unitdate type="inclusive">1996 July 5</unitdate>
          <container id="20d368021510fc0f4144ecfe34370396" label="Mixed Materials (A0000000075845)" type="box">2</container>
          <container id="40e67ca734f37dfc868245dd048e7d5f" parent="20d368021510fc0f4144ecfe34370396" type="folder">4-6</container>
        </did>
        <accessrestrict id="391e7265783eb309c372f58724caf420">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="b466c2ae20545eb902a029aabfadd4a2" level="file">
        <did>
          <unittitle>TML, 38-25 - Choice of Antimicrobial Drugs</unittitle>
          <unitdate type="inclusive">1996 March 29</unitdate>
          <container id="193c2d48360e926135c38d1fed6ca0cb" label="Mixed Materials (A0000000075845)" type="box">2</container>
          <container id="bf531823d7123302dbea6470b4717d7b" parent="193c2d48360e926135c38d1fed6ca0cb" type="folder">7-9</container>
        </did>
        <accessrestrict id="abc8cefbfb0e5ceded73db45b93e2776">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="ef71891079fc8afb056a13746e052f75" level="file">
        <did>
          <unittitle>TML, 38-52 - Drugs for Cardiac Arrythmias</unittitle>
          <unitdate type="inclusive">1996 August 30</unitdate>
          <container id="8a97d0bf61dc749d31b94022f853c995" label="Mixed Materials (A0000000075845)" type="box">2</container>
          <container id="1607c75bb17abd0873a21767eb5688df" parent="8a97d0bf61dc749d31b94022f853c995" type="folder">10-16</container>
        </did>
        <accessrestrict id="e9ba90f8f6e01a82041a2cb46e749402">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="630284f8fa9310d4604f35f82942ec99" level="file">
        <did>
          <unittitle>TML, 38-52 - Azelaic acid a new topical drug for acne</unittitle>
          <unitdate type="inclusive">1996 June 7</unitdate>
          <container id="f9f8cb527592631fb61304ec90f8ca05" label="Mixed Materials (A0000000075845)" type="box">2</container>
          <container id="3594cfd1c39a1469de58e6b7b408ae8f" parent="f9f8cb527592631fb61304ec90f8ca05" type="folder">17-18</container>
        </did>
        <accessrestrict id="7d350d2c114c77a5007cc5bd6bef48d0">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="4b06c4e94eeae1bbd7e893099db3bb23" level="file">
        <did>
          <unittitle>TML, 38-56 - Bicalutamide for prostate cancer</unittitle>
          <unitdate type="inclusive">1996 June 21</unitdate>
          <container id="6c64eccccbec8da2c5540e2645ec69fd" label="Mixed Materials (A0000000075845)" type="box">2</container>
          <container id="5e1187c4bddbfd0651d9936a78440626" parent="6c64eccccbec8da2c5540e2645ec69fd" type="folder">19-20</container>
        </did>
        <accessrestrict id="c9d5e1a415d2921805aa74b729504b02">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="cdf8cc07b4cfdaccc7c2d14cfe460d41" level="file">
        <did>
          <unittitle>TML, 38-56 - Bicalutamide for prostate cancer</unittitle>
          <unitdate type="inclusive">1996 June 21</unitdate>
          <container id="21b5a6477101db3f3eab18c25c9f2d60" label="Mixed Materials (A0000000075846)" type="box">3</container>
          <container id="4e88033d9b4cbb4d2ddb79f43d87a23e" parent="21b5a6477101db3f3eab18c25c9f2d60" type="folder">1</container>
        </did>
        <accessrestrict id="bc8ec69f68ddfbb05692b444a9d33f73">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="8e8440ccfa5de303b70df4a8556b7da1" level="file">
        <did>
          <unittitle>TML, 38-103 - Bone Density Testing</unittitle>
          <unitdate type="inclusive">1996 November 26</unitdate>
          <container id="c27b7092ae414f403172ef1595952dd5" label="Mixed Materials (A0000000075846)" type="box">3</container>
          <container id="9a84d47c8faa9ea3bd0fe9a585e1df13" parent="c27b7092ae414f403172ef1595952dd5" type="folder">2-3</container>
        </did>
        <accessrestrict id="9371d9820f979006c113e8341494696d">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="2bc3e056d1f8fa2492e7303d95310131" level="file">
        <did>
          <unittitle>TML, 37-109 - Dirithromycin</unittitle>
          <unitdate type="inclusive">1995 November 24</unitdate>
          <container id="a892699db7401f1c78bc1a111a02043b" label="Mixed Materials (A0000000075846)" type="box">3</container>
          <container id="ec37659f523d38270bd30c0785cf3f4c" parent="a892699db7401f1c78bc1a111a02043b" type="folder">4-7</container>
        </did>
        <accessrestrict id="70e63df474c05d465a52ed6834a63c2e">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="404e68490aeea4bc03276bd2e1972297" level="file">
        <did>
          <unittitle>TML, 38-108 - Calcium Supplements</unittitle>
          <unitdate type="inclusive">1996 December 6</unitdate>
          <container id="a892780158dbccb7c40593472fcef780" label="Mixed Materials (A0000000075846)" type="box">3</container>
          <container id="3eaa01d276fca6d0789ae8981ea5ef03" parent="a892780158dbccb7c40593472fcef780" type="folder">8-12</container>
        </did>
        <accessrestrict id="6397bcfd119b8dee01530ad0c01d2fe0">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="787f855d64193a39aa5fa640c29b09f9" level="file">
        <did>
          <unittitle>TML, 38-40 - Radiofrequency cather abilation for treatment of cardiac arrhythmias</unittitle>
          <unitdate type="inclusive">1996 April 26</unitdate>
          <container id="0994d92d69796c473ab54bf941f1e5a2" label="Mixed Materials (A0000000075846)" type="box">3</container>
          <container id="7e8ed8da9f9b23a772f84e23265a9a0e" parent="0994d92d69796c473ab54bf941f1e5a2" type="folder">13-16</container>
        </did>
        <accessrestrict id="9407b24c4bbb8b9a8280fd95b434f402">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="6ee9fed32bd765fba31910157fc457da" level="file">
        <did>
          <unittitle>TML, 38-23 - Cetibuten - a new oral cephalosporin</unittitle>
          <unitdate type="inclusive">1996 March 15</unitdate>
          <container id="6d3de03e314502114982699fc097cbc1" label="Mixed Materials (A0000000075846)" type="box">3</container>
          <container id="1accb90cfcf445bfd5e481253d6a339c" parent="6d3de03e314502114982699fc097cbc1" type="folder">17-19</container>
        </did>
        <accessrestrict id="fe428baa314a27bf86569a7a685bf75c">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="cf9669d33a59dba3ffbe8f50f22fca78" level="file">
        <did>
          <unittitle>TML, 38-84 - Cefepime (Maxime) - a new parenteral cephalosporin</unittitle>
          <unitdate type="inclusive">1996 September 13</unitdate>
          <container id="0b71dbb0da3281a497b129046a74ce5d" label="Mixed Materials (A0000000075847)" type="box">4</container>
          <container id="3042e2cc9723c1bce4776a3d18fdfa04" parent="0b71dbb0da3281a497b129046a74ce5d" type="folder">1-4</container>
        </did>
        <accessrestrict id="cd47248ae2cfc55d2fb4424654263054">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="7dd0747a03e955ecdd43cb4fc77cc296" level="file">
        <did>
          <unittitle>TML, 38-46 - Chlorzoxazone hepatotoxsicity</unittitle>
          <unitdate type="inclusive">1996 May 10</unitdate>
          <container id="5c6fd50a12774961df72cd5a0aa7b05f" label="Mixed Materials (A0000000075847)" type="box">4</container>
          <container id="d1a55d9eaac3bfb463e5cae827352be4" parent="5c6fd50a12774961df72cd5a0aa7b05f" type="folder">5</container>
        </did>
        <accessrestrict id="2fb3ed462271aeec0fb14801053de435">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="9050bc8c28970ad791e377582e9c079c" level="file">
        <did>
          <unittitle>TML, 38-67 - Choice of Lipid-Lowering drugs</unittitle>
          <unitdate type="inclusive">1996 August 2</unitdate>
          <container id="e55b4c8464901d13f8e6ec2db0b47712" label="Mixed Materials (A0000000075847)" type="box">4</container>
          <container id="c0ae7f9bb96cd9b876abe14a0d48ae01" parent="e55b4c8464901d13f8e6ec2db0b47712" type="folder">6-13</container>
        </did>
        <accessrestrict id="88da501863cd117b47bcae321e4b3b00">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="5c5e7299af1de05e46453f0fea0e1720" level="file">
        <did>
          <unittitle>TML, 38-21 - Cetirizine - a new antihistamine</unittitle>
          <unitdate type="inclusive">1996 March 15</unitdate>
          <container id="fcc8a6691157e7ca9a9d1725009d7f02" label="Mixed Materials (A0000000075847)" type="box">4</container>
          <container id="bf1baaf68939909741da1aaa37b47960" parent="fcc8a6691157e7ca9a9d1725009d7f02" type="folder">14-18</container>
        </did>
        <accessrestrict id="0f7c6d142759503d2196573bb0b89f9a">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="0f91362447d7a3cdff68d7ebac520b38" level="file">
        <did>
          <unittitle>TML, 38-109 - Clonidine for treatment of ADHD</unittitle>
          <unitdate type="inclusive">1996 December 6</unitdate>
          <container id="8af2d39463158b0c40b0bdbff5c1302a" label="Mixed Materials (A0000000075847)" type="box">4</container>
          <container id="f124e911f6b8d0ec956f4b772326e3cf" parent="8af2d39463158b0c40b0bdbff5c1302a" type="folder">19-20</container>
        </did>
        <accessrestrict id="4e5c9545497b1cea799d01d6d8e16965">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="c714362a04b8f852b521155e586e0af2" level="file">
        <did>
          <unittitle>TML, 38-109 - Clonidine for treatment of ADHD</unittitle>
          <unitdate type="inclusive">1996 December 6</unitdate>
          <container id="3a98eaa295933751122a3b2fcc7e013f" label="Mixed Materials (A0000000075848)" type="box">5</container>
          <container id="c786edaf82652baf0854ee6838a4216f" parent="3a98eaa295933751122a3b2fcc7e013f" type="folder">1</container>
        </did>
        <accessrestrict id="a545b57ddc41b86449988949e310c707">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="484f5bda82347b92c1fd763adae1bf8a" level="file">
        <did>
          <unittitle>TML, 38-64 - Dexfenfluramine for obesity</unittitle>
          <unitdate type="inclusive">1996 July 19</unitdate>
          <container id="ebd24ea357382fa65341c220c3bea82e" label="Mixed Materials (A0000000075848)" type="box">5</container>
          <container id="53d6087eeffe07f30bb9cdd6c14ca766" parent="ebd24ea357382fa65341c220c3bea82e" type="folder">2-5</container>
        </did>
        <accessrestrict id="0ae4223f8a683f538d4cd77c366f1250">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="8d0423127d33593f9f53a6262dc9f97c" level="file">
        <did>
          <unittitle>TML, 38-87 - Docetaxel (Taxotere) for advanced breast cancer</unittitle>
          <unitdate type="inclusive">1996 September 27</unitdate>
          <container id="9288c8c75559fe7c6eb4373905ac0349" label="Mixed Materials (A0000000075848)" type="box">5</container>
          <container id="dab9cd8ef913c7d94b6916d70c0925f6" parent="9288c8c75559fe7c6eb4373905ac0349" type="folder">6-8</container>
        </did>
        <accessrestrict id="ed7cc80f5cac6080418667469e63fcc5">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="a348057f4e83121c70f8e63e18862273" level="file">
        <did>
          <unittitle>TML, 38-14 - Epoprostenol for primary pulmonary hypertension</unittitle>
          <unitdate type="inclusive">1996 February 16</unitdate>
          <container id="ed60172f95bb922f2505ae36de537cc4" label="Mixed Materials (A0000000075848)" type="box">5</container>
          <container id="04996ee7f48c4f8f2943b89adb3bab77" parent="ed60172f95bb922f2505ae36de537cc4" type="folder">9-10</container>
        </did>
        <accessrestrict id="9060f4c1941e62cde507283711c42123">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="4fb37dc500fa2658eede9f802e9df8f8" level="file">
        <did>
          <unittitle>TML, 38-95 - Fexofenadine</unittitle>
          <unitdate type="inclusive">1996 October 25</unitdate>
          <container id="28d5ca756c69a0fc45d412152bde013e" label="Mixed Materials (A0000000075848)" type="box">5</container>
          <container id="ed4fd0ed444192bc1380c96a51e6efa8" parent="28d5ca756c69a0fc45d412152bde013e" type="folder">11-12</container>
        </did>
        <accessrestrict id="a8ff5bd8f8c9a8beb936876d0ab13404">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="64be8e3eb6b9a7f019087998bc44abd8" level="file">
        <did>
          <unittitle>TML, 37-13 - Fluvoxamine for obsessive compulsive disorder</unittitle>
          <unitdate type="inclusive">1995 February 17</unitdate>
          <container id="68333d22bf53e8a0842a6584b9e64a32" label="Mixed Materials (A0000000075848)" type="box">5</container>
          <container id="98d2cd1822879a851a4929d4a7725994" parent="68333d22bf53e8a0842a6584b9e64a32" type="folder">13-16</container>
        </did>
        <accessrestrict id="695bcbd1bf632b907b932d7960966f9f">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="892b6eca462f2e15ad9ec8aa8eca30aa" level="file">
        <did>
          <unittitle>TML, 38-83 - Fluticasone propionate for chronic asthma</unittitle>
          <unitdate type="inclusive">1996 September 13</unitdate>
          <container id="896f23fd995c08bf6a1e947a9778ca10" label="Mixed Materials (A0000000075848)" type="box">5</container>
          <container id="88971403c120dd452d6ac60c9fcf5b44" parent="896f23fd995c08bf6a1e947a9778ca10" type="folder">17-21</container>
        </did>
        <accessrestrict id="beb3673044e9a99bc1e5e6f80a600a9c">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="35c106caf84841f600db741ede502382" level="file">
        <did>
          <unittitle>TML, 38-83 - Fluticasone propionate for chronic asthma</unittitle>
          <unitdate type="inclusive">1996 September 13</unitdate>
          <container id="c470899daf8163d488cb650d632a6455" label="Mixed Materials (A0000000075849)" type="box">6</container>
          <container id="0dd5a47723add619b7e60acecdc3f5c4" parent="c470899daf8163d488cb650d632a6455" type="folder">1</container>
        </did>
        <accessrestrict id="f54d8351e9c7683733c760ddc9c6386f">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="9c02c90545e46d220940cf2a507e0a28" level="file">
        <did>
          <unittitle>TML, 38-10 - Systematic antifungal drugs</unittitle>
          <unitdate type="inclusive">1996 February 2</unitdate>
          <container id="41abd0d9734378672de83cdd656f30ba" label="Mixed Materials (A0000000075849)" type="box">6</container>
          <container id="3e3260770342ad2003b83f72b9c54f17" parent="41abd0d9734378672de83cdd656f30ba" type="folder">2-3</container>
        </did>
        <accessrestrict id="24650d75f7a4fe5ddaf748532b77d1c8">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="af3d9dfc1b1412c493e47fcf1216a75b" level="file">
        <did>
          <unittitle>TML, 38-102 - Gemcitabine for treatment of pancreatic cancer</unittitle>
          <unitdate type="inclusive">1996 November 8</unitdate>
          <container id="642959d667e6bb0711f2c8f8962d28bb" label="Mixed Materials (A0000000075849)" type="box">6</container>
          <container id="96a7eb0d3f4db1eed71e2a70de987241" parent="642959d667e6bb0711f2c8f8962d28bb" type="folder">4-6</container>
        </did>
        <accessrestrict id="7105d2dd194378e7c1b806e1786142c0">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="237f462175824d3b36e04281c83344ac" level="file">
        <did>
          <unittitle>TML, 38-47 - Glimepiride for NIDDM</unittitle>
          <unitdate type="inclusive">1996 May 24</unitdate>
          <container id="818c9d0310d07960c22f5572535fb8c3" label="Mixed Materials (A0000000075849)" type="box">6</container>
          <container id="bbdf5cb2f9c066006ba256b9ecf12d69" parent="818c9d0310d07960c22f5572535fb8c3" type="folder">7-8</container>
        </did>
        <accessrestrict id="d0c68415f609b87b8e322217b54f482b">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="f5f43d18d02fa3b8ac7f25b5d2f4bf4e" level="file">
        <did>
          <unittitle>TML, 38-92 - Drugs for chronic heart failure</unittitle>
          <unitdate type="inclusive">1996 October 11</unitdate>
          <container id="ee795866f1c5a53945eafe5d0a156185" label="Mixed Materials (A0000000075849)" type="box">6</container>
          <container id="e68decbfe6532781cf2c3d75ccc89f3d" parent="ee795866f1c5a53945eafe5d0a156185" type="folder">9-13</container>
        </did>
        <accessrestrict id="a3631f3ddc4c9deaa183f2128f324ec8">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="df185de80953b9ba72734fc53563026f" level="file">
        <did>
          <unittitle>TML, 37-73 - Grapefruit juice interactions with drugs</unittitle>
          <unitdate type="inclusive">1995 August 18</unitdate>
          <container id="d21f30e5bb59c653114a5784d07302f8" label="Mixed Materials (A0000000075849)" type="box">6</container>
          <container id="4ea1403a924372983b5d47fc2a5660d1" parent="d21f30e5bb59c653114a5784d07302f8" type="folder">14-16</container>
        </did>
        <accessrestrict id="ee2185b1e98265927be53db9e0fa2dda">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="9ea393808d7941a34a9237ff7d3e21d0" level="file">
        <did>
          <unittitle>TML - Drugs of Choice - Cardiac Arrhythmias</unittitle>
          <unitdate type="inclusive">1995</unitdate>
          <container id="2423c4564fd265df8faea2b15d0c3294" label="Mixed Materials (A0000000075849)" type="box">6</container>
          <container id="24556f8b7f16f687c745f168a479a7fd" parent="2423c4564fd265df8faea2b15d0c3294" type="folder">17-20</container>
        </did>
        <accessrestrict id="052ebcc34a91845237e97c0df53775e3">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="b5728f730c61991eb3d049832355c05c" level="file">
        <did>
          <unittitle>TML - Drugs of Choice - Cardiac Arrhythmias</unittitle>
          <unitdate type="inclusive">1995</unitdate>
          <container id="9dda0dd2bd84f4bfb8c1a048d57b5287" label="Mixed Materials (A0000000075850)" type="box">7</container>
          <container id="c591de85f27761c521761609c96ff42e" parent="9dda0dd2bd84f4bfb8c1a048d57b5287" type="folder">1-2</container>
        </did>
        <accessrestrict id="8725ceb0317248c73c37ce2386f5e01b">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="34fded3e81407289cef7298c43db888c" level="file">
        <did>
          <unittitle>TML - Drugs of Choice - Pain</unittitle>
          <unitdate type="inclusive">1995</unitdate>
          <container id="b06af5b51cdbc4214afcc26a5d2aeb3e" label="Mixed Materials (A0000000075850)" type="box">7</container>
          <container id="cc6d4982614a5119b8ee33db087c87a3" parent="b06af5b51cdbc4214afcc26a5d2aeb3e" type="folder">3-7</container>
        </did>
        <accessrestrict id="fd6c1b22c3706f5ee95e16758bf6f9f6">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="73f114dc6e630afb990634a443031d95" level="file">
        <did>
          <unittitle>TML, 37-95 - OTC H2 Blockers for heartburn</unittitle>
          <unitdate type="inclusive">1995 October 27</unitdate>
          <container id="1ce2e034860316ab8894bec05a94e36e" label="Mixed Materials (A0000000075850)" type="box">7</container>
          <container id="21e49d41037f4c4721277c7198d91d87" parent="1ce2e034860316ab8894bec05a94e36e" type="folder">8-10</container>
        </did>
        <accessrestrict id="6f9d54ac52d448a971ae1e70ff68a5a9">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="e3ff759a8063b390ff0175205e40649d" level="file">
        <did>
          <unittitle>TML, 38-6 - Rho (D) IV Immune Globulin</unittitle>
          <unitdate type="inclusive">1996 January 19</unitdate>
          <container id="45dd255f66ae3d24c5617c4353367fb1" label="Mixed Materials (A0000000075850)" type="box">7</container>
          <container id="95643325c192eca0bb631a6694292bd2" parent="45dd255f66ae3d24c5617c4353367fb1" type="folder">11-13</container>
        </did>
        <accessrestrict id="ce939d07fa2fe96e5b623cff81c37a02">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="343b5e9d7ba1058f32a08341d9be9f4a" level="file">
        <did>
          <unittitle>TML, 38-17 - Advice for Travelers</unittitle>
          <unitdate type="inclusive">1996 March 15</unitdate>
          <container id="c8157823c716ca05b8a01f7cc2a2ea76" label="Mixed Materials (A0000000075850)" type="box">7</container>
          <container id="8ff23c276e536b45c64747f4cbd8b435" parent="c8157823c716ca05b8a01f7cc2a2ea76" type="folder">14-16</container>
        </did>
        <accessrestrict id="c3bea7a676bd5b9981068ccf42242297">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="314ebfe0a12d0bad31002df2bbabf782" level="file">
        <did>
          <unittitle>TML, 37-98 - Influenza Vaccine, 1995-1996</unittitle>
          <unitdate type="inclusive">1995 September 1</unitdate>
          <container id="c27c9cad8e6c3c61b91676fd70e2f514" label="Mixed Materials (A0000000075850)" type="box">7</container>
          <container id="c3d6a86952c6b92ef4e005e24deb91af" parent="c27c9cad8e6c3c61b91676fd70e2f514" type="folder">17</container>
        </did>
        <accessrestrict id="aaa5f55ecc1b4da36b3c2d152b9841b0">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="fa30b8e25d30bd60ee7b9207731748dd" level="file">
        <did>
          <unittitle>TML, 38-86 - Influenza Vaccine, 1996-1997</unittitle>
          <unitdate type="inclusive">1996 September 13</unitdate>
          <container id="8415e09163b83a39be0247ee71d8a7ae" label="Mixed Materials (A0000000075850)" type="box">7</container>
          <container id="09c85b299e5bf9422ffa6c7511d72fc0" parent="8415e09163b83a39be0247ee71d8a7ae" type="folder">18</container>
        </did>
        <accessrestrict id="5726a4d76a933c3152d68d2618f96f58">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="76dcb6a56a7b5f83636afb906304e3de" level="file">
        <did>
          <unittitle>TML, 38-59 - Oral hypnotic drugs</unittitle>
          <unitdate type="inclusive">1996 July 5</unitdate>
          <container id="e4360ccc6a0a5239c23666795fd1c1b7" label="Mixed Materials (A0000000075850)" type="box">7</container>
          <container id="b2e1b10b89c1c76be52e740ea17420f4" parent="e4360ccc6a0a5239c23666795fd1c1b7" type="folder">19</container>
        </did>
        <accessrestrict id="c85f0b8357c82829d2a4eb5e651846cc">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="bcfc06fa9fa8a02872f2c29e1146f46b" level="file">
        <did>
          <unittitle>TML, 38-59 - Oral hypnotic drugs</unittitle>
          <unitdate type="inclusive">1996 July 5</unitdate>
          <container id="5c7d723e59d18e993c40d22c9559ee43" label="Mixed Materials (A0000000075851)" type="box">8</container>
          <container id="708abd083e452f3044b6bdc580698f3b" parent="5c7d723e59d18e993c40d22c9559ee43" type="folder">1-4</container>
        </did>
        <accessrestrict id="5afb2bc4dd74607653137719b41bcbd1">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="ca2a00af5d69b29922032ebf4abb0fa9" level="file">
        <did>
          <unittitle>TML, 38-63 - Interferon beta IA for relapsing multiple sclerosis</unittitle>
          <unitdate type="inclusive">1996 July 19</unitdate>
          <container id="95ba7091d58e31fecb32f2da57bd71d8" label="Mixed Materials (A0000000075851)" type="box">8</container>
          <container id="7d33355603a6e4dfd2e069c907adc3eb" parent="95ba7091d58e31fecb32f2da57bd71d8" type="folder">5-6</container>
        </did>
        <accessrestrict id="03343319e99b7f0ef24a7fc83ce57bad">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="c90350a57c09afa4b1edf8990faf82c4" level="file">
        <did>
          <unittitle>TML, 38-5 - Intraconazole for onychomycosis</unittitle>
          <unitdate type="inclusive">1996 January 19</unitdate>
          <container id="a37ac4af584113d1e36c0a7c18567aeb" label="Mixed Materials (A0000000075851)" type="box">8</container>
          <container id="e6d15828dbc9ccfb12f49bbf3479ee6e" parent="a37ac4af584113d1e36c0a7c18567aeb" type="folder">7-10</container>
        </did>
        <accessrestrict id="a3ae42f0dfac2f6884835c0dd4cbe74b">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="838bd206e5b57f1350c9a04ae42f2583" level="file">
        <did>
          <unittitle>TML, 38-100 - Latanoprost - A topical prostaglandin for glaucoma</unittitle>
          <unitdate type="inclusive">1996 November 8</unitdate>
          <container id="429b84d8f3cdc247053abd87e2a98969" label="Mixed Materials (A0000000075851)" type="box">8</container>
          <container id="226e6be52bd17de994cb35261e3cb552" parent="429b84d8f3cdc247053abd87e2a98969" type="folder">11-14</container>
        </did>
        <accessrestrict id="2e48e9ac6a735700c373ee378f599caa">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="45a205e5a189cb71c6708535b75c4937" level="file">
        <did>
          <unittitle>TML, 38-97 - Lispro - A rapid onset insulin</unittitle>
          <unitdate type="inclusive">1996 October 25</unitdate>
          <container id="1d952520de64e475d4f5712334755bfc" label="Mixed Materials (A0000000075851)" type="box">8</container>
          <container id="85da3db429001eefbfea296b57f1e00e" parent="1d952520de64e475d4f5712334755bfc" type="folder">15-16</container>
        </did>
        <accessrestrict id="0c7d5401af543b0c0983defbe212a6e4">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="2cbe2967f283fa20d7d713e0125238d8" level="file">
        <did>
          <unittitle>TML - HAT</unittitle>
          <unitdate type="inclusive">1996</unitdate>
          <container id="d8663f625c2bee884449328366a3e7b6" label="Mixed Materials (A0000000075851)" type="box">8</container>
          <container id="d8c3c517f18c2de399ebc51d4ca598f8" parent="d8663f625c2bee884449328366a3e7b6" type="folder">17-18</container>
        </did>
        <accessrestrict id="25976cdf1f32d7fc8a1e78cb2f48d34d">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="f7093bc2141bbd10998f3dc5ff41875b" level="file">
        <did>
          <unittitle>TML - HAT</unittitle>
          <unitdate type="inclusive">1996</unitdate>
          <container id="562d689723db527d166abed5d071b4fc" label="Mixed Materials (A0000000075852)" type="box">9</container>
          <container id="30c0408be2298f9e52c740ec29c72a46" parent="562d689723db527d166abed5d071b4fc" type="folder">1-3</container>
        </did>
        <accessrestrict id="5de98fca91cbe16591ff580840223c8c">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="e7f67d0b2048a576bdc2a8c6ef1f5674" level="file">
        <did>
          <unittitle>TML, 38-13 - Nisoldipine - a new calcium-channel blocker for hypertension</unittitle>
          <unitdate type="inclusive">1996 February 16</unitdate>
          <container id="e274b6412c2dd0b026fa156b0b8158cc" label="Mixed Materials (A0000000075852)" type="box">9</container>
          <container id="9a2cc1e393f24bef4c73ead79f94827d" parent="e274b6412c2dd0b026fa156b0b8158cc" type="folder">4-7</container>
        </did>
        <accessrestrict id="310f0f0a8b17bda4d5be0d11e8e3909a">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="0ab086d0742f0a6f31a054d358cbefcf" level="file">
        <did>
          <unittitle>TML, 35-62 - Nedocromil for asthma</unittitle>
          <unitdate type="inclusive">1993 July 9</unitdate>
          <container id="e2bde38620086104df94902f5fefc4da" label="Mixed Materials (A0000000075852)" type="box">9</container>
          <container id="4f2580a507419a54e651cffd1cda5657" parent="e2bde38620086104df94902f5fefc4da" type="folder">8-12</container>
        </did>
        <accessrestrict id="d876b6e0e035d2d97ee9711f878a831c">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="9f3042b173404cf6a3ccd9df900d20c0" level="file">
        <did>
          <unittitle>TML, 38-1 - New drugs for osteoporosis</unittitle>
          <unitdate type="inclusive">1996 January 5</unitdate>
          <container id="4c9489a662fd45538de5edb24d1ccdb5" label="Mixed Materials (A0000000075852)" type="box">9</container>
          <container id="1d84163bd40544e0b6e470d398d55abf" parent="4c9489a662fd45538de5edb24d1ccdb5" type="folder">13-18</container>
        </did>
        <accessrestrict id="059f4c0e348f3f79f9eac8942a1b7673">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="e20404fc9c2c5857d90b819cb9c70cc0" level="file">
        <did>
          <unittitle>TML, 38-53 - Prostatron</unittitle>
          <unitdate type="inclusive">1996 June 7</unitdate>
          <container id="3b6e2db0c2b068b51319a483e5b12e5b" label="Mixed Materials (A0000000075852)" type="box">9</container>
          <container id="ebadf3794bb4d75024f02e97deba3ee9" parent="3b6e2db0c2b068b51319a483e5b12e5b" type="folder">19-20</container>
        </did>
        <accessrestrict id="fa8555c81ed0ff184e52c7e939db327c">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="cbfa8d04b93b4e3d89a843bbf9e3d7f8" level="file">
        <did>
          <unittitle>TML, 38-107 - Pallidotomy for Parkinson's Disease</unittitle>
          <unitdate type="inclusive">1996 December 6</unitdate>
          <container id="8d905e3da2fbb33445dfcbab08affe84" label="Mixed Materials (A0000000075853)" type="box">10</container>
          <container id="d34b6765f60a7d4b4b6145744e99420b" parent="8d905e3da2fbb33445dfcbab08affe84" type="folder">1-3</container>
        </did>
        <accessrestrict id="6ec525e7fd9b38dcd1bce23ad46d101c">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="c1416d4fc58c7899cbc27ca73d15c172" level="file">
        <did>
          <unittitle>TML, 38-57 - Simethicone for gastrointestinal gas</unittitle>
          <unitdate type="inclusive">1996 June 21</unitdate>
          <container id="4cd06e21e1ce6d892f7eb70d08a7f6a8" label="Mixed Materials (A0000000075853)" type="box">10</container>
          <container id="b346f54088282ab6f39dff6661389b6a" parent="4cd06e21e1ce6d892f7eb70d08a7f6a8" type="folder">4-5</container>
        </did>
        <accessrestrict id="76d78aedee8d1ddf219a07affe27bb10">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="26af25957e59124a08f91eba499fc700" level="file">
        <did>
          <unittitle>TML, 38-106 - Sodium Phenylbutyrate for urea cycle enzyme deficiencies</unittitle>
          <unitdate type="inclusive">1996 November 22</unitdate>
          <container id="beb47b1a732efd5da9e85c788abb855d" label="Mixed Materials (A0000000075853)" type="box">10</container>
          <container id="f82275a10304000da35500bc496f1227" parent="beb47b1a732efd5da9e85c788abb855d" type="folder">6-7</container>
        </did>
        <accessrestrict id="8f55e867e223cf7fc8c205180e5bb1b9">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="4273a72d699f99aeabfcab12d5bde513" level="file">
        <did>
          <unittitle>TML, 38-72 - Terabinafine for onychomycosis</unittitle>
          <unitdate type="inclusive">1996 August 16</unitdate>
          <container id="43561d219eb6bf56954b7bdecc78bccc" label="Mixed Materials (A0000000075853)" type="box">10</container>
          <container id="362667c4a6b9bfc6f35e5f635bc01bdd" parent="43561d219eb6bf56954b7bdecc78bccc" type="folder">8-11</container>
        </did>
        <accessrestrict id="f99d89a3af0b743be45c7d543c9a47b3">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="afa8fcead3849c57e46148fac07fdf16" level="file">
        <did>
          <unittitle>TML, 38-49 - Androderm (Testosterone patches)</unittitle>
          <unitdate type="inclusive">1996 May 24</unitdate>
          <container id="878fc18fb36ac2f751ebd0475e686f66" label="Mixed Materials (A0000000075853)" type="box">10</container>
          <container id="cce864207c8362be22e7a2454fc7ec7b" parent="878fc18fb36ac2f751ebd0475e686f66" type="folder">12-15</container>
        </did>
        <accessrestrict id="6c9daad633f6ca6f23f9cb9675ec5725">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="e83fc33c009862fb85873ce44225451e" level="file">
        <did>
          <unittitle>TML, 38-96 - Toptecan hydrochloride for metastic ovarian cancer</unittitle>
          <unitdate type="inclusive">1996 October 25</unitdate>
          <container id="1f193149ce1af67da9b8424bb0c83736" label="Mixed Materials (A0000000075853)" type="box">10</container>
          <container id="4283cd782bf5e3749e2af7d405615482" parent="1f193149ce1af67da9b8424bb0c83736" type="folder">16-18</container>
        </did>
        <accessrestrict id="f4f4ca0b76dee28258679841660c3e53">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="1d1e2499f47a2c5a2498c508251c060e" level="file">
        <did>
          <unittitle>TML, 38-3 - Valacyclovir</unittitle>
          <unitdate type="inclusive">1996 January 5</unitdate>
          <container id="3e71148d8b61fa1240c87051d5435d16" label="Mixed Materials (A0000000075853)" type="box">10</container>
          <container id="b15d9fea0b46ed38050f989f8f413919" parent="3e71148d8b61fa1240c87051d5435d16" type="folder">19</container>
        </did>
        <accessrestrict id="5e026f0f926c42121383574e48a743ca">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="e3cd99c272218799e02c72a5e28f33c9" level="file">
        <did>
          <unittitle>TML, 38-3 - Valacyclovir</unittitle>
          <unitdate type="inclusive">1996 January 5</unitdate>
          <container id="3bfd0ac35215bd6391dd641c14331afb" label="Mixed Materials (A0000000075946)" type="box">11</container>
          <container id="ea6183d6ad356c3d5ca911afdb79e0f6" parent="3bfd0ac35215bd6391dd641c14331afb" type="folder">1-2</container>
        </did>
        <accessrestrict id="ed67782a99870c0e712a42cf95c5cfc7">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="2146f075bfb01adf0c99fddbe6268b26" level="file">
        <did>
          <unittitle>TML, 38-104 - Trandolapril - An ACE inhibitor for treatment of hypertension</unittitle>
          <unitdate type="inclusive">1996 November 22</unitdate>
          <container id="41656bda0950b7990890e976dd26a775" label="Mixed Materials (A0000000075946)" type="box">11</container>
          <container id="68a4019ddca6e3a404c75851fef77974" parent="41656bda0950b7990890e976dd26a775" type="folder">3-5</container>
        </did>
        <accessrestrict id="a1dd4aa7256167e609397b035b7478d7">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="7a2f268994b16b4876604d64167ade0b" level="file">
        <did>
          <unittitle>TML, 38-71 - Umbilical cord blood for bone marrow transplantation</unittitle>
          <unitdate type="inclusive">1996 August 16</unitdate>
          <container id="b3a99b99605557a5786f944c31f71d3a" label="Mixed Materials (A0000000075946)" type="box">11</container>
          <container id="770289aba609dad71ec2d0259cc11aab" parent="b3a99b99605557a5786f944c31f71d3a" type="folder">6-8</container>
        </did>
        <accessrestrict id="c284795ebfbae6dd142f49e2c3d64449">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="c7fa6ad1765f84becedf7fbe8dae1981" level="file">
        <did>
          <unittitle>TML, 38-51 - Clarithromycine and omeprazole of helliobacter pylori</unittitle>
          <unitdate type="inclusive">1996 June 7</unitdate>
          <container id="a9d256f175e196472f1d8c2edef75e1c" label="Mixed Materials (A0000000075946)" type="box">11</container>
          <container id="273ea48263dfdb7fa69deff060581114" parent="a9d256f175e196472f1d8c2edef75e1c" type="folder">9-11</container>
        </did>
        <accessrestrict id="d93e4e485f03621de43519409ecd0ebb">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="d2847f832cf8b7dfa8bae10d4079561b" level="file">
        <did>
          <unittitle>TML, 38-15 - New Uses of Thalidomide</unittitle>
          <unitdate type="inclusive">1996 February 16</unitdate>
          <container id="0343f653db925fa54f27e3cd1c5a142a" label="Mixed Materials (A0000000075946)" type="box">11</container>
          <container id="0baecb578736c27f4ad1fded3a48af5e" parent="0343f653db925fa54f27e3cd1c5a142a" type="folder">12-14</container>
        </did>
        <accessrestrict id="5a934c0b2b5e5cf25f836a73de95c999">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="07f911d357717fedb196ba2a95b08c6f" level="file">
        <did>
          <unittitle>TML - Antiviral drugs - Viral Infections (Non-HIV) Handbook</unittitle>
          <unitdate type="inclusive">1996</unitdate>
          <container id="5a42103724c506495dc6051547f7db5b" label="Mixed Materials (A0000000075946)" type="box">11</container>
          <container id="6a9be1f9a68ac336e230512812b3a54c" parent="5a42103724c506495dc6051547f7db5b" type="folder">15-19</container>
        </did>
        <accessrestrict id="7ad69902cf7b5b84adb8b1470b88ef97">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="c0d2ae8c9a59eb2afc81bad688a8e0d9" level="file">
        <did>
          <unittitle>TML - Antiviral drugs - Viral Infections (Non-HIV) Handbook</unittitle>
          <unitdate type="inclusive">1996</unitdate>
          <container id="506a68107afec28b712240b8bbb466bb" label="Mixed Materials (A0000000075854)" type="box">12</container>
          <container id="12e418819d1a594e3322f7a2639839fa" parent="506a68107afec28b712240b8bbb466bb" type="folder">1-2</container>
        </did>
        <accessrestrict id="42570c5418d18c7d11e5ecb6d56fc38d">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="0d91fc0adca0e054072c6a3fff1ac1f6" level="file">
        <did>
          <unittitle>TML, 38-65 - Drugs past their expiration date</unittitle>
          <unitdate type="inclusive">1996 July 19</unitdate>
          <container id="68a9982ec820d589b809ca2db48ee5ef" label="Mixed Materials (A0000000075854)" type="box">12</container>
          <container id="0d9161720d649369df882132ca85ffe6" parent="68a9982ec820d589b809ca2db48ee5ef" type="folder">3-4</container>
        </did>
        <accessrestrict id="861175c1c60e1d08ff94909fca12e380">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="b6e8488842fc6d3ed56539b8c5e7c344" level="file">
        <did>
          <unittitle>TML, 38-38 - Ibutilide</unittitle>
          <unitdate type="inclusive">1996 April 12</unitdate>
          <container id="a0498ee44434e9c698b752d393d54720" label="Mixed Materials (A0000000075854)" type="box">12</container>
          <container id="61ad8ac36796bb7b8d3828e5227c2f5b" parent="a0498ee44434e9c698b752d393d54720" type="folder">5-6</container>
        </did>
        <accessrestrict id="d854aa1bc446941f011a8970567a2b37">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="93c5ceb8486269a6440d4a1164bd8a19" level="file">
        <did>
          <unittitle>TML, 38-91 - DHEA</unittitle>
          <unitdate type="inclusive">1996 October 11</unitdate>
          <container id="8c23a176d96f39d80aa637b7333b6ea4" label="Mixed Materials (A0000000075854)" type="box">12</container>
          <container id="df092884d5f8662430e27e0286c4605b" parent="8c23a176d96f39d80aa637b7333b6ea4" type="folder">7-9</container>
        </did>
        <accessrestrict id="0b753cb331038a0a1193ae254361f43e">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="489aaa51c24f7c3822366d6381860b83" level="file">
        <did>
          <unittitle>TML, 38-88 - Meropenem - A new parenteral broad-spectrum antibiotic</unittitle>
          <unitdate type="inclusive">1996 September 27</unitdate>
          <container id="e555b28605e55ce92b1f401692a03128" label="Mixed Materials (A0000000075854)" type="box">12</container>
          <container id="a9eb4bdfad1b96a03445e917ac0b4fb9" parent="e555b28605e55ce92b1f401692a03128" type="folder">10-14</container>
        </did>
        <accessrestrict id="06a4c2f05bc64d8b4ee6a3b07e593fe9">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="3a54f51aec4a83bee985f1670be2aff6" level="file">
        <did>
          <unittitle>TML, 38-39 - Methotrexate and Misoprostol for abortion</unittitle>
          <unitdate type="inclusive">1996 April 26</unitdate>
          <container id="f3c1eb08cb1fe6e7249adf41b601e9c6" label="Mixed Materials (A0000000075854)" type="box">12</container>
          <container id="b97b7ca91dc5f205422db253dbd1df60" parent="f3c1eb08cb1fe6e7249adf41b601e9c6" type="folder">15</container>
        </did>
        <accessrestrict id="6b3edef9531f4a2fde2d3628c5d7cdd0">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="43193a32312eb0204d12fd64fa6b6993" level="file">
        <did>
          <unittitle>TML, 38-111 - Zafirlukast for asthma</unittitle>
          <unitdate type="inclusive">1996 December 20</unitdate>
          <container id="4f0dacf22fbb50ea7dfc775860dc454f" label="Mixed Materials (A0000000075854)" type="box">12</container>
          <container id="7cf366601b751c25a64e19c608822031" parent="4f0dacf22fbb50ea7dfc775860dc454f" type="folder">16-18</container>
        </did>
        <accessrestrict id="13e892949bbc4a48ce8c4285b3b1007e">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="49b7007dcadc3c636c88f299dc526e0d" level="file">
        <did>
          <unittitle>TML, 31-83 - Samarium 153 lexidronam for painful bone metastases</unittitle>
          <unitdate type="inclusive">1997 August 29</unitdate>
          <container id="2119d49e0cb41cbb9daab8c5f2b6975e" label="Mixed Materials (A0000000075855)" type="box">13</container>
          <container id="6fef315ef29380b606a40a9a3ae44a75" parent="2119d49e0cb41cbb9daab8c5f2b6975e" type="folder">1-3</container>
        </did>
        <accessrestrict id="592e1bece31e2f3f6b5ae1b6e1a8011e">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="61b0c640e3f013a34c64133724020fa2" level="file">
        <did>
          <unittitle>TML, 38-69 - Drugs for non-HIV viral infections</unittitle>
          <unitdate type="inclusive">1997 August 1</unitdate>
          <container id="01ff6503718658b9448af0a28902e9c2" label="Mixed Materials (A0000000075855)" type="box">13</container>
          <container id="ced6ed6a2a9914445d1f12615a61e662" parent="01ff6503718658b9448af0a28902e9c2" type="folder">4-12</container>
        </did>
        <accessrestrict id="84c4988675afd57f7b095139aa7bfdfe">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="133977107f40fa3272c401b7abcc89de" level="file">
        <did>
          <unittitle>TML, 39-18 - Zileuton for asthma</unittitle>
          <unitdate type="inclusive">1997 February 28</unitdate>
          <container id="12a9798fb81776dfc03fe1b35b262689" label="Mixed Materials (A0000000075855)" type="box">13</container>
          <container id="9469ee9de8f709cd652f2cd821c9329d" parent="12a9798fb81776dfc03fe1b35b262689" type="folder">13-14</container>
        </did>
        <accessrestrict id="4717fa288dd120e806e05499350ddf6f">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="be46a606b805462c6cc03b6ec8b2c39e" level="file">
        <did>
          <unittitle>TML, 39-9 - Zinc for the common cold</unittitle>
          <unitdate type="inclusive">1997 January 31</unitdate>
          <container id="10306c4e175f67f6fa43e8aaf616a48a" label="Mixed Materials (A0000000075855)" type="box">13</container>
          <container id="4c36ee03b89184f33bb8808c5226228c" parent="10306c4e175f67f6fa43e8aaf616a48a" type="folder">15-17</container>
        </did>
        <accessrestrict id="ad1088be46d6652eb0405e32258a0bf9">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="1a7499e6fbd604c0b75b6d778dc5c0f9" level="file">
        <did>
          <unittitle>TML, 39-78 - Topical drugs for aging skin</unittitle>
          <unitdate type="inclusive">1997 August 15</unitdate>
          <container id="8cfc8aeeb6383bfcafbbc0c770e9a5d9" label="Mixed Materials (A0000000075855)" type="box">13</container>
          <container id="a8f1c5575735d8ff0ba6330055ed097b" parent="8cfc8aeeb6383bfcafbbc0c770e9a5d9" type="folder">18-20</container>
        </did>
        <accessrestrict id="ebe0ac100a42ac94570bd02c0e0ccdbb">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="c3fee2e8cf6e2d58695098807e086dab" level="file">
        <did>
          <unittitle>TML, 39-78 - Topical drugs for aging skin</unittitle>
          <unitdate type="inclusive">1997 August 15</unitdate>
          <container id="0320c852460e5e91a3be526b304bab85" label="Mixed Materials (A0000000075856)" type="box">14</container>
          <container id="98c464bfd64a50ca1b1ace41885ee166" parent="0320c852460e5e91a3be526b304bab85" type="folder">1</container>
        </did>
        <accessrestrict id="898d939f278bc6e6c335eb092f07c5a8">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="393de6e6b75d4f4817695af30349dd68" level="file">
        <did>
          <unittitle>TML, 39-80 - Ropivocaine - a new local anesthetic</unittitle>
          <unitdate type="inclusive">1997 August 15</unitdate>
          <container id="a2e31a75b34c165df25db9f9b5273175" label="Mixed Materials (A0000000075856)" type="box">14</container>
          <container id="9b9a2ed46237e317cb0d77a242988b19" parent="a2e31a75b34c165df25db9f9b5273175" type="folder">2-4</container>
        </did>
        <accessrestrict id="7af0a96e2cfe06eaffa6999f5bfd2c77">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="4be741eb1bacb7f18527f5b2df647302" level="file">
        <did>
          <unittitle>TML, 39-41 - Levofloxacin and sparfloxacin</unittitle>
          <unitdate type="inclusive">1997 April 25</unitdate>
          <container id="dc56eaf78abc38dd484c5a1dd6373471" label="Mixed Materials (A0000000075856)" type="box">14</container>
          <container id="79fd5f438c8ff030e07211b1d4b8cdc0" parent="dc56eaf78abc38dd484c5a1dd6373471" type="folder">5-10</container>
        </did>
        <accessrestrict id="7550d2d00d3b056285daa384c568544b">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="b81fc7aadd5fecc407e846095655da0e" level="file">
        <did>
          <unittitle>TML, 39-10 - Lasers in dermatologic surgery</unittitle>
          <unitdate type="inclusive">1997 January 31</unitdate>
          <container id="1716e3bdd1a7c8a9bee26b591a51d7e5" label="Mixed Materials (A0000000075856)" type="box">14</container>
          <container id="48eb5c9574d294f367a929d97a3bbc8f" parent="1716e3bdd1a7c8a9bee26b591a51d7e5" type="folder">11-15</container>
        </did>
        <accessrestrict id="0f1f31dc544a7820b6b3740572840e2c">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="d6a872b6263ad2beca76d2809d741c78" level="file">
        <did>
          <unittitle>TML, 39-84 - Skin surgery with lasers - an additional note</unittitle>
          <unitdate type="inclusive">1997 August 29</unitdate>
          <container id="d50d8b32aa047591fa6775cf0474813d" label="Mixed Materials (A0000000075856)" type="box">14</container>
          <container id="854818c123c8662074abdad12ec9d818" parent="d50d8b32aa047591fa6775cf0474813d" type="folder">16</container>
        </did>
        <accessrestrict id="37b13c54d0d04ba5299304f96256cfc0">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="62572ae54e7b47c32783a5b7f9f92261" level="file">
        <did>
          <unittitle>TML, 39-51 - Topiramate for epilepsy</unittitle>
          <unitdate type="inclusive">1997 May 23</unitdate>
          <container id="f92741cbef3093b9f4fa575858264665" label="Mixed Materials (A0000000075856)" type="box">14</container>
          <container id="3415af6fd98e9c423ddd636ee3a2e6c1" parent="f92741cbef3093b9f4fa575858264665" type="folder">17-19</container>
        </did>
        <accessrestrict id="1f453b72cb65c772c8bbcb8b965fc251">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="bbfc9de7adb6df0701f6173947f38bd2" level="file">
        <did>
          <unittitle>TML, 39-96 - Tamsulosin for prostatic benign hyperplasis</unittitle>
          <unitdate type="inclusive">1997 October 10</unitdate>
          <container id="d9104e6a0a0a9d2210ded2bcb2202d72" label="Mixed Materials (A0000000075856)" type="box">14</container>
          <container id="fa049445e969d641cec803bd43a8eb47" parent="d9104e6a0a0a9d2210ded2bcb2202d72" type="folder">20</container>
        </did>
        <accessrestrict id="63c006cdd8a94fd253916b0a5c2fcbfc">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="6b378b12b2f16c81d85d36343d81a41b" level="file">
        <did>
          <unittitle>TML, 39-96 - Tamsulosin for prostatic benign hyperplasis</unittitle>
          <unitdate type="inclusive">1997 October 10</unitdate>
          <container id="1050eceeffc1103e45b7614b52dd7630" label="Mixed Materials (A0000000075857)" type="box">15</container>
          <container id="5d06d525160e7c2a7ae4b929386b51af" parent="1050eceeffc1103e45b7614b52dd7630" type="folder">1-2</container>
        </did>
        <accessrestrict id="62290c3388efd25a1b03329c60a4c2c5">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="bf256a51de793456a4c7d083f141288c" level="file">
        <did>
          <unittitle>TML, 39-65 - Tiludronate for Paget's disease of bone</unittitle>
          <unitdate type="inclusive">1997 July 18</unitdate>
          <container id="9f58958f54b759ab87a901eb29f20fd7" label="Mixed Materials (A0000000075857)" type="box">15</container>
          <container id="d04424a5e0f5ed5308f08445ebac1708" parent="9f58958f54b759ab87a901eb29f20fd7" type="folder">3-5</container>
        </did>
        <accessrestrict id="a0af36cf2f0f39c3b6bf43a2f3d1a8f3">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="e50c791d98c44790d8141d27cd4cfcab" level="file">
        <did>
          <unittitle>TML, 39-62 - Tizanidine for spasticity</unittitle>
          <unitdate type="inclusive">1997 July 4</unitdate>
          <container id="33e7277c84fee3c79f35a7b185ffa480" label="Mixed Materials (A0000000075857)" type="box">15</container>
          <container id="83537fab778f508d9aafb10dc5ef9fff" parent="33e7277c84fee3c79f35a7b185ffa480" type="folder">6-8</container>
        </did>
        <accessrestrict id="264d6479c0b4544b7007e8c452a7cee5">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="12444cf584e83734f66bfc290040544a" level="file">
        <did>
          <unittitle>TML, 39-49 - Troglitazone for non-insulin-dependent diabetes mellitus</unittitle>
          <unitdate type="inclusive">1997 May 23</unitdate>
          <container id="12bda217464578c0e0dd7a49ea1facde" label="Mixed Materials (A0000000075857)" type="box">15</container>
          <container id="34f8953ba7a2f0132763a36b21223aef" parent="12bda217464578c0e0dd7a49ea1facde" type="folder">9-11</container>
        </did>
        <accessrestrict id="c2dbaf70c1400524b9601ade32d9aa09">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="64f0edfa5bd3b5159911a74e751d912b" level="file">
        <did>
          <unittitle>TML, 39-43 - Valsartan for hypertension</unittitle>
          <unitdate type="inclusive">1997 April 25</unitdate>
          <container id="2d81e26a23727adfc72c206aa641e9e3" label="Mixed Materials (A0000000075857)" type="box">15</container>
          <container id="41227870bea744c2cfc441c616e12072" parent="2d81e26a23727adfc72c206aa641e9e3" type="folder">12-14</container>
        </did>
        <accessrestrict id="d5a76faf4ca30d9de5137cfcad807f6e">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="eb014687998353d0fb60326357526127" level="file">
        <did>
          <unittitle>TML, 39-1 - Drugs for treatment of peptic ulcers</unittitle>
          <unitdate type="inclusive">1997 January 3</unitdate>
          <container id="e34559b35d9eceb3e0b3ddb0150c4e1a" label="Mixed Materials (A0000000075857)" type="box">15</container>
          <container id="4663fc83305f99bc04a72575d193104f" parent="e34559b35d9eceb3e0b3ddb0150c4e1a" type="folder">15-20</container>
        </did>
        <accessrestrict id="1fcec8ea591c0f4b6123d11e89e69ddb">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="3436a17eac9c6f31692eb5d354b51a44" level="file">
        <did>
          <unittitle>TML, 39-109 - Pramipexole and Ropinirole for Parkinson's disease</unittitle>
          <unitdate type="inclusive">1997 November 21</unitdate>
          <container id="4577edfb1dc10954e0418634279adcfa" label="Mixed Materials (A0000000075858)" type="box">16</container>
          <container id="c9eaac2fda4f21524db826a5493ac98b" parent="4577edfb1dc10954e0418634279adcfa" type="folder">1-4</container>
        </did>
        <accessrestrict id="9f23fe9c137d23133c2b5049c5b64530">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="ea94f0229ffb76d4e8a48dbf172eec36" level="file">
        <did>
          <unittitle>TML, 39-105 - New drugs for psoriasis</unittitle>
          <unitdate type="inclusive">1997 November 7</unitdate>
          <container id="95971584d79063a008348f2cec3a9872" label="Mixed Materials (A0000000075858)" type="box">16</container>
          <container id="572551809f279a6c362de0e8395eaeeb" parent="95971584d79063a008348f2cec3a9872" type="folder">5-8</container>
        </did>
        <accessrestrict id="d1471d567708b0ca9a5c6d93f5f254f0">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="12f50952f7ba8eb3afd7e492d332b4a1" level="file">
        <did>
          <unittitle>TML, 39-33 - New drugs for psychiatric disorders</unittitle>
          <unitdate type="inclusive">1997 April 11</unitdate>
          <container id="6b72b1fcbb5f4a92e4aa9dde6f91b1bf" label="Mixed Materials (A0000000075858)" type="box">16</container>
          <container id="85aed7a5bb3bb94eebe6f366dc97d87b" parent="6b72b1fcbb5f4a92e4aa9dde6f91b1bf" type="folder">9-15</container>
        </did>
        <accessrestrict id="dbaf4673299ed575f189876448054a58">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="123a71748e8ade20af228276bab2d8b6" level="file">
        <did>
          <unittitle>TML, 39-117 - Quetiapine for schizophrenia</unittitle>
          <unitdate type="inclusive">1997 December 19</unitdate>
          <container id="9d4d622d83e03d8f929752e45b1883d2" label="Mixed Materials (A0000000075858)" type="box">16</container>
          <container id="f8e46988a8dbc86e7ee25957252695da" parent="9d4d622d83e03d8f929752e45b1883d2" type="folder">16-18</container>
        </did>
        <accessrestrict id="8bbc739b2ed931419befe4ab8eb4eb63">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="498df0f2d9dce92679b2aa347629be3f" level="file">
        <did>
          <unittitle>TML, 39-17 - Reteplase (Retavase)</unittitle>
          <unitdate type="inclusive">1997 February 28</unitdate>
          <container id="9678487f7f29a718a85eeb8e4bcff0c3" label="Mixed Materials (A0000000075859)" type="box">17</container>
          <container id="61e1ecf7aba9a61e10b0e843002730a2" parent="9678487f7f29a718a85eeb8e4bcff0c3" type="folder">1-2</container>
        </did>
        <accessrestrict id="b2dca34162d6868414a816046edfdff2">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="6ba7d8b0dcb752d130b074f42b440dd7" level="file">
        <did>
          <unittitle>TML, 39-53 - Donepezil (Aricept) for Alzheimer's disease</unittitle>
          <unitdate type="inclusive">1997 June 6</unitdate>
          <container id="d474d3aa8fd9e30a690441a848966213" label="Mixed Materials (A0000000075859)" type="box">17</container>
          <container id="86ee5c727a3d21b21037599c11d232a3" parent="d474d3aa8fd9e30a690441a848966213" type="folder">3-5</container>
        </did>
        <accessrestrict id="6532d645696e8a65297e0563e103f695">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="7c2e04e9e7b332289a442e6977a1f7d9" level="file">
        <did>
          <unittitle>TML, 39-81 - Diagnostic tests for HIV</unittitle>
          <unitdate type="inclusive">1997 August 29</unitdate>
          <container id="1ccaf0df602be6dd6e3bbfa7d5d8f8bf" label="Mixed Materials (A0000000075859)" type="box">17</container>
          <container id="6deeb01063fe7151965e09a0d4d3bcdd" parent="1ccaf0df602be6dd6e3bbfa7d5d8f8bf" type="folder">6-10</container>
        </did>
        <accessrestrict id="9570ef3f38bf3a851322c3c3fb7d17cc">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="fdd2b028e08760f46ba2467c4b638924" level="file">
        <did>
          <unittitle>TML, 39-21 - Drugs of Choice - Cancer Chemotherapy</unittitle>
          <unitdate type="inclusive">1997 March 14</unitdate>
          <container id="78149147e618b1832610761eb9ffde43" label="Mixed Materials (A0000000075859)" type="box">17</container>
          <container id="cb46a8ba2c0ebaddc742a1777315b920" parent="78149147e618b1832610761eb9ffde43" type="folder">11-16</container>
        </did>
        <accessrestrict id="28f03f207bd6c378f505103883232f68">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="42935bf2b5b11b084838a1252d3b3db8" level="file">
        <did>
          <unittitle>TML, 39-77 - Bupropion for smoking cessation</unittitle>
          <unitdate type="inclusive">1997 August 15</unitdate>
          <container id="d1042943a16184edd7541730e80b2ed4" label="Mixed Materials (A0000000075859)" type="box">17</container>
          <container id="295e9ba4680674b9e77ed6b986de7b91" parent="d1042943a16184edd7541730e80b2ed4" type="folder">17</container>
        </did>
        <accessrestrict id="6c0f62c3539d7b57d8122eb2501ba830">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="be3b6c8f67d8d9c4ef7e3226b17983fb" level="file">
        <did>
          <unittitle>TML, 39-63 - Topical butenafine for tinea pedis</unittitle>
          <unitdate type="inclusive">1997 July 4</unitdate>
          <container id="f4a32a87e21e5f660b62595687bbc554" label="Mixed Materials (A0000000075860)" type="box">18</container>
          <container id="f3863da72489643203effa2a7ef2d697" parent="f4a32a87e21e5f660b62595687bbc554" type="folder">1-2</container>
        </did>
        <accessrestrict id="5cc6b055d5b6e621ab0c71131fdd66e2">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="856acb144bbba7a94b1cb63f73185f43" level="file">
        <did>
          <unittitle>TML, 39-56 - Pentosan</unittitle>
          <unitdate type="inclusive">1997 June 6</unitdate>
          <container id="769c1827241175578dfc039e7304e96d" label="Mixed Materials (A0000000075860)" type="box">18</container>
          <container id="4d5dec408f0241bbba2bc28292400f68" parent="769c1827241175578dfc039e7304e96d" type="folder">3-4</container>
        </did>
        <accessrestrict id="9279dfdd8fa0fb9cdb6e31006d0ff6a6">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="afd34d20934d1be77bfc49f4d1241183" level="file">
        <did>
          <unittitle>TML, 39-103 - Mibefradil - a new calcium-channel blocker</unittitle>
          <unitdate type="inclusive">1997 November 7</unitdate>
          <container id="36fced6c70679afa7b7e8ffd9b0282f9" label="Mixed Materials (A0000000075860)" type="box">18</container>
          <container id="1c947198430042273fd145ebbd4f221b" parent="36fced6c70679afa7b7e8ffd9b0282f9" type="folder">5-8</container>
        </did>
        <accessrestrict id="bc77a13d4a14fc45f23bfb7a5bb57c5d">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="de42e2f43ebae331da9c0b8180abb87c" level="file">
        <did>
          <unittitle>TML, 39-59 - Midodrine for orthostatic hypotension</unittitle>
          <unitdate type="inclusive">1997 June 20</unitdate>
          <container id="d7729ecdad9b49f346d5195b287de02b" label="Mixed Materials (A0000000075860)" type="box">18</container>
          <container id="818fbe21d0f4af0b4595e9064eab759a" parent="d7729ecdad9b49f346d5195b287de02b" type="folder">9-11</container>
        </did>
        <accessrestrict id="01d73c68e8dd39b1c0b73b6d7700c7a0">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="96ceef3812b648bc28698beed66c5d75" level="file">
        <did>
          <unittitle>TML, 39-47 - Treatment of Lyme disease</unittitle>
          <unitdate type="inclusive">1997 May 9</unitdate>
          <container id="6b0b7368113ca80e4c6ba0cb15b68241" label="Mixed Materials (A0000000075860)" type="box">18</container>
          <container id="138bb85e7d490a34cc8fd4ee543eabcc" parent="6b0b7368113ca80e4c6ba0cb15b68241" type="folder">12-14</container>
        </did>
        <accessrestrict id="1456685e80bfcccf0ad9c93511c65c4d">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="eaedccce6a322747a43e566f8dfc2b7d" level="file">
        <did>
          <unittitle>TML - Drugs of Choice</unittitle>
          <unitdate type="inclusive">1997</unitdate>
          <container id="9ade864ae329cb3d06dc94d8a395764e" label="Mixed Materials (A0000000075860)" type="box">18</container>
          <container id="f566ecccf1008d5fcea2585b7a8f7d56" parent="9ade864ae329cb3d06dc94d8a395764e" type="folder">15-17</container>
        </did>
        <accessrestrict id="640807ffbd5e5ea720da4f60f781a4b9">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="95b6682482a9d062317fcf262cc7f718" level="file">
        <did>
          <unittitle>TML, 39-85 - Influenza vaccine</unittitle>
          <unitdate type="inclusive">1997 September 12</unitdate>
          <container id="ca1304ec945e1299f74a45c9a73259ab" label="Mixed Materials (A0000000075860)" type="box">18</container>
          <container id="c45a6b03fa33502c9b5db179102c5fe0" parent="ca1304ec945e1299f74a45c9a73259ab" type="folder">18</container>
        </did>
        <accessrestrict id="bae55e07ca01b84992a5b395e88b6ccc">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="9c5534af6d0a227ae1ad47876c813383" level="file">
        <did>
          <unittitle>TML, 39-8 - Irinotecan for metastatic colorectal cancer</unittitle>
          <unitdate type="inclusive">1997 January 17</unitdate>
          <container id="eccb23a5d5aa10d4d229de9813c58a1c" label="Mixed Materials (A0000000075860)" type="box">18</container>
          <container id="32b6d257b38752be73c7270e7f44d7bd" parent="eccb23a5d5aa10d4d229de9813c58a1c" type="folder">19</container>
        </did>
        <accessrestrict id="071f86249d57b3a639f1f0ac1e82c1db">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="8d02c5507ec798ca4d7bb6188acc62a5" level="file">
        <did>
          <unittitle>TML, 39-8 - Irinotecan for metastatic colorectal cancer</unittitle>
          <unitdate type="inclusive">1997 January 17</unitdate>
          <container id="edf1306101a396d82718e3f9266fe4a3" label="Mixed Materials (A0000000075861)" type="box">19</container>
          <container id="650ed01385781f8260210ff698363c1a" parent="edf1306101a396d82718e3f9266fe4a3" type="folder">1</container>
        </did>
        <accessrestrict id="36454ffdeab70b1b39646403fa3b2960">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="0cdb2a091afd3228142c89eb37d2380a" level="file">
        <did>
          <unittitle>TML, 39-118 - Imiquimod for genital warts</unittitle>
          <unitdate type="inclusive">1997 December 19</unitdate>
          <container id="84d4941bab15d264bd52c5201df57a7a" label="Mixed Materials (A0000000075861)" type="box">19</container>
          <container id="602831e0fe876136ef6cae4fe57b1efe" parent="84d4941bab15d264bd52c5201df57a7a" type="folder">2-3</container>
        </did>
        <accessrestrict id="d975c63ad23263fd275260f9460dcf1e">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="f4d2ffb826a588ff6c493adbd06a92be" level="file">
        <did>
          <unittitle>TML, 39-64 - Drugs for epilepsy</unittitle>
          <unitdate type="inclusive">1997 February 6</unitdate>
          <container id="d3e870370a696400ae0450b10bf161c6" label="Mixed Materials (A0000000075861)" type="box">19</container>
          <container id="06de95430bb5e6b01272c16ffb2ab264" parent="d3e870370a696400ae0450b10bf161c6" type="folder">4-6</container>
        </did>
        <accessrestrict id="c20b70cbd97aa855e62537fb259a09f6">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="028b89ba84e332c879eab9899c191875" level="file">
        <did>
          <unittitle>TML, 39-66 - Fosfomycin for urinary tract infections</unittitle>
          <unitdate type="inclusive">1997 July 18</unitdate>
          <container id="30863d60fa61f6890f1ac459ebf00045" label="Mixed Materials (A0000000075861)" type="box">19</container>
          <container id="9ac52fa67361d139e924ee099aaf8051" parent="30863d60fa61f6890f1ac459ebf00045" type="folder">7-9</container>
        </did>
        <accessrestrict id="e0aa9d9341298313dcd22b6a4157d3bc">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="73ee7f93d0af26d64d0c1fc7ba0c7201" level="file">
        <did>
          <unittitle>TML, 39-86 - Systemic antifungal drugs</unittitle>
          <unitdate type="inclusive">1997 September 12</unitdate>
          <container id="768e81a41a221110c2f19ddfa1fdbbb3" label="Mixed Materials (A0000000075861)" type="box">19</container>
          <container id="8d5ff99e607db305ee1f822c5bd686b5" parent="768e81a41a221110c2f19ddfa1fdbbb3" type="folder">10-13</container>
        </did>
        <accessrestrict id="226ecab6ab43654c9c5dd63a5e3e2b52">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="6bf77dfe11efd36cf8146b826560cb4c" level="file">
        <did>
          <unittitle>TML, 39-61 - Glatiramer acetate for relapsing mutiple sclerosis</unittitle>
          <unitdate type="inclusive">1997 July 4</unitdate>
          <container id="f2fb38468551f1bb5eca831f9953c1dc" label="Mixed Materials (A0000000075861)" type="box">19</container>
          <container id="d8d22c0de103880fa46222a5642161e1" parent="f2fb38468551f1bb5eca831f9953c1dc" type="folder">14-16</container>
        </did>
        <accessrestrict id="58267fbb42c582dd03ac8830411c1803">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="f36ff800dacbd73013d42dab42cf5f5b" level="file">
        <did>
          <unittitle>TML, 38-6 - Drugs for head lice</unittitle>
          <unitdate type="inclusive">1997 January 17</unitdate>
          <container id="1387b347ed76aabab323ec402e5efc0d" label="Mixed Materials (A0000000075861)" type="box">19</container>
          <container id="1bb85e11d3bd3b3b3b3ac58c9b0ac4ec" parent="1387b347ed76aabab323ec402e5efc0d" type="folder">17-18</container>
        </did>
        <accessrestrict id="92296119b0cbe67e59973a003090f421">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="e13f3fa0ec576057f7033815a81111e1" level="file">
        <did>
          <unittitle>TML, 39-91 - Glucosamine for osteoarthritis</unittitle>
          <unitdate type="inclusive">1997 September 26</unitdate>
          <container id="173a731a29c333b0bbd9141c29aad7fc" label="Mixed Materials (A0000000075861)" type="box">19</container>
          <container id="c2b0dab3bc60375a206aee98e5bef245" parent="173a731a29c333b0bbd9141c29aad7fc" type="folder">19-20</container>
        </did>
        <accessrestrict id="e7cb03a6203eb58d2833529692c66d60">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="dfc2de9cdb5bf3a8437e564fa717ffbd" level="file">
        <did>
          <unittitle>TML, 39-91 - Glucosamine for osteoarthritis</unittitle>
          <unitdate type="inclusive">1997 September 26</unitdate>
          <container id="c243fffb14bea7e376d2ded4d806a3a4" label="Mixed Materials (A0000000075862)" type="box">20</container>
          <container id="88213c338cd9054858ae4c65c4b3f718" parent="c243fffb14bea7e376d2ded4d806a3a4" type="folder">1-2</container>
        </did>
        <accessrestrict id="d913972842d3a79acf9b906df7f951e7">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="95d8be151e4ef26242db019df375f791" level="file">
        <did>
          <unittitle>TML, 39-94 - Drugs for hypertension</unittitle>
          <unitdate type="inclusive">1997 November 1</unitdate>
          <container id="aae8f8145d0d38b52d368e61a8db6717" label="Mixed Materials (A0000000075862)" type="box">20</container>
          <container id="722cae57c2de3776930c6db5d2680ec3" parent="aae8f8145d0d38b52d368e61a8db6717" type="folder">3-5</container>
        </did>
        <accessrestrict id="2db96bdb2ad3f2367bdf1559b5ea1133">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="f8696aa81da52173ff18b97bd7eb4067" level="file">
        <did>
          <unittitle>TML, 39-19 - Adapalene for acne</unittitle>
          <unitdate type="inclusive">1997 February 28</unitdate>
          <container id="805f0410a922a838e07e90817f9d2171" label="Mixed Materials (A0000000075862)" type="box">20</container>
          <container id="a9bf44115e7ce99bda927b77f5b2af05" parent="805f0410a922a838e07e90817f9d2171" type="folder">6-7</container>
        </did>
        <accessrestrict id="cefd2ab82f2cd38f2cef5b4253fea1fb">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="d3c8f38c2b75ab98def9cb12e7933ba3" level="file">
        <did>
          <unittitle>TML, 39-29 - Atorvastatin - a new lipid-lowering drug</unittitle>
          <unitdate type="inclusive">1997 March 28</unitdate>
          <container id="df37d64268017dd4bb26f22b727e14b6" label="Mixed Materials (A0000000075862)" type="box">20</container>
          <container id="07b5833cb628c40a25dcd3ea5607019c" parent="df37d64268017dd4bb26f22b727e14b6" type="folder">8-9</container>
        </did>
        <accessrestrict id="f50e6cdc96d78aa80586f8c46bb4b44f">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="b2a72d06fe2be2cec8bad5a6a0fda27b" level="file">
        <did>
          <unittitle>TML, 39-45 - Azelastine nasal spray for allergic rhinitis</unittitle>
          <unitdate type="inclusive">1997 May 9</unitdate>
          <container id="189ab3713d6fc5ec33f0d893ec09dd75" label="Mixed Materials (A0000000075862)" type="box">20</container>
          <container id="fb71a36b55bd38f732fbe8585adcddd5" parent="189ab3713d6fc5ec33f0d893ec09dd75" type="folder">10-13</container>
        </did>
        <accessrestrict id="2c8bdc164c637c083bf92b35d52554fc">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="36e76c3b20aacff333ba5d98cfca27de" level="file">
        <did>
          <unittitle>TML, 39-12 - Betaine for homocystinuria</unittitle>
          <unitdate type="inclusive">1997 January 31</unitdate>
          <container id="52281bf5cab9cf3abd59fc4eb23c9e3f" label="Mixed Materials (A0000000075862)" type="box">20</container>
          <container id="3d07c7d5e3efab6eaef4afa323039de7" parent="52281bf5cab9cf3abd59fc4eb23c9e3f" type="folder">14-15</container>
        </did>
        <accessrestrict id="55bd4c86ccf4811f99aac2673693e945">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="e4ca902373c4579a78db0d3b8d513633" level="file">
        <did>
          <unittitle>TML, 39-93 - Bromfenac for analgesia</unittitle>
          <unitdate type="inclusive">1997 October 10</unitdate>
          <container id="a2bd87a576ccd279e1c9770b1162f29c" label="Mixed Materials (A0000000075862)" type="box">20</container>
          <container id="6b5b867841eeecb0239d4c75389f1eb7" parent="a2bd87a576ccd279e1c9770b1162f29c" type="folder">16-17</container>
        </did>
        <accessrestrict id="18bd5ce580d159e1acce03ad34266cc9">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="1a9cef87a6b1f62bf27f90e19d47c4e1" level="file">
        <did>
          <unittitle>TML, 39-54 - Brimonidine - an alpha2-agonist for glaucoma</unittitle>
          <unitdate type="inclusive">1997 June 6</unitdate>
          <container id="4bd87d03a225ad110fdf0a49493e226c" label="Mixed Materials (A0000000075862)" type="box">20</container>
          <container id="9ab68fd144c67f5df44af792468a882c" parent="4bd87d03a225ad110fdf0a49493e226c" type="folder">18-19</container>
        </did>
        <accessrestrict id="c12a956b010223394c6ca9d2025942d6">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="56fc5093674d1372e80ed218ae8bd368" level="file">
        <did>
          <unittitle>TML, 39-13 - Safety of channel blockers</unittitle>
          <unitdate type="inclusive">1997 February 14</unitdate>
          <container id="111bad7a70fb313d82f31ca137ee467f" label="Mixed Materials (A0000000075862)" type="box">20</container>
          <container id="4ff42b34c945d6f31c4ee36cba7d95e9" parent="111bad7a70fb313d82f31ca137ee467f" type="folder">20</container>
        </did>
        <accessrestrict id="12b089183fda270bbeecc135b190b589">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="1f85013ec13e639596b728f22f1aafc4" level="file">
        <did>
          <unittitle>TML, 39-13 - Safety of channel blockers</unittitle>
          <unitdate type="inclusive">1997 February 14</unitdate>
          <container id="a8e0c397490f1cfe1a2381b4a8b1c1e7" label="Mixed Materials (A0000000075863)" type="box">21</container>
          <container id="ad844735fe81a7927c58fa6b50f8baff" parent="a8e0c397490f1cfe1a2381b4a8b1c1e7" type="folder">1-2</container>
        </did>
        <accessrestrict id="8a33d90a046f00da2d8b9b030020c09e">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="b4a11be555144c67db801913b3a95361" level="file">
        <did>
          <unittitle>TML, 39-58 - Cabergoline for hyperprolactinemia</unittitle>
          <unitdate type="inclusive">1997 June 20</unitdate>
          <container id="ab9e0a1b1a80791628c33844837a0995" label="Mixed Materials (A0000000075863)" type="box">21</container>
          <container id="ed9263c8ef19b1977a238af325ab2696" parent="ab9e0a1b1a80791628c33844837a0995" type="folder">3-6</container>
        </did>
        <accessrestrict id="300ca74e312c726f3bc6c5c2409ffa88">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="8fa954deb6dc2ce7385244a3d8abc5a9" level="file">
        <did>
          <unittitle>TML - Dovonex</unittitle>
          <unitdate type="inclusive">1993</unitdate>
          <container id="12bbf6b125c213f847af5a3dc5737da2" label="Mixed Materials (A0000000075863)" type="box">21</container>
          <container id="bc7b35294f542b1524a9ffc7dae28bfc" parent="12bbf6b125c213f847af5a3dc5737da2" type="folder">7</container>
        </did>
        <accessrestrict id="7ed0890a439df753466be5a70bc31770">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="c70f3345ad4c90f6af9d560ffb1f3777" level="file">
        <did>
          <unittitle>TML, 39-108 - Olopatadine for allergic conjunctivitis</unittitle>
          <unitdate type="inclusive">1997 November 21</unitdate>
          <container id="d61cc2add8b71fb09daf348b6c4250c0" label="Mixed Materials (A0000000075863)" type="box">21</container>
          <container id="21493948a9b2b07a757fd3b115ac3123" parent="d61cc2add8b71fb09daf348b6c4250c0" type="folder">8-9</container>
        </did>
        <accessrestrict id="7e05d25159387c3bcb0a7a1a1a57fbe9">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="0f25168045c3874b852fc2566864c22b" level="file">
        <did>
          <unittitle>TML, 37-1 - Drugs for asthma</unittitle>
          <unitdate type="inclusive">1996 January 6</unitdate>
          <container id="11a3d627d8278529a85b96ad6c395acc" label="Mixed Materials (A0000000075863)" type="box">21</container>
          <container id="c181163899b61847b6831df555da7f47" parent="11a3d627d8278529a85b96ad6c395acc" type="folder">10-14</container>
        </did>
        <accessrestrict id="5124cbd46d2a439f4f59c00468b6016b">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="dbe0049fdc51d967d42b54af228c58ae" level="file">
        <did>
          <unittitle>TML, 39-32 - Intra-transurethral Alprostadil for impotence</unittitle>
          <unitdate type="inclusive">1997 March 28</unitdate>
          <container id="d94cb8fec763b4a3f0a92e4ac0f8b621" label="Mixed Materials (A0000000075863)" type="box">21</container>
          <container id="edd465f006dab086d3165a9bf3e515f4" parent="d94cb8fec763b4a3f0a92e4ac0f8b621" type="folder">15-16</container>
        </did>
        <accessrestrict id="108454fd852ec91b5893f1a78b4694b9">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="3fff697896297fb5b3e546b99c7bb615" level="file">
        <did>
          <unittitle>TML, 39-14 - More new drugs for AIDS and associated infections</unittitle>
          <unitdate type="inclusive">1997 February 14</unitdate>
          <container id="636d8bb5aa0e017cd144238e313fc0d2" label="Mixed Materials (A0000000075863)" type="box">21</container>
          <container id="b73e53ce56799d8cf036dda60188a0d7" parent="636d8bb5aa0e017cd144238e313fc0d2" type="folder">17-21</container>
        </did>
        <accessrestrict id="6e01c10d6e482faec33ca1e6f744b4e2">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="ac009d8a6eba90db98f499f6852dd496" level="file">
        <did>
          <unittitle>TML, 39-14 - More new drugs for AIDS and associated infections</unittitle>
          <unitdate type="inclusive">1997 February 14</unitdate>
          <container id="5b20877e537930b48bed3feed64954c6" label="Mixed Materials (A0000000075864)" type="box">22</container>
          <container id="b71b39b3c268e04b4daf0ef4b27004e8" parent="5b20877e537930b48bed3feed64954c6" type="folder">1-3</container>
        </did>
        <accessrestrict id="1cdb7a1ff11f6e216e339e64f20c58a7">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="364c7d8d424593144cdef790c4e94d75" level="file">
        <did>
          <unittitle>TML, 39-111 - AIDS - Drugs for HIV infection</unittitle>
          <unitdate type="inclusive">1997 December 12</unitdate>
          <container id="5eed70b6af54cba174de35fb673e8d06" label="Mixed Materials (A0000000075864)" type="box">22</container>
          <container id="df05a83f2435ce3953ae88374f4f2521" parent="5eed70b6af54cba174de35fb673e8d06" type="folder">4-9</container>
        </did>
        <accessrestrict id="a96e0ada70322de7df279993ca3ff3a5">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="fe5bfd483d4da9cb09abcd8d8e9114e4" level="file">
        <did>
          <unittitle>TML, 39-97 - Antimicrobial prophylaxis in surgery</unittitle>
          <unitdate type="inclusive">1997 October 24</unitdate>
          <container id="84de83ad9e79fd41268721275137de08" label="Mixed Materials (A0000000075864)" type="box">22</container>
          <container id="9d07ea3576fa1e90596d0ee8f33bd334" parent="84de83ad9e79fd41268721275137de08" type="folder">10-15</container>
        </did>
        <accessrestrict id="ce3e85fc72e05bedc7f21da6973965b7">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="6568c1026445dec6f8e364671c21bd39" level="file">
        <did>
          <unittitle>TML, 39-120 - Anagrelide for essential thrombocythemia</unittitle>
          <unitdate type="inclusive">1997 December 19</unitdate>
          <container id="c7bb3cae78bbbfb316fcfdfd824ea66c" label="Mixed Materials (A0000000075864)" type="box">22</container>
          <container id="ad67c25a14e20bad11efda9078ca5796" parent="c7bb3cae78bbbfb316fcfdfd824ea66c" type="folder">16-18</container>
        </did>
        <accessrestrict id="8df589a9af326009da84ebecd5cf8932">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="b0b4f71d2ecf84b337ced4a504f89306" level="file">
        <did>
          <unittitle>TML, 39-94 - Ardeparin and danaparoid for prevention of deep vein thrombosis</unittitle>
          <unitdate type="inclusive">1997 October 10</unitdate>
          <container id="a0aac4d22bb9d8f0eaad3507e6f11cc9" label="Mixed Materials (A0000000075864)" type="box">22</container>
          <container id="0bf38dbb52c8aab075d05cc9d6157e2e" parent="a0aac4d22bb9d8f0eaad3507e6f11cc9" type="folder">19</container>
        </did>
        <accessrestrict id="8df622f363be5b50961c92589e209dc4">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="b1ac2f651904161cd98b8d42f99e3aa1" level="file">
        <did>
          <unittitle>TML, 39-94 - Ardeparin and danaparoid for prevention of deep vein thrombosis</unittitle>
          <unitdate type="inclusive">1997 October 10</unitdate>
          <container id="2a49f2d901e44fc3618592be340c47d0" label="Mixed Materials (A0000000075865)" type="box">23</container>
          <container id="8cb898339ca3db75849bef2dc3100aed" parent="2a49f2d901e44fc3618592be340c47d0" type="folder">1-4</container>
        </did>
        <accessrestrict id="181d3a4b218653d1790e4861871f62dd">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="edca2ebba2d38b14ec07a5b9c16a0276" level="file">
        <did>
          <unittitle>TML, 39-89 - Carvedilol for heart failure</unittitle>
          <unitdate type="inclusive">1997 September 26</unitdate>
          <container id="3eeba22ca8905a1ceab6cf68b5999ccd" label="Mixed Materials (A0000000075865)" type="box">23</container>
          <container id="e448970d3d3e8e83c9bb6ac384546433" parent="3eeba22ca8905a1ceab6cf68b5999ccd" type="folder">5-9</container>
        </did>
        <accessrestrict id="f5705dc19e306f206ec780b8d160e15c">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="3f1ba5c10401cadfc440c87da71224cb" level="file">
        <did>
          <unittitle>TML, 39-57 - Topical penciclovir for herpes labialis</unittitle>
          <unitdate type="inclusive">1997 June 20</unitdate>
          <container id="25da84b72c61754780349b33491950c5" label="Mixed Materials (A0000000075865)" type="box">23</container>
          <container id="403fd487f6cd5e3b63def30d7e28fece" parent="25da84b72c61754780349b33491950c5" type="folder">10-11</container>
        </did>
        <accessrestrict id="053d8eeeb8327c9a50460b4a07f88f4f">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="6311bd1ab3c17838b525980881eb7804" level="file">
        <did>
          <unittitle>TML, 38-17 - Drugs for migraine</unittitle>
          <unitdate type="inclusive">1995 March 3</unitdate>
          <container id="63878a2746f8f860304734e0cadea364" label="Mixed Materials (A0000000075865)" type="box">23</container>
          <container id="1bdc404500001a967999301ec62d0354" parent="63878a2746f8f860304734e0cadea364" type="folder">12-16</container>
        </did>
        <accessrestrict id="3d255045a576ae1c355c7f2fcc48b4a7">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="d46efc5621917384073357b190321659" level="file">
        <did>
          <unittitle>TML - Drugs of Choice - Drugs for Pain</unittitle>
          <unitdate type="inclusive">1997</unitdate>
          <container id="7fa67f9d5afc51d99040f0a2e9fe21a2" label="Mixed Materials (A0000000075865)" type="box">23</container>
          <container id="e4d713c9339a61755eccd9a6de548f0a" parent="7fa67f9d5afc51d99040f0a2e9fe21a2" type="folder">17-21</container>
        </did>
        <accessrestrict id="663777121320adda427992b307d1db2f">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="fa4a7928ccfffaadb72cf4771e4d8edc" level="file">
        <did>
          <unittitle>TML - Drugs of Choice - Drugs for Pain</unittitle>
          <unitdate type="inclusive">1997</unitdate>
          <container id="069a2af1cb1b62fa2eaa1be3b9dce952" label="Mixed Materials (A0000000075866)" type="box">24</container>
          <container id="0c170b6cb533490927c8dee5ed3d0fc8" parent="069a2af1cb1b62fa2eaa1be3b9dce952" type="folder">1</container>
        </did>
        <accessrestrict id="702b01fd73a7deda0a72869d6f566a47">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="318ae2efe1275c93a47e9ae522f706ea" level="file">
        <did>
          <unittitle>TML - Drugs of Choice - Parkinson's Disease</unittitle>
          <unitdate type="inclusive">1997</unitdate>
          <container id="e54d6a4b1855b14823fdea0fb7a5787a" label="Mixed Materials (A0000000075866)" type="box">24</container>
          <container id="9b043d40ba23d37e293a4eaa23aa9ead" parent="e54d6a4b1855b14823fdea0fb7a5787a" type="folder">2-3</container>
        </did>
        <accessrestrict id="f2ea2b6f0f794d84b25ea1befb0a8255">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="b4b3b22e307f4ce6c5d2eb8f6d664d9c" level="file">
        <did>
          <unittitle>TML, 38-5 - Olanzapine for schizophrenia</unittitle>
          <unitdate type="inclusive">1997 January 17</unitdate>
          <container id="bbdbca1b7139a775b98840bced80c869" label="Mixed Materials (A0000000075866)" type="box">24</container>
          <container id="cddc1db52f33d53595f10b41028caf55" parent="bbdbca1b7139a775b98840bced80c869" type="folder">4-6</container>
        </did>
        <accessrestrict id="54d3d516459a5d0fc04e78b00339b8f9">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="b5cf0dfe90fdcc6067f140e30b6809d1" level="file">
        <did>
          <unittitle>TML, 38-113 - Mirtazapine - a new anti-depressant</unittitle>
          <unitdate type="inclusive">1996 December 20</unitdate>
          <container id="6c818ad6f75ac2ae04b36e88c32577a9" label="Mixed Materials (A0000000075866)" type="box">24</container>
          <container id="c605da70e4c0a0e93c6d6bc488a10011" parent="6c818ad6f75ac2ae04b36e88c32577a9" type="folder">7-9</container>
        </did>
        <accessrestrict id="6a61863bdf42f359838de02eb3140260">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="c2e1fc197d7490d826da206b516a38a5" level="file">
        <did>
          <unittitle>TML, 40-5 - Drugs of Choice - Rheumatoid Arthritis</unittitle>
          <unitdate type="inclusive">1997</unitdate>
          <container id="c180a3c5b1169e8cf05e9896e8eb3f7f" label="Mixed Materials (A0000000075866)" type="box">24</container>
          <container id="37f761fde0fcdffb01a70010eaef9309" parent="c180a3c5b1169e8cf05e9896e8eb3f7f" type="folder">10-16</container>
        </did>
        <accessrestrict id="5d151812a70ad7aab1e31b15864a8198">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="fc12244326436c163ce3062f2ee5441e" level="file">
        <did>
          <unittitle>TML, 40-59 - Clopidogrel for reduction of artherosclerotic events</unittitle>
          <unitdate type="inclusive">1998 June 5</unitdate>
          <container id="92a3a8c2988460a164526c5e0341c53c" label="Mixed Materials (A0000000075867)" type="box">25</container>
          <container id="db004786c4fa0758d19825e8c0e05238" parent="92a3a8c2988460a164526c5e0341c53c" type="folder">1-3</container>
        </did>
        <accessrestrict id="010c90cf26351f4881154a4f6ad41ad3">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="b00d90227ff22e5ebe7df4b968c6ec73" level="file">
        <did>
          <unittitle>TML, 40-113 - Citalopram for depression</unittitle>
          <unitdate type="inclusive">1998 December 4</unitdate>
          <container id="0db5d27594bfdb224334e19d5beea4d5" label="Mixed Materials (A0000000075867)" type="box">25</container>
          <container id="a7ddeec4c4859a3cb5e332181c621e5c" parent="0db5d27594bfdb224334e19d5beea4d5" type="folder">4-8</container>
        </did>
        <accessrestrict id="e132e378e63282bf8014cd21bd84bf26">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="85788caeb20c27238d916bb497645405" level="file">
        <did>
          <unittitle>TML, 40-52 - Anthrax vaccine</unittitle>
          <unitdate type="inclusive">1998 May 8</unitdate>
          <container id="98dd6ec15a6af45dc8831a727d4685c3" label="Mixed Materials (A0000000075867)" type="box">25</container>
          <container id="ab12df33716517939d39e6586bcb463e" parent="98dd6ec15a6af45dc8831a727d4685c3" type="folder">9-10</container>
        </did>
        <accessrestrict id="0a33ad6cdce119b325c656b5c6f11151">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="7481cf56a926bcaa665f596bebcba058" level="file">
        <did>
          <unittitle>TML, 40-63 - Ginkgo Biloba for dementia</unittitle>
          <unitdate type="inclusive">1998 June 19</unitdate>
          <container id="9f00a2d2a7fc1bbc25949413d6bfa794" label="Mixed Materials (A0000000075867)" type="box">25</container>
          <container id="8722b823bc883d14b18908d11f32acde" parent="9f00a2d2a7fc1bbc25949413d6bfa794" type="folder">11-13</container>
        </did>
        <accessrestrict id="16e326bcc4bc4a1b019667382b3e42a6">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="276f7a6dda26470f835e467b2e300373" level="file">
        <did>
          <unittitle>TML, Sildenafil - Reprints</unittitle>
          <unitdate type="inclusive">1998</unitdate>
          <container id="2dc1711f2ee77b6395f56e669669379a" label="Mixed Materials (A0000000075867)" type="box">25</container>
          <container id="72b00e23d300502f8961e463fafe11e2" parent="2dc1711f2ee77b6395f56e669669379a" type="folder">14-16</container>
        </did>
        <accessrestrict id="c072f69e2c5f4579df7b9a32a2d6638a">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="8d9d5a14ea3c38a9bcf53eea15278788" level="file">
        <did>
          <unittitle>TML, 40-69 - Hyaluronan injections for osteoarthritis of the knee</unittitle>
          <unitdate type="inclusive">1998 July 3</unitdate>
          <container id="effd70803ffd0f8fd8db75241fff3bc2" label="Mixed Materials (A0000000075867)" type="box">25</container>
          <container id="6f60cccddf92ab77a9f259045caacf08" parent="effd70803ffd0f8fd8db75241fff3bc2" type="folder">17-19</container>
        </did>
        <accessrestrict id="548bd13d1ee4dd091a7071fb17973086">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="e605d151c50d15b7436fa8b95fabcc04" level="file">
        <did>
          <unittitle>TML, 40-57 - Fenoldopam - Severe Hypertension</unittitle>
          <unitdate type="inclusive">1998 May 22</unitdate>
          <container id="9df1701852b838f0a5adcaf54746d8b5" label="Mixed Materials (A0000000075867)" type="box">25</container>
          <container id="b49ee1d6258aff39025f660e0c24fbc9" parent="9df1701852b838f0a5adcaf54746d8b5" type="folder">20-21</container>
        </did>
        <accessrestrict id="72272d08b8d2095400f484d84b5c8623">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="a2c45fce823914fd5f240eb8ce64a6d3" level="file">
        <did>
          <unittitle>TML, 40-57 - Fenoldopam - Severe Hypertension</unittitle>
          <unitdate type="inclusive">1998 May 22</unitdate>
          <container id="014abb7f5c05260ca531ddbc6a9a2ea3" label="Mixed Materials (A0000000075868)" type="box">26</container>
          <container id="2733c9098daa8259833b4ffe9a2b4ca7" parent="014abb7f5c05260ca531ddbc6a9a2ea3" type="folder">1</container>
        </did>
        <accessrestrict id="e61fbc122231a69d11de05471824b4f7">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="58fc0933c16d75f16f20c226741f40fc" level="file">
        <did>
          <unittitle>TML, 40-21 - Drugs that cause psychiatric symptoms</unittitle>
          <unitdate type="inclusive">1998 February 13</unitdate>
          <container id="d6b607dd63b5e512f08e9975bb901751" label="Mixed Materials (A0000000075868)" type="box">26</container>
          <container id="983490974883de409778736ad1c149f1" parent="d6b607dd63b5e512f08e9975bb901751" type="folder">2-5</container>
        </did>
        <accessrestrict id="cd18c294101a7fb036bca53986751b48">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="f466040faafb3cd515b6f7e5924186a3" level="file">
        <did>
          <unittitle>TML, 40-47 - Advice for Travelers</unittitle>
          <unitdate type="inclusive">1998 April 24</unitdate>
          <container id="fb0dd78350ac2a0cba901100492a08b5" label="Mixed Materials (A0000000075868)" type="box">26</container>
          <container id="e84ef3cf9f8bd42a89c14f992238fb66" parent="fb0dd78350ac2a0cba901100492a08b5" type="folder">6-9</container>
        </did>
        <accessrestrict id="d3ea0598c816f490bd7b26c48572450a">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="d9d7051c247d055cb3a4caa57119bc34" level="file">
        <did>
          <unittitle>TML, 40-68 - Fenofibrate</unittitle>
          <unitdate type="inclusive">1998 July 3</unitdate>
          <container id="45497ccf4ee2e06ac1d1babaceee62c7" label="Mixed Materials (A0000000075868)" type="box">26</container>
          <container id="ab83c659402afd6f3996397d1104b77d" parent="45497ccf4ee2e06ac1d1babaceee62c7" type="folder">10-13</container>
        </did>
        <accessrestrict id="a905e6ecf288f2137eb025ea245ec0aa">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="0902f98f4048374d057a60de2d1b7855" level="file">
        <did>
          <unittitle>TML, 40-30 - Trovafloxacin</unittitle>
          <unitdate type="inclusive">1998 March 13</unitdate>
          <container id="fb61b937f874523ded68ed9e0f15a7e2" label="Mixed Materials (A0000000075868)" type="box">26</container>
          <container id="c1b196eff80040216fd097bae7251b5c" parent="fb61b937f874523ded68ed9e0f15a7e2" type="folder">14-16</container>
        </did>
        <accessrestrict id="d64cfc2f0c18fe44c79492b16479dde8">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="40a127b41aba4ab1210aebb60355f7eb" level="file">
        <did>
          <unittitle>TML - Tuberculosis - HAT</unittitle>
          <unitdate type="inclusive">1998</unitdate>
          <container id="4116f0c25975110bd0c18c74bf4dfafd" label="Mixed Materials (A0000000075868)" type="box">26</container>
          <container id="8a9851c5a3ef0febb2fea42f4a62a4cb" parent="4116f0c25975110bd0c18c74bf4dfafd" type="folder">17-18</container>
        </did>
        <accessrestrict id="aa2e94224c5f71c8078141e7e709d476">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="2821241f88ab33b4108c2fb8ef546a03" level="file">
        <did>
          <unittitle>TML - Tuberculosis - HAT</unittitle>
          <unitdate type="inclusive">1998</unitdate>
          <container id="90ec74bb31f65a697025434398a97d5c" label="Mixed Materials (A0000000075869)" type="box">27</container>
          <container id="16ef42a7dfda68c623e5cfe777d45b90" parent="90ec74bb31f65a697025434398a97d5c" type="folder">1-2</container>
        </did>
        <accessrestrict id="0fedc35030a79ffd7934a9d9c5acbe14">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="a5e3fba9d86330d4c75e3f31b4844108" level="file">
        <did>
          <unittitle>TML, 40-51 - Sildenafil - An oral drug for impotence</unittitle>
          <unitdate type="inclusive">1998 May 8</unitdate>
          <container id="2eb5114a26c0734c613be1154bebecd6" label="Mixed Materials (A0000000075869)" type="box">27</container>
          <container id="755e0f9fe5a9f4304929c88c630e6661" parent="2eb5114a26c0734c613be1154bebecd6" type="folder">3-4</container>
        </did>
        <accessrestrict id="c2a74a29c84ba08cf5bbb6cb60889b41">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="41484f1614916c304d00c6a0e2776c25" level="file">
        <did>
          <unittitle>TML, 40-67 - Sucralose - a new artificial sweetner</unittitle>
          <unitdate type="inclusive">1998 July 3</unitdate>
          <container id="17259422ca2e0273da3e382995159bf4" label="Mixed Materials (A0000000075869)" type="box">27</container>
          <container id="b7b81c35b0ee8b9cde4a197d4397b629" parent="17259422ca2e0273da3e382995159bf4" type="folder">5-7</container>
        </did>
        <accessrestrict id="9e54423aecee12c7635588555d8c357f">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="18a33071dfc9246e7c9a4f9970fc624f" level="file">
        <did>
          <unittitle>TML, 40-17 - Grepafloxacin - a new fluoroquinolone</unittitle>
          <unitdate type="inclusive">1998 January 30</unitdate>
          <container id="926ea6fb352eb10b4df2629a29f5d4a5" label="Mixed Materials (A0000000075869)" type="box">27</container>
          <container id="22a845956998b849897fa554fdce54fd" parent="926ea6fb352eb10b4df2629a29f5d4a5" type="folder">8-9</container>
        </did>
        <accessrestrict id="bc7dcf48bb1a978d5d8891678f65f0b7">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="95bd003fd739d4b3a6ffdfb96fae1bc6" level="file">
        <did>
          <unittitle>TML, 40-55 - Repaglinide for type 2 diabetes mellitus</unittitle>
          <unitdate type="inclusive">1998 May 22</unitdate>
          <container id="061f4d18cc8d3295d3ceb58380df9036" label="Mixed Materials (A0000000075869)" type="box">27</container>
          <container id="8d93173cb5827fdbc51dfbebc2e4253c" parent="061f4d18cc8d3295d3ceb58380df9036" type="folder">10-12</container>
        </did>
        <accessrestrict id="ea7f89c9aaeab7997ab0ab65a3fbabdf">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="c689105113c5b23ebb896f340bf02ea0" level="file">
        <did>
          <unittitle>TML, 40-62 - Crystal Ear hearing aid</unittitle>
          <unitdate type="inclusive">1998 June 5</unitdate>
          <container id="b1449375e8f2b3d9734a723c321715f9" label="Mixed Materials (A0000000075869)" type="box">27</container>
          <container id="edbe0d71a4c060f97d9570b7e7d67445" parent="b1449375e8f2b3d9734a723c321715f9" type="folder">13</container>
        </did>
        <accessrestrict id="dc4b7b184944400de9cfe92635a05ead">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="705d7bf07e8ff402ef32c0df389a3828" level="file">
        <did>
          <unittitle>TML, 40-89 - Antiplatelet</unittitle>
          <unitdate type="inclusive">1998 September 11</unitdate>
          <container id="d510bff7ce6421487c8e1ff7386a2c69" label="Mixed Materials (A0000000075869)" type="box">27</container>
          <container id="0295a1c39487a03bac4adf38ad78be88" parent="d510bff7ce6421487c8e1ff7386a2c69" type="folder">14-16</container>
        </did>
        <accessrestrict id="ae0c798c535816e3564f3b350306c0eb">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="cc4045365330c91030e2afc2941ff362" level="file">
        <did>
          <unittitle>TML, 40-109 - New drugs for rheumatoid arthritis</unittitle>
          <unitdate type="inclusive">1998 November 20</unitdate>
          <container id="24e39e3cc1bd4b6205bb8143e17dfd9e" label="Mixed Materials (A0000000075869)" type="box">27</container>
          <container id="505aa4b5e315797e70682ae24efcb856" parent="24e39e3cc1bd4b6205bb8143e17dfd9e" type="folder">17-19</container>
        </did>
        <accessrestrict id="d3830363a0deac040fb1a2187fcc43a6">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="74cd9f3df4304220a489f3cd523e97f4" level="file">
        <did>
          <unittitle>TML, 40-109 - New drugs for rheumatoid arthritis</unittitle>
          <unitdate type="inclusive">1998 November 20</unitdate>
          <container id="61f5ccf87aa19dd234986832564b5b10" label="Mixed Materials (A0000000075870)" type="box">28</container>
          <container id="ecc3a437b5e05cd0c0cc3e0f640c449d" parent="61f5ccf87aa19dd234986832564b5b10" type="folder">1</container>
        </did>
        <accessrestrict id="78f65a64160f8c684e6ad4a73eb82afd">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="8f7886d013678b0f444c0e7ce3af676b" level="file">
        <did>
          <unittitle>TML, 40-65 - Rituximab for non-hodgkins lymphoma</unittitle>
          <unitdate type="inclusive">1998 June 19</unitdate>
          <container id="15036c2853295febf5ef90bac7f8bd8f" label="Mixed Materials (A0000000075870)" type="box">28</container>
          <container id="f8b81ba90a135eb2a4a15a3f4302c6e8" parent="15036c2853295febf5ef90bac7f8bd8f" type="folder">2</container>
        </did>
        <accessrestrict id="8e2b80b72a52938a5c321da498c8b722">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="236c02b396ea229adb1f079d93029f01" level="file">
        <did>
          <unittitle>TML, 40-32 - Sibutramine for obesity</unittitle>
          <unitdate type="inclusive">1998 March 13</unitdate>
          <container id="f29ae16fe82b6c047e1ed76490a14a0a" label="Mixed Materials (A0000000075870)" type="box">28</container>
          <container id="3e01cccb7c0718a3f6220bff43c83b66" parent="f29ae16fe82b6c047e1ed76490a14a0a" type="folder">3-5</container>
        </did>
        <accessrestrict id="83216716b614ac8cc38fcaa01b43355e">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="34d5d1374a9121f748a24968ebe6c128" level="file">
        <did>
          <unittitle>TML, 40-27 - Zolmitriptan for migraine</unittitle>
          <unitdate type="inclusive">1998 February 27</unitdate>
          <container id="083c504892f07b99b346edd3791c5c2e" label="Mixed Materials (A0000000075870)" type="box">28</container>
          <container id="db91c0bfdb6fe79dd5c8c22fb63aa5ac" parent="083c504892f07b99b346edd3791c5c2e" type="folder">6-8</container>
        </did>
        <accessrestrict id="9f78fcde35549e85ae6f6ddddad23091">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="f1f292c6e674c3d7e6f2610c2dbf9aec" level="file">
        <did>
          <unittitle>TML, 40-73 - Becaplermin - Platelet-derived growth factor for diabetic ulcers</unittitle>
          <unitdate type="inclusive">1998 July 17</unitdate>
          <container id="2a44c1b747278aa3df493ac62b2afa2d" label="Mixed Materials (A0000000075870)" type="box">28</container>
          <container id="baa275471ce0fff6ba5b9f0656e03df8" parent="2a44c1b747278aa3df493ac62b2afa2d" type="folder">9</container>
        </did>
        <accessrestrict id="a90cd7de6fbf79e2a9a41d8e6d5f1884">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="fae1826f224dc5554dd9d77d43d63320" level="file">
        <did>
          <unittitle>TML, 40-19 - Arbutamine for stress testing</unittitle>
          <unitdate type="inclusive">1998 January 2</unitdate>
          <container id="3fc13de03d8fb44cff26b5e1027149f0" label="Mixed Materials (A0000000075870)" type="box">28</container>
          <container id="49ae02b33a6f9886e70a32084cc905d6" parent="3fc13de03d8fb44cff26b5e1027149f0" type="folder">10-11</container>
        </did>
        <accessrestrict id="3cf800c016782dc93e3a36b622f7b36c">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="b4e4ab750a7b095f09a475bb6f5bb4c1" level="file">
        <did>
          <unittitle>TML, 40-75 - Vitamin supplements</unittitle>
          <unitdate type="inclusive">1998 July 31</unitdate>
          <container id="542ae83aa998463f37628bbadb2298f9" label="Mixed Materials (A0000000075870)" type="box">28</container>
          <container id="9c151cef4de888bf3bfc8ff0d4742421" parent="542ae83aa998463f37628bbadb2298f9" type="folder">12-16</container>
        </did>
        <accessrestrict id="59259d5d91da3a2acb6cb86529f69bd9">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="06914f95afdacb00ca224c63b35cc3e5" level="file">
        <did>
          <unittitle>TML, 40-92 - Gliadel wafers for treatment of brain tumors</unittitle>
          <unitdate type="inclusive">1998 September 11</unitdate>
          <container id="431e12b06940880a0b6fbc7101837810" label="Mixed Materials (A0000000075870)" type="box">28</container>
          <container id="d9a75b49eb9d5f02952487439f0e0411" parent="431e12b06940880a0b6fbc7101837810" type="folder">17-18</container>
        </did>
        <accessrestrict id="e29a7c4b92a2feed9fd0b7e0a0bb8f72">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="f35a3fcbf2b099a50baf329b7d2a8f36" level="file">
        <did>
          <unittitle>TML - HAT</unittitle>
          <unitdate type="inclusive">1998</unitdate>
          <container id="c4d7fd37405165efecfa9ec91ea88ea8" label="Mixed Materials (A0000000075870)" type="box">28</container>
          <container id="6bd95ebab190466e68445eea14d6907d" parent="c4d7fd37405165efecfa9ec91ea88ea8" type="folder">19</container>
        </did>
        <accessrestrict id="0093f9f9cae39c07366f1e9c0c119fa4">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="bc19dc00f1b6834157cb02e6fcfef4a4" level="file">
        <did>
          <unittitle>TML - HAT</unittitle>
          <unitdate type="inclusive">1998</unitdate>
          <container id="d650130c25af64f5476092d0034a88a6" label="Mixed Materials (A0000000075871)" type="box">29</container>
          <container id="5bcedffce88a2fb553a711762107e2b8" parent="d650130c25af64f5476092d0034a88a6" type="folder">1-5</container>
        </did>
        <accessrestrict id="530223b01deda9e053da32d105382b18">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="559cb584a41d6690a7e856498ab89795" level="file">
        <did>
          <unittitle>TML, 40-106 - Trastuzumab for metastatic breast cancer</unittitle>
          <unitdate type="inclusive">1998 November 6</unitdate>
          <container id="1d35d42e1acb8b5649b7254f943a0e80" label="Mixed Materials (A0000000075871)" type="box">29</container>
          <container id="86a61ff3025a31eefb1b24ad0a6d5517" parent="1d35d42e1acb8b5649b7254f943a0e80" type="folder">6-7</container>
        </did>
        <accessrestrict id="cf7ce77fd85e6bc2a2e126d922cb2364">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="ece2250f2916521ae284b1830da4848e" level="file">
        <did>
          <unittitle>TML, 40-114 - Three new drugs for HIV infection</unittitle>
          <unitdate type="inclusive">1998 December 4</unitdate>
          <container id="2da9056b65c19287ee487e5d26ff1b8b" label="Mixed Materials (A0000000075871)" type="box">29</container>
          <container id="c1d3564f5835260d64812efa92cecfdb" parent="2da9056b65c19287ee487e5d26ff1b8b" type="folder">8-11</container>
        </did>
        <accessrestrict id="4e7f5d2236f53f8ccc2b28a5bf8873c1">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="7dd5458e0da29270a7d0b887632c23ac" level="file">
        <did>
          <unittitle>TML, Sexually Trasmitted Diseases - HAT</unittitle>
          <unitdate type="inclusive">1998</unitdate>
          <container id="8bf928e541dea6097b86b7a9d8efabaf" label="Mixed Materials (A0000000075871)" type="box">29</container>
          <container id="a857c115469dfda55048189a553a030d" parent="8bf928e541dea6097b86b7a9d8efabaf" type="folder">12-14</container>
        </did>
        <accessrestrict id="0b261ea329af56d20325ac31bcf03cbe">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="6e5b03bb37f1b1e46c63603fddb7f5a0" level="file">
        <did>
          <unittitle>TML, 40-53 - Dolasetron</unittitle>
          <unitdate type="inclusive">1998 May 8</unitdate>
          <container id="d18f3e0534760cf9d9a3242b5a3e1265" label="Mixed Materials (A0000000075871)" type="box">29</container>
          <container id="ec03ae8fc68bcc6419813d683fbfef6d" parent="d18f3e0534760cf9d9a3242b5a3e1265" type="folder">15-18</container>
        </did>
        <accessrestrict id="2f191b313a6f595b28c9d77fec25b021">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="b33fb65d9a2e71bddfa4f269d47aeef6" level="file">
        <did>
          <unittitle>TML, 40-18 - Irbesartan for hypertension</unittitle>
          <unitdate type="inclusive">1998 January 30</unitdate>
          <container id="c64eaf993f0a58cb3d1c71f0a6c8214a" label="Mixed Materials (A0000000075872)" type="box">30</container>
          <container id="d6ad3f4f4ad5c345ee7971333ad59c5b" parent="c64eaf993f0a58cb3d1c71f0a6c8214a" type="folder">1-4</container>
        </did>
        <accessrestrict id="5fe32f0354336c745f49eaad8ec99c60">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="6332598d843148b2b6fcca7483c23ff2" level="file">
        <did>
          <unittitle>TML, 40-33 - The Choice of Antibacterial Drugs</unittitle>
          <unitdate type="inclusive">1998 March 27</unitdate>
          <container id="70d1aea02347c08b17226b1ded98e36f" label="Mixed Materials (A0000000075872)" type="box">30</container>
          <container id="10a5c4ff1f500d42704704cd93c06543" parent="70d1aea02347c08b17226b1ded98e36f" type="folder">5-8</container>
        </did>
        <accessrestrict id="4de55d18dd59d1c77f9f4fdd38e7a4d2">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="6062e376e8011b03bf27092730e8219d" level="file">
        <did>
          <unittitle>TML, 40-93 - New monoclonal antibodies to prevent transplant rejection</unittitle>
          <unitdate type="inclusive">1998 September 25</unitdate>
          <container id="177fa5b3e0f902b9bef004014bdee605" label="Mixed Materials (A0000000075872)" type="box">30</container>
          <container id="f1ca12f2559de232054d4733ecd934fe" parent="177fa5b3e0f902b9bef004014bdee605" type="folder">9-12</container>
        </did>
        <accessrestrict id="a10e4c82bc99d39cee6a7ddd1ca31b10">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="de828b3fc932777396bebd27f5fab7dd" level="file">
        <did>
          <unittitle>TML, 40-117 - Choice of lipid-lowering drugs</unittitle>
          <unitdate type="inclusive">1998 December 18</unitdate>
          <container id="931b056e398b3154e5ce31a94bc0c327" label="Mixed Materials (A0000000075872)" type="box">30</container>
          <container id="7019142efacca19ae6814acd71a326b7" parent="931b056e398b3154e5ce31a94bc0c327" type="folder">13-16</container>
        </did>
        <accessrestrict id="ec87238d62e4af8195602bcb6756e8f3">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="0bba41a40cc25a8da0e7a635fb7e3df8" level="file">
        <did>
          <unittitle>TML - Drugs for Parasitic Infections</unittitle>
          <unitdate type="inclusive">1998</unitdate>
          <container id="ddec78846d681887f91d3dff2a069b93" label="Mixed Materials (A0000000075872)" type="box">30</container>
          <container id="9e5bd9260fcd2cd6b61c41f00d5d8f90" parent="ddec78846d681887f91d3dff2a069b93" type="folder">17-19</container>
        </did>
        <accessrestrict id="e69b8784cca126a51aa694fe76fa93ef">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="13029629c9a2c8c4645ba910bddc0ec5" level="file">
        <did>
          <unittitle>TML - Drugs for Parasitic Infections</unittitle>
          <unitdate type="inclusive">1998</unitdate>
          <container id="44764a01cbe2973796e45112e2fbdf1d" label="Mixed Materials (A0000000075873)" type="box">31</container>
          <container id="fd4a4ac80d5a1239b85f76c87b6e8964" parent="44764a01cbe2973796e45112e2fbdf1d" type="folder">1-3</container>
        </did>
        <accessrestrict id="efd535a28d84b26cb3f39bdbca07f951">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="c768307fb6b27100b14034cebd5227a9" level="file">
        <did>
          <unittitle>TML, 40-43 - Toremifene and Letrozole for advance breast cancer</unittitle>
          <unitdate type="inclusive">1998 April 10</unitdate>
          <container id="392b9dffbf77e533eaf14eb71b14f45b" label="Mixed Materials (A0000000075873)" type="box">31</container>
          <container id="f29a60cb466e85d4106d16bacc3a39e3" parent="392b9dffbf77e533eaf14eb71b14f45b" type="folder">4-8</container>
        </did>
        <accessrestrict id="4fead382cbe8272480e24c54bdac4aa5">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="edbc39d29ce93f5d2d89c1070b90a888" level="file">
        <did>
          <unittitle>TML, 40-95 - Brinzolamide for glaucoma</unittitle>
          <unitdate type="inclusive">1998 September 25</unitdate>
          <container id="b407161b857c3723ef42ec7d67242c0c" label="Mixed Materials (A0000000075873)" type="box">31</container>
          <container id="70d992190ebaf552192ebb19303c66a0" parent="b407161b857c3723ef42ec7d67242c0c" type="folder">9-10</container>
        </did>
        <accessrestrict id="4761d1070aff6ae3d4f74655713baaa7">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="6d7c66707bdf53045a7ff953d6e108d3" level="file">
        <did>
          <unittitle>TML, 40-45 - Tigabine for epilepsy</unittitle>
          <unitdate type="inclusive">1998 April 10</unitdate>
          <container id="8d77c2bc8d33762a1a855bdd3d5f95ff" label="Mixed Materials (A0000000075873)" type="box">31</container>
          <container id="adc423cfb922261751c6ce97b2cdbdd2" parent="8d77c2bc8d33762a1a855bdd3d5f95ff" type="folder">11-13</container>
        </did>
        <accessrestrict id="94fdedf900cf20f12d378b25deedc2ab">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="a07a54028f90ac0076d2802b57942911" level="file">
        <did>
          <unittitle>TML, 40-64 - A new rabies vaccine</unittitle>
          <unitdate type="inclusive">1998 June 14</unitdate>
          <container id="efb6981e8ff48566dfbb853d42dba05e" label="Mixed Materials (A0000000075873)" type="box">31</container>
          <container id="260a2ce9ec6be4595cae647345d381e8" parent="efb6981e8ff48566dfbb853d42dba05e" type="folder">14-15</container>
        </did>
        <accessrestrict id="47ed997eea8759fcee2c1c993e8bbb47">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="3bd95f95656aa72b9a953a7b60fc1ff8" level="file">
        <did>
          <unittitle>TML, 40-29 - Raloxifene for postmenopausal osteoporosis</unittitle>
          <unitdate type="inclusive">1998 March 13</unitdate>
          <container id="bb441a5ee5fd8bae42e66fa942d71b31" label="Mixed Materials (A0000000075873)" type="box">31</container>
          <container id="7d92d0aacb0a5eab6acd1e05bca4a085" parent="bb441a5ee5fd8bae42e66fa942d71b31" type="folder">16-18</container>
        </did>
        <accessrestrict id="072da8fc19d0e0c642d2808e0b9452ab">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="fa4c88d1fa307e4c1c36721c687359e5" level="file">
        <did>
          <unittitle>TML, 40-60 - Tolcapone for Parkinson's disease</unittitle>
          <unitdate type="inclusive">1998 June 5</unitdate>
          <container id="7db76adf40abcdf2b647b2dd784c13f1" label="Mixed Materials (A0000000075873)" type="box">31</container>
          <container id="ae0f17d2dea2b23e6aa6cbc004e941a7" parent="7db76adf40abcdf2b647b2dd784c13f1" type="folder">19</container>
        </did>
        <accessrestrict id="4326873ad2b2259141a757cbab189cb2">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="b31307f7682d799e34699487a403a926" level="file">
        <did>
          <unittitle>TML, 40-60 - Tolcapone for Parkinson's disease</unittitle>
          <unitdate type="inclusive">1998 June 5</unitdate>
          <container id="7132c071b86be3f01066f4c03247eb21" label="Mixed Materials (A0000000075874)" type="box">32</container>
          <container id="749898270785c5b53706aa189b292756" parent="7132c071b86be3f01066f4c03247eb21" type="folder">1-2</container>
        </did>
        <accessrestrict id="2802926a9875868eb77bbf4162293dea">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="c0f605353f7f9186d9e181b0e5a7b35c" level="file">
        <did>
          <unittitle>TML, 40-15 - Budesonide turbuhaler for asthma</unittitle>
          <unitdate type="inclusive">1998 January 16</unitdate>
          <container id="4088cce870d24c9436615c8c9728ac87" label="Mixed Materials (A0000000075874)" type="box">32</container>
          <container id="4fd813dc6142f88a9d9d397c3111354e" parent="4088cce870d24c9436615c8c9728ac87" type="folder">3-8</container>
        </did>
        <accessrestrict id="63c818b79b8463447ba0a35c3ed08e0e">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="fc1c9413add7682bf34765d07e37871c" level="file">
        <did>
          <unittitle>TML - Cholesterol-Lowering - Reprints</unittitle>
          <unitdate type="inclusive">1998</unitdate>
          <container id="b5c009a8247999d6f63a992c26ffad24" label="Mixed Materials (A0000000075874)" type="box">32</container>
          <container id="fa2a27cc0883b458e5753fb69713c29a" parent="b5c009a8247999d6f63a992c26ffad24" type="folder">9-10</container>
        </did>
        <accessrestrict id="263b366a38ae16d96e1447c8e1c8953b">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="9212aaed4209e15330e340d1c8675d23" level="file">
        <did>
          <unittitle>TML - Parasitic Infections - Reprints</unittitle>
          <unitdate type="inclusive">1998</unitdate>
          <container id="fa5d251faae8049247a9064c7267ca2a" label="Mixed Materials (A0000000075874)" type="box">32</container>
          <container id="4b0778ffcad75da97821b6fde8350b0d" parent="fa5d251faae8049247a9064c7267ca2a" type="folder">11-14</container>
        </did>
        <accessrestrict id="5db4f9b0242f10ed336d20896e08899c">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="367ee47d6747fc683d4571ad991fcb28" level="file">
        <did>
          <unittitle>TML - Malaria - Drugs for parastic infections</unittitle>
          <unitdate type="inclusive">1998</unitdate>
          <container id="c757ee147e8073b1bcb7ce28abf201b3" label="Mixed Materials (A0000000075874)" type="box">32</container>
          <container id="d5996de8c5dc1d9c308affd78c196b02" parent="c757ee147e8073b1bcb7ce28abf201b3" type="folder">15-16</container>
        </did>
        <accessrestrict id="e3f66807c02c01517706efbf9eeaff5f">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="d64c5c233f60d11993a1dd5cef9c5ec4" level="file">
        <did>
          <unittitle>TML - Antimicrobial drugs - Reprints</unittitle>
          <unitdate type="inclusive">1998</unitdate>
          <container id="53efc6e5d57fb87d9c688713a75774d4" label="Mixed Materials (A0000000075874)" type="box">32</container>
          <container id="1f4eef399caf4791bb50ee604afb9dea" parent="53efc6e5d57fb87d9c688713a75774d4" type="folder">17</container>
        </did>
        <accessrestrict id="f6a6fff3786ff1d521cdf342567849ee">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="3d41d005cf4c13e14913cd67a32a5047" level="file">
        <did>
          <unittitle>TML - Antimicrobial drugs - Reprints</unittitle>
          <unitdate type="inclusive">1998</unitdate>
          <container id="3b1ad4588ab1212df7207ccf483a3d07" label="Mixed Materials (A0000000075875)" type="box">33</container>
          <container id="34382dacea3f23c079b04884ed922209" parent="3b1ad4588ab1212df7207ccf483a3d07" type="folder">1-2</container>
        </did>
        <accessrestrict id="8075ff059f0d4d931fa3535cefb097fc">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="a70dd9355ee98a30aebc26b8daacffc8" level="file">
        <did>
          <unittitle>TML - Psychiatric Symptoms - Reprints</unittitle>
          <unitdate type="inclusive">1998</unitdate>
          <container id="8133989d62c161a2ae572e491d251ed4" label="Mixed Materials (A0000000075875)" type="box">33</container>
          <container id="d81555e1e1c47e374b435f1d26729bf9" parent="8133989d62c161a2ae572e491d251ed4" type="folder">3</container>
        </did>
        <accessrestrict id="9dfab18fed33b99b2f9c6ca42c51a487">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="878b0cb8e4fc058b68a1ed9db09469eb" level="file">
        <did>
          <unittitle>TML, 40-109 - Candesartan</unittitle>
          <unitdate type="inclusive">1998 November 20</unitdate>
          <container id="68f88c39c17c821c1d477af9b2b0a8b3" label="Mixed Materials (A0000000075875)" type="box">33</container>
          <container id="9b4520042e6a4d99a9738d169b93e715" parent="68f88c39c17c821c1d477af9b2b0a8b3" type="folder">4-6</container>
        </did>
        <accessrestrict id="ba7cc6a8281cf2cb771c412c8f89cd3f">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="e61911867cf616602aa72255f38dc9ba" level="file">
        <did>
          <unittitle>TML, 40-77 - Interleukin-11</unittitle>
          <unitdate type="inclusive">1998 July 31</unitdate>
          <container id="cde1913c7a9290a9ca324c67f66b689d" label="Mixed Materials (A0000000075875)" type="box">33</container>
          <container id="d3c10c994cf75b24c7e817f6a10d2822" parent="cde1913c7a9290a9ca324c67f66b689d" type="folder">7-9</container>
        </did>
        <accessrestrict id="4f66d0ee0cc0c75d98d5ce57dfee6a86">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="4f7233bf7c77fcfc22d806ea70169968" level="file">
        <did>
          <unittitle>TML, 40-85 - Cefdinir</unittitle>
          <unitdate type="inclusive">1998 August 28</unitdate>
          <container id="1a8062c7f0614f6534ffd8039063d923" label="Mixed Materials (A0000000075875)" type="box">33</container>
          <container id="15cfe5011bd372654bdf507a18631e13" parent="1a8062c7f0614f6534ffd8039063d923" type="folder">10-12</container>
        </did>
        <accessrestrict id="028c35e32d1addf3672d48cb03ad70d7">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="910ff3d576f61dcba1783abe6210dff1" level="file">
        <did>
          <unittitle>TML, 40-79 - Drugs for pain</unittitle>
          <unitdate type="inclusive">1998 August 14</unitdate>
          <container id="6fb789bf03856447a81672e125e962bf" label="Mixed Materials (A0000000075875)" type="box">33</container>
          <container id="1fae24ef75413edbfe467474f8b78f02" parent="6fb789bf03856447a81672e125e962bf" type="folder">13-17</container>
        </did>
        <accessrestrict id="72993e3876c2683037ab6df23f908193">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="960c1722fd9da508635b32ac38c60f80" level="file">
        <did>
          <unittitle>TML, 40-87 - Risedronate</unittitle>
          <unitdate type="inclusive">1998 August 28</unitdate>
          <container id="5caa8fc94637f1527a5b53e4992415b3" label="Mixed Materials (A0000000075875)" type="box">33</container>
          <container id="38a092a5779f25b5f854e996813639e4" parent="5caa8fc94637f1527a5b53e4992415b3" type="folder">18-19</container>
        </did>
        <accessrestrict id="c3d8c6875a01ba6968c3fea93fe65185">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="8e8879c55ee8242081f7f64851b4db08" level="file">
        <did>
          <unittitle>TML, 40-87 - Risedronate</unittitle>
          <unitdate type="inclusive">1998 August 28</unitdate>
          <container id="8e21490c5d5a4d411a75b10462992e57" label="Mixed Materials (A0000000075876)" type="box">34</container>
          <container id="d5bd26cd9de0ef3af5efce8d3628ed34" parent="8e21490c5d5a4d411a75b10462992e57" type="folder">1-2</container>
        </did>
        <accessrestrict id="54d5c0c828c3316a8382b3f15461804c">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="5d664f33dcd2cabbe962a4227379c390" level="file">
        <did>
          <unittitle>TML, 40-94 - Lepirudin for heparin-induced thrombocytopenia</unittitle>
          <unitdate type="inclusive">1998 September 25</unitdate>
          <container id="5eedbe8308382086963c2fe86ebcd535" label="Mixed Materials (A0000000075876)" type="box">34</container>
          <container id="436c6c4b4c5e96eb7d79a7fb33b7b2cf" parent="5eedbe8308382086963c2fe86ebcd535" type="folder">3-4</container>
        </did>
        <accessrestrict id="df311ee9e0d78fb33b148774389da7c3">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="3d76a36572332e4c480702f762cc9918" level="file">
        <did>
          <unittitle>TML, 40-25 - Propecia and Rogaine Extra Stength for Alopecia</unittitle>
          <unitdate type="inclusive">1998 February 27</unitdate>
          <container id="809d1a0d620d713b1760adc135fa81dc" label="Mixed Materials (A0000000075876)" type="box">34</container>
          <container id="436ff5ad74b50e369bdaa13a76735bee" parent="809d1a0d620d713b1760adc135fa81dc" type="folder">5-8</container>
        </did>
        <accessrestrict id="c3ab3185c9cf9153482322e821491aa5">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="affe7599f3c787d823e95823bfc0cbfc" level="file">
        <did>
          <unittitle>TML, 40-106 - Capecitabine for metastatic breast cancer</unittitle>
          <unitdate type="inclusive">1998 November</unitdate>
          <container id="3586eaccec5b0cdfccead5f667227913" label="Mixed Materials (A0000000075876)" type="box">34</container>
          <container id="ce5c0ebbede3a735384fd8ebf0a5a957" parent="3586eaccec5b0cdfccead5f667227913" type="folder">9-10</container>
        </did>
        <accessrestrict id="544789c77c743995f3e1041b8e18aab6">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="2e2e66929019d8531954a7ad095700fb" level="file">
        <did>
          <unittitle>TML, 40-13 - Cerivastatin for hypercholesterolemia</unittitle>
          <unitdate type="inclusive">1998 January 16</unitdate>
          <container id="838e4b2a57da6eddea9708a3f781b2d8" label="Mixed Materials (A0000000075876)" type="box">34</container>
          <container id="02bc201cf423495dc9c5b7e79746122c" parent="838e4b2a57da6eddea9708a3f781b2d8" type="folder">11-13</container>
        </did>
        <accessrestrict id="c00a8622a08054369fa43b3f435559cc">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="4043d39a1cb0cf7a9edea397c7574337" level="file">
        <did>
          <unittitle>TML, 40-101 - Tolterodine for overactive bladder</unittitle>
          <unitdate type="inclusive">1998 October 23</unitdate>
          <container id="5ea9c3b014e1d755ad1eb6294c31918b" label="Mixed Materials (A0000000075876)" type="box">34</container>
          <container id="cfe8d466db51bb81cbf598cd657cea7b" parent="5ea9c3b014e1d755ad1eb6294c31918b" type="folder">14-16</container>
        </did>
        <accessrestrict id="5ed653620eb193653bb7be17c3823301">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="e5341af61e6a0539c242e29242b615c6" level="file">
        <did>
          <unittitle>TML, 40-102 - An Emergency Contraceptive Kit</unittitle>
          <unitdate type="inclusive">1998 October 23</unitdate>
          <container id="79de6c27b5163046b7a3fa768499b6c4" label="Mixed Materials (A0000000075876)" type="box">34</container>
          <container id="a230d31ac57f8acf160bf769bfc27af3" parent="79de6c27b5163046b7a3fa768499b6c4" type="folder">17-18</container>
        </did>
        <accessrestrict id="5f3dbedbdfcd288cd297f8d578fd4ced">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="3f39fb343e118836671bfce7c8c9e0be" level="file">
        <did>
          <unittitle>TML, 40-71 - Montelukast for persistent asthma</unittitle>
          <unitdate type="inclusive">1998 July 17</unitdate>
          <container id="ee3d21b76922af8646e384c647c29aad" label="Mixed Materials (A0000000075876)" type="box">34</container>
          <container id="b10835d76ccef6f113bae54f5e7eaa16" parent="ee3d21b76922af8646e384c647c29aad" type="folder">19</container>
        </did>
        <accessrestrict id="a3bdebd3c863cd5e8915acd5b9e97a95">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="e43a7710b28863a0de4803cfd4c0b542" level="file">
        <did>
          <unittitle>TML, 40-71 - Montelukast for persistent asthma</unittitle>
          <unitdate type="inclusive">1998 July 17</unitdate>
          <container id="42b16ab419056fe7a0cf6d9c8e625f6d" label="Mixed Materials (A0000000075877)" type="box">35</container>
          <container id="05aa47200b5e25a03bbc056770037076" parent="42b16ab419056fe7a0cf6d9c8e625f6d" type="folder">1-2</container>
        </did>
        <accessrestrict id="4b8fa308ff1db3b9b6869466f7f0fe98">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="f487b7ea1e7909af55b4d7eeee8db68c" level="file">
        <did>
          <unittitle>TML, 40-103 - Thalidomide</unittitle>
          <unitdate type="inclusive">1998 October 23</unitdate>
          <container id="c3a1e810ffb145f83821c3cbb70094e1" label="Mixed Materials (A0000000075877)" type="box">35</container>
          <container id="c71560c4b5bfc18d58058582e4591dbe" parent="c3a1e810ffb145f83821c3cbb70094e1" type="folder">3-6</container>
        </did>
        <accessrestrict id="afd021cfb4388a63de5e218998fd47c7">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="31cfa0b79a02b7866aa0dc7e48743280" level="file">
        <did>
          <unittitle>TML, 40-97 - New Triptans and other drugs for migraine</unittitle>
          <unitdate type="inclusive">1998 October 9</unitdate>
          <container id="d654ebaa612ea321ae3862831f7aae27" label="Mixed Materials (A0000000075877)" type="box">35</container>
          <container id="7a6633eec4805cfb367a5984d560436a" parent="d654ebaa612ea321ae3862831f7aae27" type="folder">7-12</container>
        </did>
        <accessrestrict id="43083e8c7ccdb0aa74b842657cd508ab">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="f35138cee47bea646beb32b2995d4598" level="file">
        <did>
          <unittitle>TML, 40-91 - Influenza vaccine, 1998-1999</unittitle>
          <unitdate type="inclusive">1998 September 11</unitdate>
          <container id="76affabb18a36295478dbf63d241d30f" label="Mixed Materials (A0000000075877)" type="box">35</container>
          <container id="b0b1aa3ade8ca3ae28e1d448771ab030" parent="76affabb18a36295478dbf63d241d30f" type="folder">13</container>
        </did>
        <accessrestrict id="a29dd57181aa1c5e6c3a1e5d3b488af7">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="7c2b7e050833f74d66d0b600d186eae5" level="file">
        <did>
          <unittitle>TML, 40-105 - Creatine and Androstenedione - two "dietary supplements"</unittitle>
          <unitdate type="inclusive">1998 November 6</unitdate>
          <container id="8e0f4d51beae276a9596d74bc36c7b99" label="Mixed Materials (A0000000075877)" type="box">35</container>
          <container id="f8392a44d06802486990817aaf7c7585" parent="8e0f4d51beae276a9596d74bc36c7b99" type="folder">14-16</container>
        </did>
        <accessrestrict id="bcbeeba99d41f442379b4633e1dc7778">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="a4342729d9ef2567742167972402009f" level="file">
        <did>
          <unittitle>TML, 39-107 - St. John's Wort</unittitle>
          <unitdate type="inclusive">1997 November 21</unitdate>
          <container id="47dbd4501a961a1ed5211237f1f3044c" label="Mixed Materials (A0000000075877)" type="box">35</container>
          <container id="577d83dbc94fd84df6b6f91895f697f2" parent="47dbd4501a961a1ed5211237f1f3044c" type="folder">17-18</container>
        </did>
        <accessrestrict id="f27838dbfd9cecfa9e71bf77f07fe682">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="ddfb397d4b944785854d8ea719c202bd" level="file">
        <did>
          <unittitle>TML, 41-73 - Malathion for treatment of head lice</unittitle>
          <unitdate type="inclusive">1999 August 13</unitdate>
          <container id="f20a025a39882a900a65a90b903b3df0" label="Mixed Materials (A0000000075878)" type="box">36</container>
          <container id="087ddbd1ebad597c2dbf8fcfb300b644" parent="f20a025a39882a900a65a90b903b3df0" type="folder">1-2</container>
        </did>
        <accessrestrict id="854b0f58396665c4e2d4a0465f949fd7">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2025</p>
        </accessrestrict>
      </c>
      <c id="35b97709b422b46ecdc94c987c5952ec" level="file">
        <did>
          <unittitle>TML, 41-39 - Advice for travelers</unittitle>
          <unitdate type="inclusive">1999 April 23</unitdate>
          <container id="30f3dcf323f9820e5f41f3baff719c95" label="Mixed Materials (A0000000075878)" type="box">36</container>
          <container id="9c82c54b04e48f578c7e44b8c5964e7e" parent="30f3dcf323f9820e5f41f3baff719c95" type="folder">3-4</container>
        </did>
        <accessrestrict id="04ad6f830bf72709637049c7b301499d">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2025</p>
        </accessrestrict>
      </c>
      <c id="f916a9e5c338ff7fc1707311815267f1" level="file">
        <did>
          <unittitle>TML, 41-30 - Modafinil for narcolepsy</unittitle>
          <unitdate type="inclusive">1999 March 26</unitdate>
          <container id="d876cc1e027d0d1e16aae11dae01c7cd" label="Mixed Materials (A0000000075878)" type="box">36</container>
          <container id="e1a5fe40b684232a2f1b2e1bf59a2db7" parent="d876cc1e027d0d1e16aae11dae01c7cd" type="folder">5-7</container>
        </did>
        <accessrestrict id="113f676d893d247079b5e4ff614aec1e">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2025</p>
        </accessrestrict>
      </c>
      <c id="2fc16ae414cf9dd501de68ee706014d5" level="file">
        <did>
          <unittitle>TML, 41-51 - Levalbuterol for asthma</unittitle>
          <unitdate type="inclusive">1999 June 4</unitdate>
          <container id="07b07b445e6f7bcb5767d05188adce89" label="Mixed Materials (A0000000075878)" type="box">36</container>
          <container id="a2d917f587f79c500f85a058a645044a" parent="07b07b445e6f7bcb5767d05188adce89" type="folder">8-10</container>
        </did>
        <accessrestrict id="17d7935132e18e8bac890aeefcb5960f">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2025</p>
        </accessrestrict>
      </c>
      <c id="3922b9c381c0b19cb3d63cbe803305a6" level="file">
        <did>
          <unittitle>TML, 41-16 - Mometasone furoate nasal spray for allergic rhinitis</unittitle>
          <unitdate type="inclusive">1999 February 12</unitdate>
          <container id="2af2af67f4136bd0d9d3a86af6aac905" label="Mixed Materials (A0000000075878)" type="box">36</container>
          <container id="65828d6291a5446549a4c36285f929e9" parent="2af2af67f4136bd0d9d3a86af6aac905" type="folder">11-12</container>
        </did>
        <accessrestrict id="481e161096febedcc11b1ed837e0109b">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2025</p>
        </accessrestrict>
      </c>
      <c id="4d4ebb415f82a62d6c6b5091a9afeb7a" level="file">
        <did>
          <unittitle>TML, 41-50 - Vaccine for rotavirus</unittitle>
          <unitdate type="inclusive">1999 May 21</unitdate>
          <container id="e7cff81892db7ce77c8267595e272aeb" label="Mixed Materials (A0000000075878)" type="box">36</container>
          <container id="6d8c8bf0a906730fba8da98f4824aad9" parent="e7cff81892db7ce77c8267595e272aeb" type="folder">13-14</container>
        </did>
        <accessrestrict id="b72eb586cf031b15f2ce8b6037f013b2">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2025</p>
        </accessrestrict>
      </c>
      <c id="65d972dc57e884b250ec76744f2d84f9" level="file">
        <did>
          <unittitle>TML, 41-91 - Two neuraminidase inhibitors for treatment of influenza</unittitle>
          <unitdate type="inclusive">1999 October 8</unitdate>
          <container id="58b721f93575702651bdef06d54492b4" label="Mixed Materials (A0000000075878)" type="box">36</container>
          <container id="d4590099df44432dbfaa30e3a7641706" parent="58b721f93575702651bdef06d54492b4" type="folder">15-17</container>
        </did>
        <accessrestrict id="6e3fe48fdf68db20082fc8bad62e904f">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2025</p>
        </accessrestrict>
      </c>
      <c id="26fd68ebafc0d8085fe92d2eb77fcbf6" level="file">
        <did>
          <unittitle>TML, 41-93 - Zaleplon for insomnia</unittitle>
          <unitdate type="inclusive">1999 October 8</unitdate>
          <container id="0b8a4728ba9f3658e002f072fd7924fa" label="Mixed Materials (A0000000075879)" type="box">37</container>
          <container id="a5a0847ecbe0c4d1bd579747f971702c" parent="0b8a4728ba9f3658e002f072fd7924fa" type="folder">1-4</container>
        </did>
        <accessrestrict id="b25acf713bbbe8621cf294856e16ba28">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2025</p>
        </accessrestrict>
      </c>
      <c id="ec877eb8397cacf7d82d77f65b127412" level="file">
        <did>
          <unittitle>TML, 41-1 - Tamoxife for the prevention of breast cancer</unittitle>
          <unitdate type="inclusive">1999 January 1</unitdate>
          <container id="e4005a68877ea78b349f445b0d6ed4ea" label="Mixed Materials (A0000000075879)" type="box">37</container>
          <container id="a255b8292f084033ad6b14423fdf7f19" parent="e4005a68877ea78b349f445b0d6ed4ea" type="folder">5-6</container>
        </did>
        <accessrestrict id="5090105f2f60079c4d3f971adf860516">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2025</p>
        </accessrestrict>
      </c>
      <c id="94ff8cec3e58b5c4d7bd8582a705f051" level="file">
        <did>
          <unittitle>TML, 41-123 - Temozolomide</unittitle>
          <unitdate type="inclusive">1999 December 17</unitdate>
          <container id="6860e53662f74eb7e3e753117331561c" label="Mixed Materials (A0000000075879)" type="box">37</container>
          <container id="5e4e7937a09388290aab4863ada50f3d" parent="6860e53662f74eb7e3e753117331561c" type="folder">7-8</container>
        </did>
        <accessrestrict id="7a64776358d5df180bb0a5ddbff0bef7">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2025</p>
        </accessrestrict>
      </c>
      <c id="a4b43b9f4b92e02c161ee56d03e178c9" level="file">
        <did>
          <unittitle>TML, 41-53 - Interferon plus ribavirin for chronic hepatitis C</unittitle>
          <unitdate type="inclusive">1999 June 4</unitdate>
          <container id="a9b9624c85a7d68f3b4d581b0bfe2ff9" label="Mixed Materials (A0000000075879)" type="box">37</container>
          <container id="1b1df87b252e9b585ccc8a12f845f006" parent="a9b9624c85a7d68f3b4d581b0bfe2ff9" type="folder">9-11</container>
        </did>
        <accessrestrict id="af177345fcae67c9d255185c0a10e870">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2025</p>
        </accessrestrict>
      </c>
      <c id="024012e8b7f7de531d716961ead029ce" level="file">
        <did>
          <unittitle>TML, 41-49 - Miglitol for Type 2 diabetes mellitus</unittitle>
          <unitdate type="inclusive">1999 May 21</unitdate>
          <container id="906276aa836615eb5c439c1601c55169" label="Mixed Materials (A0000000075879)" type="box">37</container>
          <container id="68dfbb8f9bc592fa4df7d78437b5ec91" parent="906276aa836615eb5c439c1601c55169" type="folder">12-13</container>
        </did>
        <accessrestrict id="d6f81a58c2dc3eaf1f79b5dc23f9a66b">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2025</p>
        </accessrestrict>
      </c>
      <c id="a9621527ed50246d7a862b61f10afb79" level="file">
        <did>
          <unittitle>TML, 41-110 - Rabeprazole</unittitle>
          <unitdate type="inclusive">1999 November 9</unitdate>
          <container id="fa03815c7ca8e411519ca5bdbf9076b2" label="Mixed Materials (A0000000075879)" type="box">37</container>
          <container id="c18fa1ba81ad67acd067c0501572cb06" parent="fa03815c7ca8e411519ca5bdbf9076b2" type="folder">14-15</container>
        </did>
        <accessrestrict id="fa2239be1fca64f3de4ed0688d43b5a6">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2025</p>
        </accessrestrict>
      </c>
      <c id="fcec222c26512f8ebe8b672bf459fbe9" level="file">
        <did>
          <unittitle>TML, 41-21 - Rifapentine for tuberculosis</unittitle>
          <unitdate type="inclusive">1999 February 26</unitdate>
          <container id="13f1d779ce9981a27d5f10c1d829543e" label="Mixed Materials (A0000000075879)" type="box">37</container>
          <container id="9135732b312e378108ddd0591ff06bc1" parent="13f1d779ce9981a27d5f10c1d829543e" type="folder">16-17</container>
        </did>
        <accessrestrict id="5eabb94693fe31a0f053df4c9645327d">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2025</p>
        </accessrestrict>
      </c>
      <c id="c2530250616ca691ba7d71e8d92ca5e1" level="file">
        <did>
          <unittitle>TML, 41-109 - Quinupristin (Dalfopristin)</unittitle>
          <unitdate type="inclusive">1999 November 19</unitdate>
          <container id="56b8ed0f4ba555898ceb378ddf7a2a37" label="Mixed Materials (A0000000075879)" type="box">37</container>
          <container id="6f33f4a11697b4ebecd77714ec093cc1" parent="56b8ed0f4ba555898ceb378ddf7a2a37" type="folder">18-19</container>
        </did>
        <accessrestrict id="96db099c24d150d666b7ebe07b50d611">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2025</p>
        </accessrestrict>
      </c>
      <c id="e80acff708763c79ba27fdf7b90311e5" level="file">
        <did>
          <unittitle>TML, 41-71 - Rosiglitazone for Type 2 diabetes mellitus</unittitle>
          <unitdate type="inclusive">1999 August 13</unitdate>
          <container id="178ff87beae5277b5f6b68275ae2d6ab" label="Mixed Materials (A0000000075880)" type="box">38</container>
          <container id="5ab8e9950079cbaf7e41378e760ef1af" parent="178ff87beae5277b5f6b68275ae2d6ab" type="folder">1-3</container>
        </did>
        <accessrestrict id="165ec4ab5ea0c075fdbea5fe2e192f3d">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2025</p>
        </accessrestrict>
      </c>
      <c id="703b499487840917db1eeb7a3bbf97c3" level="file">
        <did>
          <unittitle>TML - Drugs of Choice - Rheumatoid Arthritis</unittitle>
          <unitdate type="inclusive">1999</unitdate>
          <container id="a68a007375db22d118faf9d53c300844" label="Mixed Materials (A0000000075880)" type="box">38</container>
          <container id="9d26d123b93bd15cbf327106d0159b91" parent="a68a007375db22d118faf9d53c300844" type="folder">4-7</container>
        </did>
        <accessrestrict id="15f525d3017c59fe2b80a8ae96ac839d">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2025</p>
        </accessrestrict>
      </c>
      <c id="d1121bbf04acf6873bc6f6be66e80e1c" level="file">
        <did>
          <unittitle>TML, 41-59 - Rofecoxib for osteoarthritis and pain</unittitle>
          <unitdate type="inclusive">1999 July 2</unitdate>
          <container id="880aad83ce771000dddb90fe69473661" label="Mixed Materials (A0000000075880)" type="box">38</container>
          <container id="ab7e3ff6f8d4f327ca668ebcbee903b9" parent="880aad83ce771000dddb90fe69473661" type="folder">8-10</container>
        </did>
        <accessrestrict id="11221f9e1bc9230aebbe4b8afe4c8c85">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2025</p>
        </accessrestrict>
      </c>
      <c id="755deaec93a3a8f46413cdb9d38a9847" level="file">
        <did>
          <unittitle>TML, 41-84 - Pneumococcal vaccine</unittitle>
          <unitdate type="inclusive">1999 September 10</unitdate>
          <container id="501d9428b7f8cf30f8dfb59331c8d5e9" label="Mixed Materials (A0000000075880)" type="box">38</container>
          <container id="8166fbc73c19351ba44d3322101b9e24" parent="501d9428b7f8cf30f8dfb59331c8d5e9" type="folder">11-13</container>
        </did>
        <accessrestrict id="ad40d9598ad03e97e0de7ff5b12324c2">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2025</p>
        </accessrestrict>
      </c>
      <c id="0ee2e8ec8ef4a025a102da4125d330c6" level="file">
        <did>
          <unittitle>TML, 41-20 - Homeopathic products</unittitle>
          <unitdate type="inclusive">1999 February 26</unitdate>
          <container id="2c16924c1ebd82a54dec8cb5bd7a41d4" label="Mixed Materials (A0000000075880)" type="box">38</container>
          <container id="633b3c3bf0b6a5bd0cfe6b5c1ef2ed5c" parent="2c16924c1ebd82a54dec8cb5bd7a41d4" type="folder">14-16</container>
        </did>
        <accessrestrict id="1d27c989e3d0f4c9ca2d59fcac0ed578">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2025</p>
        </accessrestrict>
      </c>
      <c id="0f8ace5b9ab967ce17459254fb17ca75" level="file">
        <did>
          <unittitle>TML, 41-55 - Orlistat for obesity</unittitle>
          <unitdate type="inclusive">1999 June 18</unitdate>
          <container id="7fbde40f5217a1429ad82c18a3bea2f3" label="Mixed Materials (A0000000075880)" type="box">38</container>
          <container id="1999737523610fe75119b16b71e1a631" parent="7fbde40f5217a1429ad82c18a3bea2f3" type="folder">17</container>
        </did>
        <accessrestrict id="3afad4f5d733d9716d22ba16c44983fc">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2025</p>
        </accessrestrict>
      </c>
      <c id="b2928e0b146edbf6a03684604b2f6230" level="file">
        <did>
          <unittitle>TML, 41-69 - Prosorba column for rheumatoid arthritis</unittitle>
          <unitdate type="inclusive">1999 July 30</unitdate>
          <container id="efad7d2917460333aefd4910c1ba26b6" label="Mixed Materials (A0000000075880)" type="box">38</container>
          <container id="681186329232fadbe7dae8325f8d5de1" parent="efad7d2917460333aefd4910c1ba26b6" type="folder">18</container>
        </did>
        <accessrestrict id="f89d8a299f3aa1cb78fdeda3584f26e4">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2025</p>
        </accessrestrict>
      </c>
      <c id="e394fdb910a180949b33fcfe30e8b17c" level="file">
        <did>
          <unittitle>TML, 41-23 - Drugs for hypertension</unittitle>
          <unitdate type="inclusive">1999 March 12</unitdate>
          <container id="412988b88b2935925c43f29c2a74f71b" label="Mixed Materials (A0000000075881)" type="box">39</container>
          <container id="fc7b555945667b4ec60b1f3902b00e29" parent="412988b88b2935925c43f29c2a74f71b" type="folder">1-6</container>
        </did>
        <accessrestrict id="a85ce10fe729a0b9b0f29f163788bcd8">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2025</p>
        </accessrestrict>
      </c>
      <c id="1a3e95e6f5eb2cbf5b0cdb530d4df8b2" level="file">
        <did>
          <unittitle>TML, 41-113 - Drugs for non-HIV viral infection</unittitle>
          <unitdate type="inclusive">1999 December 3</unitdate>
          <container id="fefb0341b5719d27fa46fba17328b14e" label="Mixed Materials (A0000000075881)" type="box">39</container>
          <container id="0d4e0301523d793c1976896b19c329ee" parent="fefb0341b5719d27fa46fba17328b14e" type="folder">7-10</container>
        </did>
        <accessrestrict id="ddc058cf574899e5d0347e37efa9598e">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2025</p>
        </accessrestrict>
      </c>
      <c id="e42d2f63edb58feb20931053061b1339" level="file">
        <did>
          <unittitle>TML, 41-112 - Pioglitazone (Actos)</unittitle>
          <unitdate type="inclusive">1999 November 19</unitdate>
          <container id="9a76ebea399b3a59207cf5645b79451b" label="Mixed Materials (A0000000075881)" type="box">39</container>
          <container id="87ddf2cb2ebe4e9222fdfcd1e9aa2ca9" parent="9a76ebea399b3a59207cf5645b79451b" type="folder">11</container>
        </did>
        <accessrestrict id="2bf75590065032d73df0e0fa13732a7d">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2025</p>
        </accessrestrict>
      </c>
      <c id="28427104a307e9895b1500110c4ba78c" level="file">
        <did>
          <unittitle>TML, 41-43 - Suncreens - Are they safe and effective</unittitle>
          <unitdate type="inclusive">1999 May 7</unitdate>
          <container id="5b1a8fe89ce4a8e96a39430d89ed4f82" label="Mixed Materials (A0000000075881)" type="box">39</container>
          <container id="127df7b22bbd0a56804b5ceb69feec18" parent="5b1a8fe89ce4a8e96a39430d89ed4f82" type="folder">12-16</container>
        </did>
        <accessrestrict id="d50144a362c7ab5f8c046503c10ecf2a">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2025</p>
        </accessrestrict>
      </c>
      <c id="a4c7b991a97b85bed8305af27776e491" level="file">
        <did>
          <unittitle>TML, 41-56 - Cholesterol-lowering margarines</unittitle>
          <unitdate type="inclusive">1999 June 18</unitdate>
          <container id="c18d3477933138b750a6f4d151bf78ae" label="Mixed Materials (A0000000075881)" type="box">39</container>
          <container id="c6a5f42619bc1ba861f9112b0375bb30" parent="c18d3477933138b750a6f4d151bf78ae" type="folder">17-18</container>
        </did>
        <accessrestrict id="9b77ea87c2f2795c19e71f426864b471">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2025</p>
        </accessrestrict>
      </c>
      <c id="efd202ef6564adfebc4106108c9561f2" level="file">
        <did>
          <unittitle>TML, 41-56 - Cholesterol-lowering margarines</unittitle>
          <unitdate type="inclusive">1999 June 18</unitdate>
          <container id="11914ead65e4bf79de56ab83b0d335a8" label="Mixed Materials (A0000000075882)" type="box">40</container>
          <container id="1c1528d6c795bb17151bff1f65e12837" parent="11914ead65e4bf79de56ab83b0d335a8" type="folder">1-2</container>
        </did>
        <accessrestrict id="6304e26af10a0e94e7ef043fee53ad70">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2025</p>
        </accessrestrict>
      </c>
      <c id="5422bbde47d91ace2df22b5b7527a0e6" level="file">
        <did>
          <unittitle>TML, 41-105 - A new ACE inhibitorand two new angiotensin receptor blockers for hypertension</unittitle>
          <unitdate type="inclusive">1999 November 5</unitdate>
          <container id="7d7a25e4e2a1881727357000f81d2c72" label="Mixed Materials (A0000000075882)" type="box">40</container>
          <container id="11fc5552fab406efcb361ddf5e0fc133" parent="7d7a25e4e2a1881727357000f81d2c72" type="folder">3-6</container>
        </did>
        <accessrestrict id="e16a540da639162df21cb6fa8cf623e4">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2025</p>
        </accessrestrict>
      </c>
      <c id="087aeda452bdc8c1f70b599b752d152a" level="file">
        <did>
          <unittitle>TML, 41-67 - A new conjugated estrogen</unittitle>
          <unitdate type="inclusive">1999 July 30</unitdate>
          <container id="f3b10e7e7d4189a824ef7b95311d2b89" label="Mixed Materials (A0000000075882)" type="box">40</container>
          <container id="727ce461f7824007fea94e8e8baec5f5" parent="f3b10e7e7d4189a824ef7b95311d2b89" type="folder">7-8</container>
        </did>
        <accessrestrict id="3dd21eec3f06c65a80aa71eae6b88575">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2025</p>
        </accessrestrict>
      </c>
      <c id="e1ba3784eccce1db97752b63119a9737" level="file">
        <did>
          <unittitle>TML, 41-15 - Drugs and vaccines against biological warfare</unittitle>
          <unitdate type="inclusive">1999 February 12</unitdate>
          <container id="5d5c4ef26a1a7de072b58298027585f4" label="Mixed Materials (A0000000075882)" type="box">40</container>
          <container id="83896cb568583b95a5df54e3a9e1cfb1" parent="5d5c4ef26a1a7de072b58298027585f4" type="folder">9</container>
        </did>
        <accessrestrict id="a078c6c919634b8920e26478d73bef6a">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2025</p>
        </accessrestrict>
      </c>
      <c id="ee9f72d21997962aa5e1d76e60f28954" level="file">
        <did>
          <unittitle>TML, 41-68 - Laser hair removal</unittitle>
          <unitdate type="inclusive">1999 July 30</unitdate>
          <container id="fd4d8b6fba17fa863545dba91041fcf4" label="Mixed Materials (A0000000075882)" type="box">40</container>
          <container id="aee3fbc05ee8f1ab5537b76e228de074" parent="fd4d8b6fba17fa863545dba91041fcf4" type="folder">10-11</container>
        </did>
        <accessrestrict id="0797b526bde059f59517ea165bdcb518">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2025</p>
        </accessrestrict>
      </c>
      <c id="0f4d6a53975d9232738144f364667da0" level="file">
        <did>
          <unittitle>TML - Drugs of Choice - Parkinson's Disease</unittitle>
          <unitdate type="inclusive">1999</unitdate>
          <container id="71d3dba7cd202b03510d5633237d2294" label="Mixed Materials (A0000000075882)" type="box">40</container>
          <container id="bef7d207ae57f76ead2d29bca107e0d6" parent="71d3dba7cd202b03510d5633237d2294" type="folder">12-16</container>
        </did>
        <accessrestrict id="ca7184a59b6ddfe5ef00a19434c19c48">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2025</p>
        </accessrestrict>
      </c>
      <c id="5db523527161519d86f176dd07137b4b" level="file">
        <did>
          <unittitle>TML, 41-5 - Drugs for Asthma</unittitle>
          <unitdate type="inclusive">1999 January 15</unitdate>
          <container id="1e7950d28bb02a83d662c13dff0c62fe" label="Mixed Materials (A0000000075883)" type="box">41</container>
          <container id="19c935f66fdb6408dcfe13dbf6b86ef5" parent="1e7950d28bb02a83d662c13dff0c62fe" type="folder">1-5</container>
        </did>
        <accessrestrict id="24b467056399b27bd316ca395f5c8a5e">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2025</p>
        </accessrestrict>
      </c>
      <c id="3c1f55d592280bce047dbd773f816697" level="file">
        <did>
          <unittitle>TML, 41-12 - Drugs for chronic heart failure</unittitle>
          <unitdate type="inclusive">1999 January 29</unitdate>
          <container id="1ef0569a59b2a223b2641af6da1f1134" label="Mixed Materials (A0000000075883)" type="box">41</container>
          <container id="f9f02efdcba188800982fc7a7e0673b8" parent="1ef0569a59b2a223b2641af6da1f1134" type="folder">6-8</container>
        </did>
        <accessrestrict id="a82b9541fad7707df8ff8e0ecec045a1">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2025</p>
        </accessrestrict>
      </c>
      <c id="a5ef95fdd53a4ad00be13d575b720a90" level="file">
        <did>
          <unittitle>TML, 41-32 - Valrubicin for bladder cancer</unittitle>
          <unitdate type="inclusive">1999 March 26</unitdate>
          <container id="1cb18a2f1a6ee7fbabbb5984ab5dc5dc" label="Mixed Materials (A0000000075883)" type="box">41</container>
          <container id="e85d723642213bd3127084a1c8f577eb" parent="1cb18a2f1a6ee7fbabbb5984ab5dc5dc" type="folder">9</container>
        </did>
        <accessrestrict id="1246d47b99a5b28275ca7ac909e04e17">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2025</p>
        </accessrestrict>
      </c>
      <c id="c9b5394af1307b91512bebaa47987a03" level="file">
        <did>
          <unittitle>TML, 41-19 - Infliximab (Remicade) for Crohn's disease</unittitle>
          <unitdate type="inclusive">1999 February 26</unitdate>
          <container id="b143eff0bd3a0e704a7e9a22fb2880e0" label="Mixed Materials (A0000000075883)" type="box">41</container>
          <container id="992115f4965495242f6459778987edfc" parent="b143eff0bd3a0e704a7e9a22fb2880e0" type="folder">10-11</container>
        </did>
        <accessrestrict id="bceed6a85bb227d8a5c9b54693104fa7">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2025</p>
        </accessrestrict>
      </c>
      <c id="9431f5004a39b8a0d9a05be98633933b" level="file">
        <did>
          <unittitle>TML, 41-82 - Influenza vaccine, 1999-2000</unittitle>
          <unitdate type="inclusive">1999 September 10</unitdate>
          <container id="6b8c41dbd7ebbeec3134c759d21dd2fe" label="Mixed Materials (A0000000075883)" type="box">41</container>
          <container id="e2d58b24a60d67f042beb42368305622" parent="6b8c41dbd7ebbeec3134c759d21dd2fe" type="folder">12-13</container>
        </did>
        <accessrestrict id="cab250b6e8f335e1e9356ce49870aa0f">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2025</p>
        </accessrestrict>
      </c>
      <c id="aa75d744d2b7b8eae4e0c83305434171" level="file">
        <did>
          <unittitle>TML, 41-81 - Spironolactone for heart failure</unittitle>
          <unitdate type="inclusive">1999 September 10</unitdate>
          <container id="942fc60cc2219c128a12ef11f90242e5" label="Mixed Materials (A0000000075883)" type="box">41</container>
          <container id="8c7077c9d330057d38f8f13f540406e8" parent="942fc60cc2219c128a12ef11f90242e5" type="folder">14-15</container>
        </did>
        <accessrestrict id="4baffc7980c89aadb8cef585c345f731">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2025</p>
        </accessrestrict>
      </c>
      <c id="12a411c26719cadf670414ea9db35b3a" level="file">
        <did>
          <unittitle>TML, 41-2 - Growth-hormone-releasing factor for growth hormone deficiency</unittitle>
          <unitdate type="inclusive">1999 January 1</unitdate>
          <container id="669a268591bbfdedf6da6cf77dc019f6" label="Mixed Materials (A0000000075883)" type="box">41</container>
          <container id="6d6369ae6b58641c21c9fcf76c9a74c5" parent="669a268591bbfdedf6da6cf77dc019f6" type="folder">16-18</container>
        </did>
        <accessrestrict id="f46608e112550ebc9f422dd17a55e3b3">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2025</p>
        </accessrestrict>
      </c>
      <c id="50fdbec047db8cdec50f09ae8f09ce33" level="file">
        <did>
          <unittitle>TML, 41-18 - Saw Palmetto for benign prostatic hyperplasia</unittitle>
          <unitdate type="inclusive">1999 February 12</unitdate>
          <container id="3ae2e55ce7dacb09003205290a5e81f2" label="Mixed Materials (A0000000075884)" type="box">42</container>
          <container id="94746c87461743f7e7bfcd7f1f9a9f40" parent="3ae2e55ce7dacb09003205290a5e81f2" type="folder">1-3</container>
        </did>
        <accessrestrict id="ebda9b553416d292abf3337874edf243">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2025</p>
        </accessrestrict>
      </c>
      <c id="12974761e15d5b5a631f8a1708a1d0e6" level="file">
        <did>
          <unittitle>TML, 41-107 - SAMe for depression</unittitle>
          <unitdate type="inclusive">1999 November 5</unitdate>
          <container id="f7188f5ec626c0ac578de36d5f744e72" label="Mixed Materials (A0000000075884)" type="box">42</container>
          <container id="f10919fd74ebae9ed96e0410f5af23bf" parent="f7188f5ec626c0ac578de36d5f744e72" type="folder">4-7</container>
        </did>
        <accessrestrict id="9f6ccc892b5225ac4e542904aba616bf">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2025</p>
        </accessrestrict>
      </c>
      <c id="2891c6463578c91c35a01dfbc0867c34" level="file">
        <did>
          <unittitle>TML, 41-3 - Palivizumab (Synagis) for prevention of RSV infection</unittitle>
          <unitdate type="inclusive">1999 January 1</unitdate>
          <container id="0930d971a72db585133e026dd7441a7a" label="Mixed Materials (A0000000075884)" type="box">42</container>
          <container id="42f5344ca2ed9c9f88a1b8f021869cd7" parent="0930d971a72db585133e026dd7441a7a" type="folder">8-9</container>
        </did>
        <accessrestrict id="b084224a8b4665a510e8da9d5962cae8">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2025</p>
        </accessrestrict>
      </c>
      <c id="aa2d0e7ffb5da88f1ad0bda04c4f91da" level="file">
        <did>
          <unittitle>TML, 41:47 - Generic Drugs</unittitle>
          <unitdate type="inclusive">1999 May 21</unitdate>
          <container id="433c630871effa3c9d8b8c71ce03ed38" label="Mixed Materials (A0000000075884)" type="box">42</container>
          <container id="f83cad4f25175cd47bd3db6c401c07f9" parent="433c630871effa3c9d8b8c71ce03ed38" type="folder">10-15</container>
        </did>
        <accessrestrict id="d25ac57dbed224f7c437f5c406d80bfb">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2025</p>
        </accessrestrict>
      </c>
      <c id="d463206ca7312a03520c55b4035d6d7c" level="file">
        <did>
          <unittitle>TML, 41-64 - Amprenavir - a new HIV protease inhibitor</unittitle>
          <unitdate type="inclusive">1999 July 16</unitdate>
          <container id="1dae327397ee47a76ebdafda7961851f" label="Mixed Materials (A0000000075884)" type="box">42</container>
          <container id="993fe4b5c85c56808bfe45f65110d9de" parent="1dae327397ee47a76ebdafda7961851f" type="folder">16-17</container>
        </did>
        <accessrestrict id="bebb6703e7e1148e21f6bff4883b5f0e">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2025</p>
        </accessrestrict>
      </c>
      <c id="dacba7e70abbc68ca64fcd4963a6f95a" level="file">
        <did>
          <unittitle>TML, 41-75 - Antimicrobial prophylaxis in surgery</unittitle>
          <unitdate type="inclusive">1999 August 27</unitdate>
          <container id="1c9644e9692fd292d72cc4886397f437" label="Mixed Materials (A0000000075884)" type="box">42</container>
          <container id="f9470197d21ff53a671f877f70617f7c" parent="1c9644e9692fd292d72cc4886397f437" type="folder">18</container>
        </did>
        <accessrestrict id="a555f10f258ebdc237376c5bf299600d">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2025</p>
        </accessrestrict>
      </c>
      <c id="813dc879c0e4261b5ae728f45f81e536" level="file">
        <did>
          <unittitle>TML, 41-75 - Antimicrobial prophylaxis in surgery</unittitle>
          <unitdate type="inclusive">1999 August 27</unitdate>
          <container id="633a90f22396be35270f5f557b4e5161" label="Mixed Materials (A0000000075885)" type="box">43</container>
          <container id="aec61605b27a97e8e9cb616daeb51eb8" parent="633a90f22396be35270f5f557b4e5161" type="folder">1-3</container>
        </did>
        <accessrestrict id="64327b946a10f94bc40f30737c8f1cd2">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2025</p>
        </accessrestrict>
      </c>
      <c id="bdc50b4955f16ee4564f9a2f1ecc15ee" level="file">
        <did>
          <unittitle>TML, 41-95 - The Choice of antibacterial drugs</unittitle>
          <unitdate type="inclusive">1999 October 22</unitdate>
          <container id="1b6c3041849d8d7d9dc2483d0125e1a6" label="Mixed Materials (A0000000075885)" type="box">43</container>
          <container id="a87592ce1847a6a86663bb1625e94cb1" parent="1b6c3041849d8d7d9dc2483d0125e1a6" type="folder">4-8</container>
        </did>
        <accessrestrict id="6b1bb72d82bf5bc8c23cfe7d730b6597">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2025</p>
        </accessrestrict>
      </c>
      <c id="9edd35ab1f22644cf6c65fedb0f5fd9d" level="file">
        <did>
          <unittitle>TML, 41-63 - Cosmetic use of botulinum toxin</unittitle>
          <unitdate type="inclusive">1999 July 16</unitdate>
          <container id="0b2b6cec41854e80287eff6553e6d469" label="Mixed Materials (A0000000075885)" type="box">43</container>
          <container id="960589c778ba7c9202087057b8299700" parent="0b2b6cec41854e80287eff6553e6d469" type="folder">9-12</container>
        </did>
        <accessrestrict id="dfa20e59cc18902aef49d7b5c22d5eb5">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2025</p>
        </accessrestrict>
      </c>
      <c id="cadd4aba2aafedf04d2457bcd20ecb68" level="file">
        <did>
          <unittitle>TML, 41-29 - Lyme disease vaccine</unittitle>
          <unitdate type="inclusive">1999 March 26</unitdate>
          <container id="b7054dca8b3dc302e42ecc6d154e7b82" label="Mixed Materials (A0000000075885)" type="box">43</container>
          <container id="d86ceed3c5d8899b94a24164e5c53479" parent="b7054dca8b3dc302e42ecc6d154e7b82" type="folder">13-16</container>
        </did>
        <accessrestrict id="ebb5315c0e462b0e2629b5dcb90203c8">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2025</p>
        </accessrestrict>
      </c>
      <c id="bb27af27ca7507bfd777f78da0d17147" level="file">
        <did>
          <unittitle>TML, 41-121 - Rapid diagnostic tests for influenza</unittitle>
          <unitdate type="inclusive">1999 December 17</unitdate>
          <container id="26654a5cb7b08da2ab0d6cf76f2fae4f" label="Mixed Materials (A0000000075885)" type="box">43</container>
          <container id="a4fe3567c04e45650555fd6c008d1d9b" parent="26654a5cb7b08da2ab0d6cf76f2fae4f" type="folder">17-18</container>
        </did>
        <accessrestrict id="86662934e660af89d7aeaa4e4d013446">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2025</p>
        </accessrestrict>
      </c>
      <c id="cf44b51a4bbfd2f5063743b63c4a93e3" level="file">
        <did>
          <unittitle>TML, 41-85 - Drugs for sexually transmitted infections</unittitle>
          <unitdate type="inclusive">1999 September 24</unitdate>
          <container id="e5e96cf757eb3719cce772c7332cad24" label="Mixed Materials (A0000000075885)" type="box">43</container>
          <container id="453c388e063a3a1588a87156fe40c9d6" parent="e5e96cf757eb3719cce772c7332cad24" type="folder">19</container>
        </did>
        <accessrestrict id="53ace92e24d776a3c07d0e679ac418eb">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2025</p>
        </accessrestrict>
      </c>
      <c id="98fd7e915d5c04bccf9bfee05be98149" level="file">
        <did>
          <unittitle>TML, 41-85 - Drugs for sexually transmitted infections</unittitle>
          <unitdate type="inclusive">1999 September 24</unitdate>
          <container id="dfec8769660c40c5430c8765d646ee05" label="Mixed Materials (A0000000075886)" type="box">44</container>
          <container id="41978a9de286834c473383aa18ee2b6f" parent="dfec8769660c40c5430c8765d646ee05" type="folder">1-3</container>
        </did>
        <accessrestrict id="4fa538c8b0c22de3e0eea7db981ae287">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2025</p>
        </accessrestrict>
      </c>
      <c id="47b865bf089a172b75b4d43ce7a1e447" level="file">
        <did>
          <unittitle>TML, 41-33 - Depression and anxiety</unittitle>
          <unitdate type="inclusive">1999 April 9</unitdate>
          <container id="4820c99f3ab915070637f8b8f889621f" label="Mixed Materials (A0000000075886)" type="box">44</container>
          <container id="229b485cec31adaf5fbe3f08679b05b6" parent="4820c99f3ab915070637f8b8f889621f" type="folder">4-13</container>
        </did>
        <accessrestrict id="b0f422d658f31862e120da53fa05b6f9">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2025</p>
        </accessrestrict>
      </c>
      <c id="71225c0666898a85e784b2cb281888c6" level="file">
        <did>
          <unittitle>TML, 41-122 - Corneal surgery for correction of refractive errors</unittitle>
          <unitdate type="inclusive">1999 December 17</unitdate>
          <container id="ecb4a5577063de694b0738187d5fa636" label="Mixed Materials (A0000000075886)" type="box">44</container>
          <container id="47b93c287470db329a64622c623e867e" parent="ecb4a5577063de694b0738187d5fa636" type="folder">14-16</container>
        </did>
        <accessrestrict id="383c5c203f77ebf4dd9e3dfe67c24cf7">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2025</p>
        </accessrestrict>
      </c>
      <c id="45f2b2be0a5f877794d8dab41d1e2c89" level="file">
        <did>
          <unittitle>TML - Drugs of Choice - Epilepsy</unittitle>
          <unitdate type="inclusive">1999</unitdate>
          <container id="c6d498e4734af59db385978f5152bc65" label="Mixed Materials (A0000000075886)" type="box">44</container>
          <container id="5928b5bfd8363344981933819a92989d" parent="c6d498e4734af59db385978f5152bc65" type="folder">17-18</container>
        </did>
        <accessrestrict id="149a9e74e2c2eb4d35105c1043e77fd1">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2025</p>
        </accessrestrict>
      </c>
      <c id="59f39d33e558df2c7a53b2df2d17a4ae" level="file">
        <did>
          <unittitle>TML - Drugs of Choice - Epilepsy</unittitle>
          <unitdate type="inclusive">1999</unitdate>
          <container id="e3582c00ade4ceb14feadc7dd39d6a7d" label="Mixed Materials (A0000000075887)" type="box">45</container>
          <container id="946108214240a0d3d4533628d3084c36" parent="e3582c00ade4ceb14feadc7dd39d6a7d" type="folder">1-3</container>
        </did>
        <accessrestrict id="6cab2eae0fd66d97ea7c349b2f4718db">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2025</p>
        </accessrestrict>
      </c>
      <c id="8d82b612550e56f5febd997b649248f6" level="file">
        <did>
          <unittitle>TML - Drugs for Cardiac Arrhythmias</unittitle>
          <unitdate type="inclusive">1999</unitdate>
          <container id="c6d74f250357b42d82ec85cc318444c9" label="Mixed Materials (A0000000075887)" type="box">45</container>
          <container id="ce75c8ae0610f1c13062284d9ef86194" parent="c6d74f250357b42d82ec85cc318444c9" type="folder">4-9</container>
        </did>
        <accessrestrict id="9ea5dcafb096eb9d1dba6ab8571932c7">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2025</p>
        </accessrestrict>
      </c>
      <c id="729c9bb0e1660ceb032fe6da8350333c" level="file">
        <did>
          <unittitle>TML - Drugs of Choice for cancer chemotherapy</unittitle>
          <unitdate type="inclusive">1999</unitdate>
          <container id="3476e0ef72a0cd228b11a43c4a3f5e04" label="Mixed Materials (A0000000075887)" type="box">45</container>
          <container id="27c64570858d65bc9e6f5c5fbda859cf" parent="3476e0ef72a0cd228b11a43c4a3f5e04" type="folder">10-16</container>
        </did>
        <accessrestrict id="5ad67e35d3361f03756bfe78c6e60019">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2025</p>
        </accessrestrict>
      </c>
      <c id="737148b055ba101acbd8ee7df7c07e4c" level="file">
        <did>
          <unittitle>TML, 41-44 - Cilostazol for intermittent claudication</unittitle>
          <unitdate type="inclusive">1999 May 7</unitdate>
          <container id="792624347f70c20beaaf6c609987c6eb" label="Mixed Materials (A0000000075887)" type="box">45</container>
          <container id="cabc2022a1fff2bbc3fb79bc5930b630" parent="792624347f70c20beaaf6c609987c6eb" type="folder">17-20</container>
        </did>
        <accessrestrict id="91985532c77a98b2be6619b3829a2c87">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2025</p>
        </accessrestrict>
      </c>
      <c id="6e0f28a2b5a8cac84be32ec338816dac" level="file">
        <did>
          <unittitle>TML, 41-11 - Celecoxib for arthritis</unittitle>
          <unitdate type="inclusive">1999 January 29</unitdate>
          <container id="3ce7701ef5c1d594a963ae8ace36fead" label="Mixed Materials (A0000000075888)" type="box">46</container>
          <container id="1828264a8059a38e6c6e17ef3544435b" parent="3ce7701ef5c1d594a963ae8ace36fead" type="folder">1-4</container>
        </did>
        <accessrestrict id="5220646ffa341e43aaef650d57ef5cbb">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2025</p>
        </accessrestrict>
      </c>
      <c id="47ee2aa0e1414311aab659a0b7791d48" level="file">
        <did>
          <unittitle>TML, 41-61 - Drug interactions</unittitle>
          <unitdate type="inclusive">1999 July 2</unitdate>
          <container id="3d478f3d23612b1459141b742110e7a8" label="Mixed Materials (A0000000075945)" type="box">103</container>
          <container id="19e278b384b06cbb827d034344939b9a" parent="3d478f3d23612b1459141b742110e7a8" type="folder">1-4</container>
        </did>
        <accessrestrict id="2310dca3aaada449df04e476753e097f">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2025</p>
        </accessrestrict>
      </c>
      <c id="ca7a582ccc3762635c6b2b1ab49c2e38" level="file">
        <did>
          <unittitle>TML, 42-51 - Ciclopirox (Penlac) nail lacquer for onychomysis</unittitle>
          <unitdate type="inclusive">2000 June 12</unitdate>
          <container id="f0e73193d3e575c75402dde909f516e9" label="Mixed Materials (A0000000075889)" type="box">47</container>
          <container id="4f5303d07f082a340b822cdb87369d7d" parent="f0e73193d3e575c75402dde909f516e9" type="folder">1-2</container>
        </did>
        <accessrestrict id="9580c594e1986354a883d0b4d0b71bc3">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="4b13f0ecb976a0758dff29129231c5ab" level="file">
        <did>
          <unittitle>TML, 42-70 - Cevimeline (Evoxac) for dry mouth</unittitle>
          <unitdate type="inclusive">2000 August 7</unitdate>
          <container id="387b53cd62728da12a76f82785ec14b3" label="Mixed Materials (A0000000075889)" type="box">47</container>
          <container id="9223c925a92d2b02790ad8a5a068bf9f" parent="387b53cd62728da12a76f82785ec14b3" type="folder">3</container>
        </did>
        <accessrestrict id="ab5ca835a64facd8b0328a6bddeaa9db">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="65fedbec948e0fc83c65d93e86ad6afd" level="file">
        <did>
          <unittitle>TML, 42-13 - Sirolimus (Rapamune) for transplant rejection</unittitle>
          <unitdate type="inclusive">2000 February 7</unitdate>
          <container id="7e0717ce68638b480d4710ee93eaa846" label="Mixed Materials (A0000000075889)" type="box">47</container>
          <container id="e4344c622081d6af65af1e02004e3607" parent="7e0717ce68638b480d4710ee93eaa846" type="folder">4-6</container>
        </did>
        <accessrestrict id="7082abcbc2a52e308ef67322853d8731">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="43b3f1afcb8ce7fdcc73ea538a9dcaef" level="file">
        <did>
          <unittitle>TML, 42-56 - Drug interactions with St. John's Wort</unittitle>
          <unitdate type="inclusive">2000 June 26</unitdate>
          <container id="fccc92073b01832d8c589e1f56c3a6f6" label="Mixed Materials (A0000000075889)" type="box">47</container>
          <container id="d3c2fd7feaec2fcd73f004fe3f3a6ff7" parent="fccc92073b01832d8c589e1f56c3a6f6" type="folder">7-9</container>
        </did>
        <accessrestrict id="fc05579a4affa53f15f6bf7701c8c36c">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="13d9761c756a2fe7adb0ccd2bd89e5c3" level="file">
        <did>
          <unittitle>TML, 42-27 - Curosurf</unittitle>
          <unitdate type="inclusive">2000 March 20</unitdate>
          <container id="56e0ee8e52dbf89bdfc8b0a8be9fdd4e" label="Mixed Materials (A0000000075889)" type="box">47</container>
          <container id="6abbc13a61d07797027f21dc0868152a" parent="56e0ee8e52dbf89bdfc8b0a8be9fdd4e" type="folder">10-12</container>
        </did>
        <accessrestrict id="a42091b45287859d025abbb92f4814dc">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="c1fd925b81d971c06ec273ef08f3cb74" level="file">
        <did>
          <unittitle>TML, 42-81 - Photodynamic therapy with veterfporfin (Visudyne) for macular degeneration</unittitle>
          <unitdate type="inclusive">2000 September 4</unitdate>
          <container id="54ec1d4312e337bca718948e8b104408" label="Mixed Materials (A0000000075889)" type="box">47</container>
          <container id="aa49850b5083cf314992de6c03d060ce" parent="54ec1d4312e337bca718948e8b104408" type="folder">13-15</container>
        </did>
        <accessrestrict id="25831287c40dd007e7ad4f179aa90da2">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="259c3ccf591bab51ffdaba3a9994e765" level="file">
        <did>
          <unittitle>TML, 42-57 - Drugs for rheumatoid arthritis</unittitle>
          <unitdate type="inclusive">2000 July 10</unitdate>
          <container id="a1e34d26a6478108ab5e1cc472919e5d" label="Mixed Materials (A0000000075889)" type="box">47</container>
          <container id="febc63974852f7e7f6631a1e55418ee4" parent="a1e34d26a6478108ab5e1cc472919e5d" type="folder">16-20</container>
        </did>
        <accessrestrict id="162cb0e7647f4a98954f5445c257c882">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="62b6871b865b6d75c47266161b21cb21" level="file">
        <did>
          <unittitle>TML, 42-113 - Phenylpropanolamine</unittitle>
          <unitdate type="inclusive">2000 December 11</unitdate>
          <container id="ec9114d62f1571debf7b67ef3377c9f4" label="Mixed Materials (A0000000075890)" type="box">48</container>
          <container id="1703217eccab041225b5d65443eb74bd" parent="ec9114d62f1571debf7b67ef3377c9f4" type="folder">1</container>
        </did>
        <accessrestrict id="3a8380c96fc7714fa7d33e8fc9eda5f1">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="7e8cf0d2095db89bdcf602dcfa388b37" level="file">
        <did>
          <unittitle>TML, 42-94 - Zonisamide (Zonegran) for epilepsy</unittitle>
          <unitdate type="inclusive">2000 August 1</unitdate>
          <container id="70228f1b3bc7794c51d13622b8f90aa1" label="Mixed Materials (A0000000075890)" type="box">48</container>
          <container id="a7be374b28820ca3702dc37ab9792162" parent="70228f1b3bc7794c51d13622b8f90aa1" type="folder">2-4</container>
        </did>
        <accessrestrict id="af9a344f43755a6c943435e3e709888a">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="505b60f40ff960c724ff856e304ce951" level="file">
        <did>
          <unittitle>TML, 42-10 - Emergency Contraception - Plan B</unittitle>
          <unitdate type="inclusive">2000 January 24</unitdate>
          <container id="ff29b105710e16132e82e9a100807031" label="Mixed Materials (A0000000075890)" type="box">48</container>
          <container id="3e36855ee00e612765f751f9b2365ff1" parent="ff29b105710e16132e82e9a100807031" type="folder">5</container>
        </did>
        <accessrestrict id="3cd71612bf2f98b55022fa5ad125e9e2">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="86b41328d3a3f3bd0b39258221d169af" level="file">
        <did>
          <unittitle>TML, 42-42 - Oral contraceptives</unittitle>
          <unitdate type="inclusive">2000 May 15</unitdate>
          <container id="00af07a4c4e45c5ef73655066d4af4e4" label="Mixed Materials (A0000000075890)" type="box">48</container>
          <container id="7700240cf58de54f85c0c4d1880f28ae" parent="00af07a4c4e45c5ef73655066d4af4e4" type="folder">6-11</container>
        </did>
        <accessrestrict id="362a441b3fc8d8a82b31585a57ea0665">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="5af9d8711bf691d44ab3b1e5bb256681" level="file">
        <did>
          <unittitle>TML, 42-17 - Phytoestrogens</unittitle>
          <unitdate type="inclusive">2000 February 21</unitdate>
          <container id="7d23bf3c02d1088e3a210c683423cbfa" label="Mixed Materials (A0000000075890)" type="box">48</container>
          <container id="9ca361a16f09c06a97913173fc34d5ca" parent="7d23bf3c02d1088e3a210c683423cbfa" type="folder">12-14</container>
        </did>
        <accessrestrict id="b6923da0f1e80e36ed724d7930240ab0">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="408be2b8c6034a613b1211f2ecf9b661" level="file">
        <did>
          <unittitle>TML, 42-29 - Calcium citrate vs Calcium carbonate calcium supplements</unittitle>
          <unitdate type="inclusive">2000 April 3</unitdate>
          <container id="850e52cd6d7b33c063351bb1344c1f9e" label="Mixed Materials (A0000000075890)" type="box">48</container>
          <container id="3277f0375fd9c3bbb214b407fde14e76" parent="850e52cd6d7b33c063351bb1344c1f9e" type="folder">15-16</container>
        </did>
        <accessrestrict id="f012aa712ae69a791944518eafe15ae9">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="3335c85c5f584c0623918d305860bba9" level="file">
        <did>
          <unittitle>TML, 42-47 - Meloxicam (Mobic) for osteoarthritis</unittitle>
          <unitdate type="inclusive">2000 May 29</unitdate>
          <container id="85b15fb87050cf5d5bcca439034c3219" label="Mixed Materials (A0000000075890)" type="box">48</container>
          <container id="c02865b489c0db7de1a976de4507ffb6" parent="85b15fb87050cf5d5bcca439034c3219" type="folder">17-18</container>
        </did>
        <accessrestrict id="55427e8bb48ad2b8315333c1ff339476">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="c6d41dc2321b4992a2ce79264290f903" level="file">
        <did>
          <unittitle>TML, 42-47 - Meloxicam (Mobic) for osteoarthritis</unittitle>
          <unitdate type="inclusive">2000 May 29</unitdate>
          <container id="a893c7e4b617cc2f2a9b0a1048d2cf55" label="Mixed Materials (A0000000075891)" type="box">49</container>
          <container id="eaccd39c9e75b51b7af43ec29fa4322d" parent="a893c7e4b617cc2f2a9b0a1048d2cf55" type="folder">1</container>
        </did>
        <accessrestrict id="a4945089c03fcb0a219bdaccf387431a">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="1ff03efd208b21a2efb1beeeca59fbe2" level="file">
        <did>
          <unittitle>TML, 42-41 - Dofetilide for atrial fibrillation</unittitle>
          <unitdate type="inclusive">2000 May 15</unitdate>
          <container id="1b3aae4dc640ddb08f119bebfa90d5c4" label="Mixed Materials (A0000000075891)" type="box">49</container>
          <container id="992af2348d8893c6574dac15cd9f8597" parent="1b3aae4dc640ddb08f119bebfa90d5c4" type="folder">2-4</container>
        </did>
        <accessrestrict id="f05aa84b2f28b6ffb33fe96ec43cd992">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="97e9932d34799dd8520be9e13f8a01ce" level="file">
        <did>
          <unittitle>TML, 40-102 - Colesevelam (Welchol) for hypercholesterolemia</unittitle>
          <unitdate type="inclusive">2000 October 30</unitdate>
          <container id="3f5dcac0560ad4c31539c8b369e9d4b2" label="Mixed Materials (A0000000075891)" type="box">49</container>
          <container id="c9c51154b2cf01d9ab288ef20b8a380a" parent="3f5dcac0560ad4c31539c8b369e9d4b2" type="folder">5</container>
        </did>
        <accessrestrict id="349dee1a0f2981a7afaffa486ad92400">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="b1e989f44b7978ab2b1aaaf201f34aeb" level="file">
        <did>
          <unittitle>TML, 42-108 - Docosanal cream (Abreva) for recurrent herpes labialis</unittitle>
          <unitdate type="inclusive">2000 November 13</unitdate>
          <container id="ca99b7f008ed218a5318147686ad5b08" label="Mixed Materials (A0000000075891)" type="box">49</container>
          <container id="5296d73de021bdb5753a28e56c49db10" parent="ca99b7f008ed218a5318147686ad5b08" type="folder">6</container>
        </did>
        <accessrestrict id="086b94bfdd5ebcae1564c66a07d71bf4">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="e0e61fb5a1e14299b5769bb3645966af" level="file">
        <did>
          <unittitle>TML, 42-106 - Temecteplase (TNKASE) for thrombolysis</unittitle>
          <unitdate type="inclusive">2000 November 13</unitdate>
          <container id="ecc1393c5ceda0e72f02019f83609039" label="Mixed Materials (A0000000075891)" type="box">49</container>
          <container id="69e9fd85e1c7c8dad056f2d7dab5eb91" parent="ecc1393c5ceda0e72f02019f83609039" type="folder">7-10</container>
        </did>
        <accessrestrict id="6881f1eb6305a22e4485bcca7bf92f20">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="3d342507f2c128f34587c4f458c47ae3" level="file">
        <did>
          <unittitle>TML, 42-113 - Valproate and other anticonvulsants for psychiatric disorders</unittitle>
          <unitdate type="inclusive">2000 December 11</unitdate>
          <container id="ec91e069254357b1ff3a6a54cb1f6ba7" label="Mixed Materials (A0000000075891)" type="box">49</container>
          <container id="c00e4e1b7a06da83c74cb3732e624fb2" parent="ec91e069254357b1ff3a6a54cb1f6ba7" type="folder">11-14</container>
        </did>
        <accessrestrict id="175706ce1b1be1373cdbf4234daea11e">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="89f1be4de95ddec6822bda7f0e83b385" level="file">
        <did>
          <unittitle>TML, 42-8 - Prevention of malaria</unittitle>
          <unitdate type="inclusive">2000 January 24</unitdate>
          <container id="4151732ca76f655bc0f0b5d68d9b0dbc" label="Mixed Materials (A0000000075891)" type="box">49</container>
          <container id="e974a62dbdd4af55465bb788a6e149fa" parent="4151732ca76f655bc0f0b5d68d9b0dbc" type="folder">15</container>
        </did>
        <accessrestrict id="9af6ac60aa40dc6005ce4edb57dc6970">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="da557a8aeefe93b11b7b65ef3275ee26" level="file">
        <did>
          <unittitle>TML, 42-37 - Lyme disease</unittitle>
          <unitdate type="inclusive">2000 May 1</unitdate>
          <container id="ceaeca0a6ef5c9002b29cf68002b34e1" label="Mixed Materials (A0000000075891)" type="box">49</container>
          <container id="1c136c26cff99e7bd36d913aa8eea8ca" parent="ceaeca0a6ef5c9002b29cf68002b34e1" type="folder">16-18</container>
        </did>
        <accessrestrict id="50f594b6d9dec7b83b3b83386b475dcd">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="b9d25758af7747ace6aaf80757aac85f" level="file">
        <did>
          <unittitle>TML, 42-18 - Aspirin for primary prevention of cardiovascular disease</unittitle>
          <unitdate type="inclusive">2000 February 21</unitdate>
          <container id="1ece379f8dc77258995e6d92f66bf349" label="Mixed Materials (A0000000075891)" type="box">49</container>
          <container id="817ef5a124e048ea7989e808e24ffc4b" parent="1ece379f8dc77258995e6d92f66bf349" type="folder">19-20</container>
        </did>
        <accessrestrict id="bd7e6d6a5d2765181060a6c4e5bc8024">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="8827ef8acb277df2d477589d43015ed3" level="file">
        <did>
          <unittitle>TML, 42-73 - Drugs for pain</unittitle>
          <unitdate type="inclusive">2000 August 21</unitdate>
          <container id="18c830dfef6c4bcdab41f672a38d9860" label="Mixed Materials (A0000000075892)" type="box">50</container>
          <container id="884a50ce433bf2445beee393ece931e8" parent="18c830dfef6c4bcdab41f672a38d9860" type="folder">1-6</container>
        </did>
        <accessrestrict id="45351d67ab671d76012768894632e65f">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="7ca68fc3cc569b193dc410a094f9a61f" level="file">
        <did>
          <unittitle>TML, 42-19 - Drugs for Asthma</unittitle>
          <unitdate type="inclusive">2000 March 6</unitdate>
          <container id="f601a1039c6ce1e00c4bf81d2dbb9f16" label="Mixed Materials (A0000000075892)" type="box">50</container>
          <container id="8d52f602f2071fc262696381b9437b3e" parent="f601a1039c6ce1e00c4bf81d2dbb9f16" type="folder">7-10</container>
        </did>
        <accessrestrict id="843840cc3a1f4f944dcd68fb679ac778">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="11f2fac87764b93bfe43bd87321c6e78" level="file">
        <did>
          <unittitle>TML, 42-49 - Androgel</unittitle>
          <unitdate type="inclusive">2000 June 1</unitdate>
          <container id="8f8f96fc22cd6f08880c48a4936e0f39" label="Mixed Materials (A0000000075892)" type="box">50</container>
          <container id="af80a70a1c829cc6f24af2589aedd5d1" parent="8f8f96fc22cd6f08880c48a4936e0f39" type="folder">11-13</container>
        </did>
        <accessrestrict id="373b10f2aaf453294914d4fe78b9487f">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="f519c54c8f624fc16003fa1c04fa88f0" level="file">
        <did>
          <unittitle>TML, 42-97 - Drugs for prevention and treatment of postmenopausal osteoporosis</unittitle>
          <unitdate type="inclusive">2000 October 16</unitdate>
          <container id="00d4ac6ee72b2f5d4025ad9bc74af28d" label="Mixed Materials (A0000000075892)" type="box">50</container>
          <container id="1ba85c96343eed41406ff107412f27d1" parent="00d4ac6ee72b2f5d4025ad9bc74af28d" type="folder">14-18</container>
        </did>
        <accessrestrict id="f6c66097c55fc7906c4f0813a2f589d8">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="da9eaff7a676c3ce93fb52a83c4df992" level="file">
        <did>
          <unittitle>TML, 42-93 - Rivastigmine (Exelon) for Alzheimer's disease</unittitle>
          <unitdate type="inclusive">2000 October 2</unitdate>
          <container id="49e0d1f538aabac34cc2c26065fed999" label="Mixed Materials (A0000000075892)" type="box">50</container>
          <container id="d9bd3619fb7529f38ec82a2a3f6ad529" parent="49e0d1f538aabac34cc2c26065fed999" type="folder">19-20</container>
        </did>
        <accessrestrict id="0b717ab0083f68384631636b834fec64">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="f307fe5a6bafa6083a914965f47c224f" level="file">
        <did>
          <unittitle>TML, 42-93 - Rivastigmine (Exelon) for Alzheimer's disease</unittitle>
          <unitdate type="inclusive">2000 October 2</unitdate>
          <container id="57d94c6bb48f84fd74fd19266bd85262" label="Mixed Materials (A0000000075893)" type="box">51</container>
          <container id="d59c1c322df6db19af9f726cabccee96" parent="57d94c6bb48f84fd74fd19266bd85262" type="folder">1</container>
        </did>
        <accessrestrict id="dc26934d88198182e177b592f4868a43">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="0d88056c01b79b6a4d890ffb52ef26d7" level="file">
        <did>
          <unittitle>TML, 42-31 - Bexrotene</unittitle>
          <unitdate type="inclusive">2000 April 3</unitdate>
          <container id="0b36f3d82de986b9984107eeccd0963d" label="Mixed Materials (A0000000075893)" type="box">51</container>
          <container id="ebde095de0234b2ae15fb2bb8c40b022" parent="0b36f3d82de986b9984107eeccd0963d" type="folder">2-4</container>
        </did>
        <accessrestrict id="9a8c86a85c6d5ea077e55d9b7597d55f">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="78aad480d71976b1ac63856f8414b2de" level="file">
        <did>
          <unittitle>TML, 42-116 - Portable Defibrillators</unittitle>
          <unitdate type="inclusive">2000 December 11</unitdate>
          <container id="f8669984632dd3cdf598c59ff6f2b0ea" label="Mixed Materials (A0000000075893)" type="box">51</container>
          <container id="6c0b150f37683d33ebaedbb218a36e19" parent="f8669984632dd3cdf598c59ff6f2b0ea" type="folder">5-6</container>
        </did>
        <accessrestrict id="da50ccc68a37dbb555145dfbcf8f1e7c">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="8856ac6d297ba039f5f59b8393406463" level="file">
        <did>
          <unittitle>TML, 42-111 - Drugs that may cause cognitive disorders in the elderly</unittitle>
          <unitdate type="inclusive">2000 November 27</unitdate>
          <container id="876f0d6a11198b82bf377bc20866f859" label="Mixed Materials (A0000000075893)" type="box">51</container>
          <container id="fd34a9ad4335b619c5456ac8ca4edda6" parent="876f0d6a11198b82bf377bc20866f859" type="folder">7-10</container>
        </did>
        <accessrestrict id="2247b3013b5d4bd66554d265282ec46f">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="d791d0f324ea7d0ebc4dcab430fc3a36" level="file">
        <did>
          <unittitle>TML, 42-36 - Substituting for troglitazone (Rezulin)</unittitle>
          <unitdate type="inclusive">2000 April 17</unitdate>
          <container id="0ea662c52dcf5d07869af08d154c0c72" label="Mixed Materials (A0000000075893)" type="box">51</container>
          <container id="76fc88c7a0bc2f67da4cd0ae80399c2f" parent="0ea662c52dcf5d07869af08d154c0c72" type="folder">11</container>
        </did>
        <accessrestrict id="35757c84324de4837de836a4d664e4bd">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="390553fd7a4eea2f5cbee5002f2322bc" level="file">
        <did>
          <unittitle>TML, 42-109 - Atovaquone - Proguanil (Malarone) for malaria</unittitle>
          <unitdate type="inclusive">2000 November 27</unitdate>
          <container id="fc8c117da211a0dce179484455e0fbf5" label="Mixed Materials (A0000000075893)" type="box">51</container>
          <container id="88ad5deddd19800dc8d695f7aefcd022" parent="fc8c117da211a0dce179484455e0fbf5" type="folder">12-15</container>
        </did>
        <accessrestrict id="717bd1e1f90c70ff656382467cc26f89">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="102174d0143d0b7b46d5dbdfb6ee2e6c" level="file">
        <did>
          <unittitle>TML, 42-39 - Ketotifen and Pemirlostat - New drugs for allergic conjunctivitis</unittitle>
          <unitdate type="inclusive">2000 May 1</unitdate>
          <container id="728cd551f800a4fbc84d40a841a88326" label="Mixed Materials (A0000000075893)" type="box">51</container>
          <container id="495d43526b4aa0fb4d2b55a50d7ed688" parent="728cd551f800a4fbc84d40a841a88326" type="folder">16-17</container>
        </did>
        <accessrestrict id="c0dedfa65ff00b42eaec283e7dbe5ee3">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="968dfa06d929ab040463fb621fb94e15" level="file">
        <did>
          <unittitle>TML - HAT - Systemic antifungal</unittitle>
          <unitdate type="inclusive">2000</unitdate>
          <container id="4b8ac134bee338f6df3b15f4971fac8a" label="Mixed Materials (A0000000075893)" type="box">51</container>
          <container id="e925d095b697dc0f62ab5af61ed9d4d4" parent="4b8ac134bee338f6df3b15f4971fac8a" type="folder">18-19</container>
        </did>
        <accessrestrict id="a7608b2e6d21017e82cac99f4c300d04">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="ffb773729eccb5c024461cb32728a1f5" level="file">
        <did>
          <unittitle>TML - HAT - Systemic antifungal</unittitle>
          <unitdate type="inclusive">2000</unitdate>
          <container id="a1cc39814c17ace1b30bec78a8767dd8" label="Mixed Materials (A0000000075894)" type="box">52</container>
          <container id="921fc991af4ea91e526490bfc5953cbc" parent="a1cc39814c17ace1b30bec78a8767dd8" type="folder">1-2</container>
        </did>
        <accessrestrict id="fc274c9d6d48168ac3a11ea6067869e0">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="b5adf750afaa8fb0be9aa2061a43e3b8" level="file">
        <did>
          <unittitle>TML, 42-96 - Eflornithine cream for facial hair reduction</unittitle>
          <unitdate type="inclusive">2000 October 2</unitdate>
          <container id="273dd386238ffb501b7deac9f288082f" label="Mixed Materials (A0000000075894)" type="box">52</container>
          <container id="6956652a0f5839985c77c89b2ce7f651" parent="273dd386238ffb501b7deac9f288082f" type="folder">3</container>
        </did>
        <accessrestrict id="97998d665049bfafbdf7f044ef962ac2">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="c88b481d9cf92fe516e086aa696f2759" level="file">
        <did>
          <unittitle>TML, 42-67 - Gemtuzumab for relapsed acute myeloid leukemia</unittitle>
          <unitdate type="inclusive">2000 July 24</unitdate>
          <container id="2ffec0bb4cde4a20e43feb8392d71550" label="Mixed Materials (A0000000075894)" type="box">52</container>
          <container id="5a51e335f4044cb6011889d721101596" parent="2ffec0bb4cde4a20e43feb8392d71550" type="folder">4-5</container>
        </did>
        <accessrestrict id="8158423ad1861ed096a1f762bea5ed19">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="d316d036d1c1c8b5e65cc5a3309c50cf" level="file">
        <did>
          <unittitle>TML, 42-52 - Atkin's diet</unittitle>
          <unitdate type="inclusive">2000 June 12</unitdate>
          <container id="66ee7cc929c2d0aac70fdd3a430dd1ae" label="Mixed Materials (A0000000075894)" type="box">52</container>
          <container id="174d1422e25c1c6b2d8104e487fd1f40" parent="66ee7cc929c2d0aac70fdd3a430dd1ae" type="folder">6-8</container>
        </did>
        <accessrestrict id="0024c5f9b90643b42da0ff940f490484">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="f039186b802088d6736b63d8692ff877" level="file">
        <did>
          <unittitle>TML, 42-71 - Hypnotic drugs</unittitle>
          <unitdate type="inclusive">2000 August 7</unitdate>
          <container id="33b3ecb9a988aa1914f50cfb7eeda542" label="Mixed Materials (A0000000075894)" type="box">52</container>
          <container id="e853c764eb19d43df4a1b52d0a7954a3" parent="33b3ecb9a988aa1914f50cfb7eeda542" type="folder">9-12</container>
        </did>
        <accessrestrict id="66081d4df14137512de48118dd485bfc">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="ddaac639270ba0e3369ea6c5bef18c02" level="file">
        <did>
          <unittitle>TML, 42-79 - Influenza update 2000-2001</unittitle>
          <unitdate type="inclusive">2000 September 4</unitdate>
          <container id="d5eee782d355afb7e2b65348a65798a8" label="Mixed Materials (A0000000075894)" type="box">52</container>
          <container id="56160dec929c41a400ed95128507eb4a" parent="d5eee782d355afb7e2b65348a65798a8" type="folder">13-14</container>
        </did>
        <accessrestrict id="2370a9ec5de5c8b19f6823b89c720366">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="3b89f483901c2a204aeb8a707d5f619e" level="file">
        <did>
          <unittitle>TML, 42-35 - Exemestane for advanced breast cancer</unittitle>
          <unitdate type="inclusive">2000 April 17</unitdate>
          <container id="c67c4d7ca4dd8ad1aaf2b76157e465fe" label="Mixed Materials (A0000000075894)" type="box">52</container>
          <container id="34d0e2270f711c4ae48fea67555c59ab" parent="c67c4d7ca4dd8ad1aaf2b76157e465fe" type="folder">15-17</container>
        </did>
        <accessrestrict id="908ae2bf04aa596e7e5c1b4a0b435a1a">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="5b4d37f27c36f2cf78b12c02f16d9dd0" level="file">
        <did>
          <unittitle>TML, 42-12 - Epirubicin for adjuvant therapy in node-positive breast cancer</unittitle>
          <unitdate type="inclusive">2000 February 7</unitdate>
          <container id="cd845797e4f8f69ffc5a89e16a06f319" label="Mixed Materials (A0000000075894)" type="box">52</container>
          <container id="39e3443e18650537d698d32cc5b734ae" parent="cd845797e4f8f69ffc5a89e16a06f319" type="folder">18-20</container>
        </did>
        <accessrestrict id="231c8f3761cd29bf8b9da59c1db76773">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="ea21c93279b7213ac4ebcf26ac90ac01" level="file">
        <did>
          <unittitle>TML, 42-33 - Oxcarbazepine and Levetiracetam - Two new drugs for epilepsy</unittitle>
          <unitdate type="inclusive">2000 April 17</unitdate>
          <container id="6259c0eb20df09e031a259d4e9fc6a21" label="Mixed Materials (A0000000075894)" type="box">52</container>
          <container id="339d61c82b6efb3a3d03d35365a01e32" parent="6259c0eb20df09e031a259d4e9fc6a21" type="folder">21</container>
        </did>
        <accessrestrict id="ecde6f626cda50967973b161a20fcc74">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="0670855c3da978011ef91e63b94b8614" level="file">
        <did>
          <unittitle>TML, 42-33 - Oxcarbazepine and Levetiracetam - Two new drugs for epilepsy</unittitle>
          <unitdate type="inclusive">2000 April 17</unitdate>
          <container id="151fccf5e8f7b56816fb9d24b060b653" label="Mixed Materials (A0000000075895)" type="box">53</container>
          <container id="0776f6f59ebc8f87e8f36eea0fcd0fb3" parent="151fccf5e8f7b56816fb9d24b060b653" type="folder">1-2</container>
        </did>
        <accessrestrict id="b1545fba52ccf81c38c8688169dab34a">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="b9f3b0c3756751d471fc83952e9cdb9e" level="file">
        <did>
          <unittitle>TML - HAT - Adverse Effects</unittitle>
          <unitdate type="inclusive">2000</unitdate>
          <container id="cd795d8d31b294ab63ec5a27acb15eaa" label="Mixed Materials (A0000000075895)" type="box">53</container>
          <container id="388ef5be497ee35a3165d5a266b159df" parent="cd795d8d31b294ab63ec5a27acb15eaa" type="folder">3-4</container>
        </did>
        <accessrestrict id="f035a5812a9a5ba9f187b537f909316a">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="0f64e1cb70a81058fe2a570f1ccb8c4a" level="file">
        <did>
          <unittitle>TML - Perinopril - A new ACE inhibitor for hypertension</unittitle>
          <unitdate type="inclusive">2000 May 26</unitdate>
          <container id="1823abc2a607dedf47cb05cbf9d22593" label="Mixed Materials (A0000000075895)" type="box">53</container>
          <container id="e0521297a3f93ceba851eea97c2b4081" parent="1823abc2a607dedf47cb05cbf9d22593" type="folder">5-8</container>
        </did>
        <accessrestrict id="8e19dab12d3196a7486bcf0f13a7475f">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="9370ffe6e8855002d778fc797c644238" level="file">
        <did>
          <unittitle>TML, 42-65 - Pantoprazole (Protonix)</unittitle>
          <unitdate type="inclusive">2000 July 24</unitdate>
          <container id="f31fd3b44ea646ba2ca7d281290d9c9b" label="Mixed Materials (A0000000075895)" type="box">53</container>
          <container id="7c3dfb8cb303064d46e564e6d3f0dd4b" parent="f31fd3b44ea646ba2ca7d281290d9c9b" type="folder">9-12</container>
        </did>
        <accessrestrict id="a1015b3acc8c847466def1105f15644b">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="354614b4cdeb7c25dce7323acfe3837f" level="file">
        <did>
          <unittitle>TML, 42-15 - Gatifloxacin and Moxifloxacin - Two new fluoroquinolones</unittitle>
          <unitdate type="inclusive">2000 February 21</unitdate>
          <container id="6e95d0f6e24b78544113564a8a73f102" label="Mixed Materials (A0000000075895)" type="box">53</container>
          <container id="a3ed46e73de49dfb3ee20a83f104e6ad" parent="6e95d0f6e24b78544113564a8a73f102" type="folder">13-18</container>
        </did>
        <accessrestrict id="5bf74d558644f64e23255ce061463c78">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="ee26dc57604d2e8beb15f5282094c199" level="file">
        <did>
          <unittitle>TML, HAT - Antimicrobial Dosage</unittitle>
          <unitdate type="inclusive">2000</unitdate>
          <container id="6d144aa9f9ebde5f2b3b1a22d77824d6" label="Mixed Materials (A0000000075895)" type="box">53</container>
          <container id="f33ac0ad3172d24ce3e66643c6538af4" parent="6d144aa9f9ebde5f2b3b1a22d77824d6" type="folder">19</container>
        </did>
        <accessrestrict id="11c3455a2f2e87c2b16773aa9e6aea7c">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="a088080df443869d26625b88cfb8357c" level="file">
        <did>
          <unittitle>TML, 42-105 - Glyburide - Metformin (Glucovance) for type 2 diabetes</unittitle>
          <unitdate type="inclusive">2000 November 13</unitdate>
          <container id="f1bd3d776abc17b7d71121f6e51743c7" label="Mixed Materials (A0000000075895)" type="box">53</container>
          <container id="04f8f4d9f95bc013659f1d0e1aa6820e" parent="f1bd3d776abc17b7d71121f6e51743c7" type="folder">20</container>
        </did>
        <accessrestrict id="204852f90f3648c6b6e5e6274cb652ab">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="4786db2a3aa9c724f7f60dcf4fcf9164" level="file">
        <did>
          <unittitle>TML, 42-105 - Glyburide - Metformin (Glucovance) for type 2 diabetes</unittitle>
          <unitdate type="inclusive">2000 November 13</unitdate>
          <container id="cae16819b717b4b3e8a283ec70bd5383" label="Mixed Materials (A0000000075896)" type="box">54</container>
          <container id="2f476faf01f84037103a97dd0c7838da" parent="cae16819b717b4b3e8a283ec70bd5383" type="folder">1-2</container>
        </did>
        <accessrestrict id="19470d2540faf3143d53c5e0f0f04553">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="ff8898d4bdb05f23855cdb33eaefc878" level="file">
        <did>
          <unittitle>TML, 42-53 - Alosetron (Lotronex) for irritable bowel syndrome</unittitle>
          <unitdate type="inclusive">2000 June 26</unitdate>
          <container id="697df15e90aa257d23479a2a631946b5" label="Mixed Materials (A0000000075896)" type="box">54</container>
          <container id="e46ec7ef3c8b7f552aaab8ad4ad505e0" parent="697df15e90aa257d23479a2a631946b5" type="folder">3-4</container>
        </did>
        <accessrestrict id="a92fba8d7b374bd5ed2b6377d7f5dfcf">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="c83dbfe7a53fd4d335c81b6902eff92d" level="file">
        <did>
          <unittitle>TML, 42-25 - Conjugated pneumococcal vaccine for infants and children</unittitle>
          <unitdate type="inclusive">2000 March 20</unitdate>
          <container id="c73b834465adc88e54924b135a82d4fb" label="Mixed Materials (A0000000075896)" type="box">54</container>
          <container id="cc880406bbb3d2f1067d89333ace1009" parent="c73b834465adc88e54924b135a82d4fb" type="folder">5-7</container>
        </did>
        <accessrestrict id="aee461894cb0482b20c2792522b46e12">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="0c6944c64d3e895d17a92cb7a840b2cc" level="file">
        <did>
          <unittitle>TML, 42-69 - Meningococcal vaccine - College students</unittitle>
          <unitdate type="inclusive">2000 August 7</unitdate>
          <container id="ec6c72629816270d13d389b7c012ae89" label="Mixed Materials (A0000000075896)" type="box">54</container>
          <container id="283b4369f547dc09973f305f2168e3cf" parent="ec6c72629816270d13d389b7c012ae89" type="folder">8-9</container>
        </did>
        <accessrestrict id="df37cebc2f1268161ba89264e0aa24c3">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="f8521e46162fc0e16135537e8fe60e0e" level="file">
        <did>
          <unittitle>TML, 42-80 - A new long-acting methylphenidate</unittitle>
          <unitdate type="inclusive">2000 September 4</unitdate>
          <container id="04eb628420bbecda4207337d6167786b" label="Mixed Materials (A0000000075896)" type="box">54</container>
          <container id="56e4b10f167a331068b512e32a4b82bf" parent="04eb628420bbecda4207337d6167786b" type="folder">10-11</container>
        </did>
        <accessrestrict id="a4aa4fa7be7331aba5f8a5db5ecf9418">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="77d873ab9fa6653d75e07ecd29388474" level="file">
        <did>
          <unittitle>TML, 42-17 - Entacapone for Parkinson's disease</unittitle>
          <unitdate type="inclusive">2000 January 24</unitdate>
          <container id="b0665763bc5c9a7821054123d6fffbf1" label="Mixed Materials (A0000000075896)" type="box">54</container>
          <container id="80398f226d6d6c015d8b3d370ace08cf" parent="b0665763bc5c9a7821054123d6fffbf1" type="folder">12-14</container>
        </did>
        <accessrestrict id="c4cc72e54e77645b47ebceda334dae90">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="2c3c36361f7d26d6245b10967d53cba6" level="file">
        <did>
          <unittitle>TML, 42-45 - Linezolid (Zyvox)</unittitle>
          <unitdate type="inclusive">2000 May 29</unitdate>
          <container id="1124d4a64cbe99d7569267cd6299ef79" label="Mixed Materials (A0000000075896)" type="box">54</container>
          <container id="e482e8e4817a7837f00919156b95d2ab" parent="1124d4a64cbe99d7569267cd6299ef79" type="folder">15-18</container>
        </did>
        <accessrestrict id="134bd94a116d4a00868b6be7c821b669">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="f3db800fbd8c30fd18c0ce7421c0675c" level="file">
        <did>
          <unittitle>TML, 42-1 - Drugs for HIV</unittitle>
          <unitdate type="inclusive">2000 January 10</unitdate>
          <container id="51622e7f6ab82eea481729898f7f4068" label="Mixed Materials (A0000000075896)" type="box">54</container>
          <container id="a70775dd6b6dd00117bdbc889c019631" parent="51622e7f6ab82eea481729898f7f4068" type="folder">19-21</container>
        </did>
        <accessrestrict id="6357a8604ec2f14301f33a46a3a3ee64">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="c29c016865d236b6f578b647c46a6676" level="file">
        <did>
          <unittitle>TML, 42-1 - Drugs for HIV</unittitle>
          <unitdate type="inclusive">2000 January 10</unitdate>
          <container id="ffc6681f121fe4601ace3b21e7d06f57" label="Mixed Materials (A0000000075897)" type="box">55</container>
          <container id="4a932a191f7a51056483b9596e6ad53b" parent="ffc6681f121fe4601ace3b21e7d06f57" type="folder">1-2</container>
        </did>
        <accessrestrict id="8e3afc9c0897bcf7957059afb787d613">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="0ef84e9be7c32e14ccb4cf39bfd45359" level="file">
        <did>
          <unittitle>TML - Rheumatoid Arthritis - Reprints</unittitle>
          <unitdate type="inclusive">2000</unitdate>
          <container id="ffe0076fdb7ec3286602f3e277b9813a" label="Mixed Materials (A0000000075897)" type="box">55</container>
          <container id="ab0f560d76129958159f236235f19c83" parent="ffe0076fdb7ec3286602f3e277b9813a" type="folder">3-6</container>
        </did>
        <accessrestrict id="9bb37702887fbb2a3b6b04978a2797eb">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="cc6bb16d28e33a08e3172f055c9bc2b1" level="file">
        <did>
          <unittitle>TML, 42-11 - Aggrenox - A combination of antiplatelet drugs for stroke prevention</unittitle>
          <unitdate type="inclusive">2000 February 7</unitdate>
          <container id="8350e9be63093130738c30492828cab8" label="Mixed Materials (A0000000075897)" type="box">55</container>
          <container id="bd4c83dd4bbb7962338929005bb5007a" parent="8350e9be63093130738c30492828cab8" type="folder">7-8</container>
        </did>
        <accessrestrict id="b6c3f76765c91d59d07d1942830fb182">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="7fc91d920ef13c04bcd488ff67fb27eb" level="file">
        <did>
          <unittitle>TML - 42-54 - Beta Blockers for heart failure</unittitle>
          <unitdate type="inclusive">2000 June 26</unitdate>
          <container id="f75d773fb4926bd96451fefa18715fee" label="Mixed Materials (A0000000075897)" type="box">55</container>
          <container id="af8db3baff42e27bc2b7169cbbdeb7a9" parent="f75d773fb4926bd96451fefa18715fee" type="folder">9-13</container>
        </did>
        <accessrestrict id="ddd4e956f4e4703f485c6e09538b3de5">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="2659d96c29ea4c72cecf071a3ffe82cf" level="file">
        <did>
          <unittitle>TML, 42-83 - Drugs of Choice - Cancer chemotherapy</unittitle>
          <unitdate type="inclusive">2000 September 18</unitdate>
          <container id="0286c2559e1276f658b651e2fa3d19ce" label="Mixed Materials (A0000000075897)" type="box">55</container>
          <container id="2716dcdc700ad540cea12086799a86e5" parent="0286c2559e1276f658b651e2fa3d19ce" type="folder">14-18</container>
        </did>
        <accessrestrict id="fdc72de4846ddb965722a850fb816e7f">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="85452dc178e1dadec0332fe42563215d" level="file">
        <did>
          <unittitle>TML - Drugs of Choice - Drugs for Tuberculosis</unittitle>
          <unitdate type="inclusive">2000</unitdate>
          <container id="c8c4ccce93be8e4d1111e605db504b4b" label="Mixed Materials (A0000000075898)" type="box">56</container>
          <container id="a7b7a8b320f9003ae2c084896c0053b9" parent="c8c4ccce93be8e4d1111e605db504b4b" type="folder">1-4</container>
        </did>
        <accessrestrict id="f9bcd6fc9775a8cd44d753ed67359607">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="9c48a5236a35ed8f3ce7136401b6da9e" level="file">
        <did>
          <unittitle>TML, 42-101 - Mifepristone (RU 486)</unittitle>
          <unitdate type="inclusive">2000 October 30</unitdate>
          <container id="021d20df2a3115cb259e679e46d38138" label="Mixed Materials (A0000000075898)" type="box">56</container>
          <container id="a9cb26e61bc511416e08cbf31ef729f0" parent="021d20df2a3115cb259e679e46d38138" type="folder">5-8</container>
        </did>
        <accessrestrict id="512097af868e6310c2ef7aa3a3ab7af5">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="41cb55e32ff2281af228fcf98e48db43" level="file">
        <did>
          <unittitle>TML - Osteoporosis - Reprints</unittitle>
          <unitdate type="inclusive">2000</unitdate>
          <container id="87b6a7e201cad2d8539976a63789cb37" label="Mixed Materials (A0000000075898)" type="box">56</container>
          <container id="5e15074d70e596e00e257723b4c405ee" parent="87b6a7e201cad2d8539976a63789cb37" type="folder">9-12</container>
        </did>
        <accessrestrict id="a1eb04973eb4447d22f3324b1056f9bf">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="669d4a856fe8af2c5b04130d94fa8d3e" level="file">
        <did>
          <unittitle>TML - Asthma - Reprints</unittitle>
          <unitdate type="inclusive">2000</unitdate>
          <container id="038f8933c46da04a9766b46e13c153d8" label="Mixed Materials (A0000000075898)" type="box">56</container>
          <container id="baa346a1384d5199f043e3e732f0bad8" parent="038f8933c46da04a9766b46e13c153d8" type="folder">13-16</container>
        </did>
        <accessrestrict id="38e2af006895a52bd2de3eb894293ec3">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="0ec6c4e753e63df5926b6bb8dc0ec41d" level="file">
        <did>
          <unittitle>TML - Drugs of Choice - Drugs for Parasitic infections</unittitle>
          <unitdate type="inclusive">2000</unitdate>
          <container id="f5d3d52548449cccd93ec419e3a304da" label="Mixed Materials (A0000000075898)" type="box">56</container>
          <container id="1a6738c1ffbaf0a892e66afd40e8ad9d" parent="f5d3d52548449cccd93ec419e3a304da" type="folder">17-20</container>
        </did>
        <accessrestrict id="d8d94d63528159d44953c7215892b5f2">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="1716a9979d5479baf368216eb3017f50" level="file">
        <did>
          <unittitle>TML - Drugs of Choice - Drugs for Parasitic infections</unittitle>
          <unitdate type="inclusive">2000</unitdate>
          <container id="8c55e4955d8417eebfcb45cd83d1195e" label="Mixed Materials (A0000000075899)" type="box">57</container>
          <container id="d886c1c71b8d586b01d44172344f07db" parent="8c55e4955d8417eebfcb45cd83d1195e" type="folder">1-4</container>
        </did>
        <accessrestrict id="7be18115960dc69ccd463738ce3438d7">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="296856f8c0a6139989dec83e2967a3f6" level="file">
        <did>
          <unittitle>TML - HAT</unittitle>
          <unitdate type="inclusive">2000</unitdate>
          <container id="00c32bbe2f9d2161148d3f834ad58427" label="Mixed Materials (A0000000075899)" type="box">57</container>
          <container id="f7d2456200856ac5649853c0552c7e4b" parent="00c32bbe2f9d2161148d3f834ad58427" type="folder">5</container>
        </did>
        <accessrestrict id="44a20fdcc0c5ee5bc8f27d1eb7439095">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="41a4f1b5ec21dcacfcb1590a26be0255" level="file">
        <did>
          <unittitle>TML - HAT</unittitle>
          <unitdate type="inclusive">2000</unitdate>
          <container id="66ae7ded93404e5d8fbbd33f96b0968b" label="Mixed Materials (A0000000075900)" type="box">58</container>
          <container id="ddaca307b3b6f0a8f5972dddb2321209" parent="66ae7ded93404e5d8fbbd33f96b0968b" type="folder">1-3</container>
        </did>
        <accessrestrict id="aae3719b7a851cb67c17470197b044d1">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="8d745390980b9c7fe7639600ac855496" level="file">
        <did>
          <unittitle>TML, 43-92 - Antimicrobial prophylaxis in surgery</unittitle>
          <unitdate type="inclusive">2001 October 29</unitdate>
          <container id="1d9016e62b580733748ec6910a62715e" label="Mixed Materials (A0000000075901)" type="box">59</container>
          <container id="5183cb08e1b86cfae3dccee66f687269" parent="1d9016e62b580733748ec6910a62715e" type="folder">1-3</container>
        </did>
        <accessrestrict id="08c08b71a5f549bb03c9e539391bf0c3">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="c8e27cfe3b70673df671446dc0f171dd" level="file">
        <did>
          <unittitle>TML, 43-43 - Choice of Lipid-lowering drugs</unittitle>
          <unitdate type="inclusive">2001 May 28</unitdate>
          <container id="05e0678d701b943ad1536ab3d50e8cf2" label="Mixed Materials (A0000000075901)" type="box">59</container>
          <container id="4f4bde03f16df6af4b0c137ea503dcba" parent="05e0678d701b943ad1536ab3d50e8cf2" type="folder">4-10</container>
        </did>
        <accessrestrict id="12c485e70ce77057b564f5f005de3180">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="b12b140d39cce8b86f62018ce31197dd" level="file">
        <did>
          <unittitle>TML, 43-1 - Lopinavir - Ritonavir - A protease-inhibitor combination</unittitle>
          <unitdate type="inclusive">2001 January 8</unitdate>
          <container id="5d368a4c5c3a698613be1d5220dc1737" label="Mixed Materials (A0000000075901)" type="box">59</container>
          <container id="1b2e06ca7a6477526ddff010262bf3ec" parent="5d368a4c5c3a698613be1d5220dc1737" type="folder">11-13</container>
        </did>
        <accessrestrict id="cb4f314cadf4551b7cb834b70eadf1cc">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="f3e4fd1faa4faa99ba52ed68b8dde6c9" level="file">
        <did>
          <unittitle>TML, 43-87 - Drugs and vaccines against biological warfare</unittitle>
          <unitdate type="inclusive">2001 October 19</unitdate>
          <container id="4ca836674310926ac46729932d3a37f8" label="Mixed Materials (A0000000075901)" type="box">59</container>
          <container id="d07f865cbc9cad3cec7511fc39b21665" parent="4ca836674310926ac46729932d3a37f8" type="folder">14-17</container>
        </did>
        <accessrestrict id="19d192e97e549e2b446276124a3eb6b6">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="f8fecc1cfd922fa2df867ba43e2d95e6" level="file">
        <did>
          <unittitle>TML, 43-37 - Bivalirudin (Angiomax) for angioplasty</unittitle>
          <unitdate type="inclusive">2001 April 30</unitdate>
          <container id="e6eef17609030cd44e010df937d99850" label="Mixed Materials (A0000000075901)" type="box">59</container>
          <container id="f7748d62d5f68b100437bcf107c33fdf" parent="e6eef17609030cd44e010df937d99850" type="folder">18</container>
        </did>
        <accessrestrict id="bf0a0b9053f30a04f40935cc85ba1264">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="3283e79cbed2dd24ba8423865f0e23c0" level="file">
        <did>
          <unittitle>TML, 43-37 - Bivalirudin (Angiomax) for angioplasty</unittitle>
          <unitdate type="inclusive">2001 April 30</unitdate>
          <container id="6c5a24ab0c242a18b10e475dafb97597" label="Mixed Materials (A0000000075902)" type="box">60</container>
          <container id="0d6c5c1498a3a15a3a720e7d34a80b2a" parent="6c5a24ab0c242a18b10e475dafb97597" type="folder">1</container>
        </did>
        <accessrestrict id="f2c531fe46fbd0a55fbf3a371d0cfb12">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="b08aa5d6ed86fd5fceee0126fd84fd06" level="file">
        <did>
          <unittitle>TML, 43-9 - Beta-Blockers</unittitle>
          <unitdate type="inclusive">2001 February 5</unitdate>
          <container id="381bf4a8f8d035262d54da87660eac9e" label="Mixed Materials (A0000000075902)" type="box">60</container>
          <container id="c20cd68f79d7006ecdc785a5b1c45007" parent="381bf4a8f8d035262d54da87660eac9e" type="folder">2-6</container>
        </did>
        <accessrestrict id="6048933eb3a55f5f2d6a90721d4dd65f">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="efb930d3872ae9d77c1298a07d7d5921" level="file">
        <did>
          <unittitle>TML, 43-62 - Balsalazide (Colazal) for ulcerative colitis</unittitle>
          <unitdate type="inclusive">2001 July</unitdate>
          <container id="f3e6cb77405f8e3d911be17fb9b69c6c" label="Mixed Materials (A0000000075902)" type="box">60</container>
          <container id="b384f67884ef126d9e818d2e93f497be" parent="f3e6cb77405f8e3d911be17fb9b69c6c" type="folder">7-9</container>
        </did>
        <accessrestrict id="a454b4aa29b54507db7a4b31bd4c8d5f">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="b522bd1a5159bd2d2194d2263cc22904" level="file">
        <did>
          <unittitle>TML, 43-11 - Argatroban for treatment of heparin-induced thrombocytopenia</unittitle>
          <unitdate type="inclusive">2001 February 5</unitdate>
          <container id="ed27281b69fb46327df752e55e72111a" label="Mixed Materials (A0000000075902)" type="box">60</container>
          <container id="06fd4ac87834d53e09ce81922c82acd6" parent="ed27281b69fb46327df752e55e72111a" type="folder">10-12</container>
        </did>
        <accessrestrict id="a20e6edf2b912e65b1924e6cbfaf7256">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="46514d81205269c17a4b19d49a573235" level="file">
        <did>
          <unittitle>TML - Drugs of Choice - Cardiac Arrhythmias</unittitle>
          <unitdate type="inclusive">2001</unitdate>
          <container id="55d186e15e98b13ff46b25f88c3052cf" label="Mixed Materials (A0000000075902)" type="box">60</container>
          <container id="34d48bc06e399795700c21059e3d3bdf" parent="55d186e15e98b13ff46b25f88c3052cf" type="folder">13-15</container>
        </did>
        <accessrestrict id="0ac715d063832982eec2283c964a4110">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="6dc4850ed3f15e6085336df184251532" level="file">
        <did>
          <unittitle>TML - Drugs of Choice - Osteoporosis</unittitle>
          <unitdate type="inclusive">2001</unitdate>
          <container id="8f954550afb7d96a78f7daf5441131c0" label="Mixed Materials (A0000000075902)" type="box">60</container>
          <container id="3b95aaacc039a9ea3e2288f49f81b6dc" parent="8f954550afb7d96a78f7daf5441131c0" type="folder">16</container>
        </did>
        <accessrestrict id="a5d61d385919f6ecefd5058c2bf3e8d5">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="02fc378d7f3b4b93e45c3eef89379858" level="file">
        <did>
          <unittitle>TML, 43-69 - Choice of Antibacterial drugs</unittitle>
          <unitdate type="inclusive">2001 August 20</unitdate>
          <container id="e54ce5ec5605aee316855bef98c3b0fd" label="Mixed Materials (A0000000075902)" type="box">60</container>
          <container id="fc66f84824f8c1ed31c6008cc9d118ad" parent="e54ce5ec5605aee316855bef98c3b0fd" type="folder">17-18</container>
        </did>
        <accessrestrict id="a1e5c73ef6115e61a317948cb85a9927">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="2c6bff42d1f14c6a829324e9782c498a" level="file">
        <did>
          <unittitle>TML, 43-69 - Choice of Antibacterial drugs</unittitle>
          <unitdate type="inclusive">2001 August 20</unitdate>
          <container id="0b49bebc0262f13c36b723064b85ee53" label="Mixed Materials (A0000000075903)" type="box">61</container>
          <container id="be95f0b990060ac79be993d6e8cd9486" parent="0b49bebc0262f13c36b723064b85ee53" type="folder">1-3</container>
        </did>
        <accessrestrict id="5b52a18cd7491854824957b6528aa161">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="6bf6928a0695a21bf35c621f43a5b338" level="file">
        <did>
          <unittitle>TML - Antimicrobial prophylaxis and Endocarditis - Reprints</unittitle>
          <unitdate type="inclusive">2001</unitdate>
          <container id="68eed6876149da05da8e8f9800eab518" label="Mixed Materials (A0000000075903)" type="box">61</container>
          <container id="b271b5c31d83e1de8f9108cda462622a" parent="68eed6876149da05da8e8f9800eab518" type="folder">4-6</container>
        </did>
        <accessrestrict id="7c855f662c00758a77e6169900e656ac">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="e83ae1dbb9d2dcd79b2efc11e8415787" level="file">
        <did>
          <unittitle>TML - AIDS - Reprints</unittitle>
          <unitdate type="inclusive">2001</unitdate>
          <container id="dcefe3b50ef4bfe2caff956709b95cad" label="Mixed Materials (A0000000075903)" type="box">61</container>
          <container id="ae56eaa842606a0bcc635793d24a01bf" parent="dcefe3b50ef4bfe2caff956709b95cad" type="folder">7-11</container>
        </did>
        <accessrestrict id="6f3b8da68a968edcf7612c6c7ab0d96d">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="c6e64d3eb72280cbc65604fd0d1ef63b" level="file">
        <did>
          <unittitle>TML, 43-91 - Post Exposure Anthrax prophylaxis</unittitle>
          <unitdate type="inclusive">2001 October 29</unitdate>
          <container id="7893299ead991e191e6e8dc98ab7d827" label="Mixed Materials (A0000000075903)" type="box">61</container>
          <container id="3eb75d3bc79b5beef1b5ddc3d0b3e4aa" parent="7893299ead991e191e6e8dc98ab7d827" type="folder">12-13</container>
        </did>
        <accessrestrict id="c107fed35cdd31085f732308990ad842">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="41aa0763a7e36f6ce380706ce01181e3" level="file">
        <did>
          <unittitle>TML, 43-54 - PEG-Intron for chronic Hepatitis C</unittitle>
          <unitdate type="inclusive">2001 June 25</unitdate>
          <container id="c4368f99e4dd185f605af367bdf99557" label="Mixed Materials (A0000000075903)" type="box">61</container>
          <container id="d701e7b85bdee25c39b5c62bc29ccd1d" parent="c4368f99e4dd185f605af367bdf99557" type="folder">14-16</container>
        </did>
        <accessrestrict id="10b78f31b326647359759629918503ac">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="21f79f7c6b4acd8a596b33dacb48841b" level="file">
        <did>
          <unittitle>TML, 43-110 - Insulin Glargine - a new long-acting insulin</unittitle>
          <unitdate type="inclusive">2001 August 6</unitdate>
          <container id="ac7edab498b67e040923b87923867368" label="Mixed Materials (A0000000075903)" type="box">61</container>
          <container id="36f81fbb3df29387bd31176e1d304dc4" parent="ac7edab498b67e040923b87923867368" type="folder">17-19</container>
        </did>
        <accessrestrict id="ce544613fec94a632b764ccaa6155e27">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="2eed515acb400c24339036029a7a8f49" level="file">
        <did>
          <unittitle>TML, 43-29 - Nateglinide for Type 2 diabetes</unittitle>
          <unitdate type="inclusive">2001 April 2</unitdate>
          <container id="07a9fa5f689121d3ce516121cbbbf3ee" label="Mixed Materials (A0000000075904)" type="box">62</container>
          <container id="ec10fde34c24806bcde4bfb9ea81f854" parent="07a9fa5f689121d3ce516121cbbbf3ee" type="folder">1-3</container>
        </did>
        <accessrestrict id="7bf007b3c2f616cf82e76b675923a0ae">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="ccba2cedcccf56cdefa0e205fc19e877" level="file">
        <did>
          <unittitle>TML - Drugs of Choice - Cancer</unittitle>
          <unitdate type="inclusive">2001</unitdate>
          <container id="e4d81df8e17bf4538eb56bf3241242c5" label="Mixed Materials (A0000000075904)" type="box">62</container>
          <container id="aba996782ae44fd0ce32fe8794a572b6" parent="e4d81df8e17bf4538eb56bf3241242c5" type="folder">4-5</container>
        </did>
        <accessrestrict id="d687a473729a78247a1c380123065159">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="8b4de852b3dcabc7ad6e003cb57745bf" level="file">
        <did>
          <unittitle>TML, 43-100 - Nesiritide for decompensated congestive heart failure</unittitle>
          <unitdate type="inclusive">2001 November 12</unitdate>
          <container id="9330fa8b8e15a30553671bb99d271f12" label="Mixed Materials (A0000000075904)" type="box">62</container>
          <container id="4a1abdd1b139f6d98116ce2a5992af7d" parent="9330fa8b8e15a30553671bb99d271f12" type="folder">6-9</container>
        </did>
        <accessrestrict id="60722a1253dc5c989a1fb84363bf8347">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="ae81e26ee03016b7e8a19efe2323b2b6" level="file">
        <did>
          <unittitle>TML, 43-35 - Non-Sedating Antihistamines</unittitle>
          <unitdate type="inclusive">2001 April 30</unitdate>
          <container id="34ea90c2f9c5611bf135ddaea49d4b18" label="Mixed Materials (A0000000075904)" type="box">62</container>
          <container id="08814fc36505c1a889d030190474fa34" parent="34ea90c2f9c5611bf135ddaea49d4b18" type="folder">10-13</container>
        </did>
        <accessrestrict id="e3c9df3f442f047a5b6b393b36042f5b">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="ebbf6e65860c02f436f6ca0982c14e3e" level="file">
        <did>
          <unittitle>TML, 43-17 - Drugs for hypertension</unittitle>
          <unitdate type="inclusive">2001 March 5</unitdate>
          <container id="b563aee389fceb5820eace5c86b5579e" label="Mixed Materials (A0000000075904)" type="box">62</container>
          <container id="eef5f6ed0e7edf3d68c7f2fffa3968a8" parent="b563aee389fceb5820eace5c86b5579e" type="folder">14-18</container>
        </did>
        <accessrestrict id="3e2fa8d34c5d3f85b91b8b755235d673">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="dc20397e0f8fc97006ecdf0d5f679b73" level="file">
        <did>
          <unittitle>TML, 43-62 - Botulinum Toxin Type A for cervical Dystonia</unittitle>
          <unitdate type="inclusive">2001 July 23</unitdate>
          <container id="67502568f996b4fd60e29de88eb27384" label="Mixed Materials (A0000000075904)" type="box">62</container>
          <container id="58e4a17ba34e4ac1ef4349f18a9961bd" parent="67502568f996b4fd60e29de88eb27384" type="folder">19</container>
        </did>
        <accessrestrict id="bedf8436e8ecc88cef43b4466703321f">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="2a3e11c7291578855058677f583ba4cc" level="file">
        <did>
          <unittitle>TML, 43-62 - Botulinum Toxin Type A for cervical Dystonia</unittitle>
          <unitdate type="inclusive">2001 July 23</unitdate>
          <container id="2a574d7daaf15679500df9c81669ae2c" label="Mixed Materials (A0000000075905)" type="box">63</container>
          <container id="fd567cafa839ac307c7507c8a44d1b3d" parent="2a574d7daaf15679500df9c81669ae2c" type="folder">1-2</container>
        </did>
        <accessrestrict id="1faf2fbe4c747499b17f777c7da8d367">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="7aeba34ec44547fe9581d43a0fc4043e" level="file">
        <did>
          <unittitle>TML, 43-6 - Nebulized Budesonide for Asthma in children</unittitle>
          <unitdate type="inclusive">2001 January 27</unitdate>
          <container id="1b9fe0e0741715f6e854b61e369b9ac0" label="Mixed Materials (A0000000075905)" type="box">63</container>
          <container id="e31c0818dbf9167d1cbc95555d373d5b" parent="1b9fe0e0741715f6e854b61e369b9ac0" type="folder">3-7</container>
        </did>
        <accessrestrict id="d1f83bcd9d1dba630ab83fe624589365">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="9011b2319d9d385461bdca83ff03a269" level="file">
        <did>
          <unittitle>TML, 42-2 - Cool Click - a needle-free device for growth hormone delivery</unittitle>
          <unitdate type="inclusive">2001 January 8</unitdate>
          <container id="9d05fab1cf6b0dd5cd8d4cb09ae31145" label="Mixed Materials (A0000000075905)" type="box">63</container>
          <container id="90829073d026c982cd6b285440f5ed15" parent="9d05fab1cf6b0dd5cd8d4cb09ae31145" type="folder">8-10</container>
        </did>
        <accessrestrict id="d1142cfc576dc71445c5513786f60e47">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="43f128e719abd7716a8b552dab41b4ca" level="file">
        <did>
          <unittitle>TML, 43-84 - Cord Blood Banks</unittitle>
          <unitdate type="inclusive">2001 October 1</unitdate>
          <container id="c1b6e7a09bef9c12cf48ab74760f1ef2" label="Mixed Materials (A0000000075905)" type="box">63</container>
          <container id="dda6e7d48b4851ebd4bf4c9687cc0a44" parent="c1b6e7a09bef9c12cf48ab74760f1ef2" type="folder">11-14</container>
        </did>
        <accessrestrict id="d355e32a24f6cffb35162f5a565f8aad">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="2ca4ec46f32a50a21f55760304d5080b" level="file">
        <did>
          <unittitle>TML, 43-59 - Initital treatment of Parkinson's disease</unittitle>
          <unitdate type="inclusive">2001 July 9</unitdate>
          <container id="49234bf97b9348a38e2e00838c293f48" label="Mixed Materials (A0000000075905)" type="box">63</container>
          <container id="4addc09bafcf0fdcf598c0b51e253edc" parent="49234bf97b9348a38e2e00838c293f48" type="folder">15-16</container>
        </did>
        <accessrestrict id="12449f363aa33b967622999d1c656f25">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="f4881e412a79293a02fce06ab7ada62d" level="file">
        <did>
          <unittitle>TML - Drugs of Choice - Treatment of Parkinson's disease</unittitle>
          <unitdate type="inclusive">2001</unitdate>
          <container id="1da42d49cddbf4d03cb0453cca8236e1" label="Mixed Materials (A0000000075905)" type="box">63</container>
          <container id="410bce4b4398506e381993b3b08f98ef" parent="1da42d49cddbf4d03cb0453cca8236e1" type="folder">17-20</container>
        </did>
        <accessrestrict id="762520a711ae5cf2f881c37d75c585e4">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="076a7f8b55c4644de3dc62c6db843a72" level="file">
        <did>
          <unittitle>TML - Drugs of Choice - Treatment of Parkinson's disease</unittitle>
          <unitdate type="inclusive">2001</unitdate>
          <container id="5cc2ed4bfa4e337dd94f9912b21527c1" label="Mixed Materials (A0000000075906)" type="box">64</container>
          <container id="1272b492380afd0b47c5fb075fde743a" parent="5cc2ed4bfa4e337dd94f9912b21527c1" type="folder">1-2</container>
        </did>
        <accessrestrict id="0e6e931602cabb1fe060a758f1e09d3e">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="98d5e522f0e12ef676f68b6296b375c4" level="file">
        <did>
          <unittitle>TML, 43-61 - Lung Cancer screening</unittitle>
          <unitdate type="inclusive">2001 July 23</unitdate>
          <container id="1b316749d4ab70c06befd12664128539" label="Mixed Materials (A0000000075906)" type="box">64</container>
          <container id="13c3f877634e28f6dfa60e211fc4e836" parent="1b316749d4ab70c06befd12664128539" type="folder">3-5</container>
        </did>
        <accessrestrict id="1fa9376a18b8cabf3a1ced8db4bc6995">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="bbfbf04fd92af083cfe5f2803138df54" level="file">
        <did>
          <unittitle>TML, 43-7 - Mirena</unittitle>
          <unitdate type="inclusive">2001 January 22</unitdate>
          <container id="7156afadde63b9ed22f723192f9299e2" label="Mixed Materials (A0000000075906)" type="box">64</container>
          <container id="d6e14bede92db64e9c1a15d5bd5518b9" parent="7156afadde63b9ed22f723192f9299e2" type="folder">6-8</container>
        </did>
        <accessrestrict id="6eb2c131de0d820a3d57bfd6b90300e6">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="3b86dfd5896dc8ed385111ad16cbd218" level="file">
        <did>
          <unittitle>TML, 43-109 - Darbopoetin (Aranesp) - a long acting erythropoietin</unittitle>
          <unitdate type="inclusive">2001 December 10</unitdate>
          <container id="82ff22f5ba5e3c4b5829bd9c7be1afe8" label="Mixed Materials (A0000000075906)" type="box">64</container>
          <container id="f01627a664c446ba81b8eef6641dec75" parent="82ff22f5ba5e3c4b5829bd9c7be1afe8" type="folder">9-10</container>
        </did>
        <accessrestrict id="f505d3982f99b3e642ccbf40fbd75883">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="0f9927bdf850374dd901cc030c68dc7c" level="file">
        <did>
          <unittitle>TML - Drugs for chronic heart failure</unittitle>
          <unitdate type="inclusive">2001 April 6</unitdate>
          <container id="af4a7af5e2db60be756294961248a158" label="Mixed Materials (A0000000075906)" type="box">64</container>
          <container id="104adf956050aa5e50827c06011c048c" parent="af4a7af5e2db60be756294961248a158" type="folder">11-14</container>
        </did>
        <accessrestrict id="6be4b2a90096d23f4c7270994aa74f17">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="97fc093a6a8e4909bb2c604168b0b754" level="file">
        <did>
          <unittitle>TML, 43-58 - Caspofungin (Candidas) for aspergillosis</unittitle>
          <unitdate type="inclusive">2001 July 9</unitdate>
          <container id="fbd20735ef0a0294692dd22213bff303" label="Mixed Materials (A0000000075906)" type="box">64</container>
          <container id="c6b2bb032f7fbee014f67f11c152401e" parent="fbd20735ef0a0294692dd22213bff303" type="folder">15-18</container>
        </did>
        <accessrestrict id="f836855e02f4d6fe9f63b628886a4c85">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="6da20ff4a72dc0604ae511c5634291e7" level="file">
        <did>
          <unittitle>TML, 43-55 - A new snake antivenin</unittitle>
          <unitdate type="inclusive">2001 June 25</unitdate>
          <container id="260af9ca9e2b5dfb443020a49ae03dd9" label="Mixed Materials (A0000000075906)" type="box">64</container>
          <container id="a465430b3299c20fa1ffd526a411a309" parent="260af9ca9e2b5dfb443020a49ae03dd9" type="folder">19-20</container>
        </did>
        <accessrestrict id="f08173f37c2607c4d273372be7fedab1">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="ede8d569017eb650ffb86947aa817ebe" level="file">
        <did>
          <unittitle>TML, 43-110 - Zometa (Zoledronic Acid) for injection</unittitle>
          <unitdate type="inclusive">2001 December 10</unitdate>
          <container id="2193e509df0e3e3558222a5f5fc41d54" label="Mixed Materials (A0000000075907)" type="box">65</container>
          <container id="42b50f7f566b519bb5a44cf733bffd37" parent="2193e509df0e3e3558222a5f5fc41d54" type="folder">1-3</container>
        </did>
        <accessrestrict id="3a54c329c0d6d0bc229bdd0616332d9d">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="a2f1959db87c3ed2aeb2a70eafd0d767" level="file">
        <did>
          <unittitle>TML, 43-51 - Ziprasidone (Geodon) for schizophrenia</unittitle>
          <unitdate type="inclusive">2001 June 11</unitdate>
          <container id="ffdfa967df76c0a15465295808bf62c2" label="Mixed Materials (A0000000075907)" type="box">65</container>
          <container id="b7e68e1ada3c32c499f04d454e314b5b" parent="ffdfa967df76c0a15465295808bf62c2" type="folder">4-7</container>
        </did>
        <accessrestrict id="810ad5d825ba01f69c55af09b52e33af">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="8068f52546b65b321ac2f5fa6a731f4c" level="file">
        <did>
          <unittitle>TML, - Drugs for depression and anxiety</unittitle>
          <unitdate type="inclusive">2001 February 14</unitdate>
          <container id="b191c030cfb70d67e60154fe02241358" label="Mixed Materials (A0000000075907)" type="box">65</container>
          <container id="f0e78bf7101366cf0b9701fae6c2096f" parent="b191c030cfb70d67e60154fe02241358" type="folder">8-10</container>
        </did>
        <accessrestrict id="67940cb71724cb07bb1c047808a223cf">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="55a8ca16b598343eb87537a2d296ecd1" level="file">
        <did>
          <unittitle>TML, 43-15 - PC-Spes</unittitle>
          <unitdate type="inclusive">2001 February 19</unitdate>
          <container id="25f21a28924e71fd4a75d86e4062987a" label="Mixed Materials (A0000000075907)" type="box">65</container>
          <container id="9759286ca2d70cdc53b7bb12ce944bc5" parent="25f21a28924e71fd4a75d86e4062987a" type="folder">11-12</container>
        </did>
        <accessrestrict id="75c2794ebd1f11660bcef03019daccd2">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="ebe0e5315e3cdfa6495aed9cdada44d6" level="file">
        <did>
          <unittitle>TML, 43-83 - Metadate (Extended-Release Methylphenidate)</unittitle>
          <unitdate type="inclusive">2001 October 1</unitdate>
          <container id="7e8e6762201fb7a278cb7f015bd9ad71" label="Mixed Materials (A0000000075907)" type="box">65</container>
          <container id="434cb77803a88c69740cafa17c92f609" parent="7e8e6762201fb7a278cb7f015bd9ad71" type="folder">13-16</container>
        </did>
        <accessrestrict id="07f8b933648e23ed47138c1bef096df8">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="833ebff3fb7c7c45c0c064414304d04f" level="file">
        <did>
          <unittitle>TML, 43-49 - Gleevec (STI-571) for chronic myeloid leukemia</unittitle>
          <unitdate type="inclusive">2001 June 11</unitdate>
          <container id="51acb742464153f10d3c8b9702a960c0" label="Mixed Materials (A0000000075907)" type="box">65</container>
          <container id="128eb7b6e117f9227932aba4e8464d39" parent="51acb742464153f10d3c8b9702a960c0" type="folder">17-18</container>
        </did>
        <accessrestrict id="8a48c9bb323707808cd2699c098b90df">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="e579c81ba72fe1f002ea554c42ec0eb7" level="file">
        <did>
          <unittitle>TML, 43-79 - Substituting for Cerivastatin (Baycol)</unittitle>
          <unitdate type="inclusive">2001 September 17</unitdate>
          <container id="cc818a557680d7f4b03695ddaf8a9bcd" label="Mixed Materials (A0000000075907)" type="box">65</container>
          <container id="f7b2a0ead95f42d80db59652c031bbd9" parent="cc818a557680d7f4b03695ddaf8a9bcd" type="folder">19</container>
        </did>
        <accessrestrict id="5b72b0c715fd854e87ba957e71353a88">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="2c8e55774a1bb77e5eb47e4cd5592dca" level="file">
        <did>
          <unittitle>TML, 43-79 - Substituting for Cerivastatin (Baycol)</unittitle>
          <unitdate type="inclusive">2001 September 17</unitdate>
          <container id="0bd09268e209b269c21c09d8c3e7b1c4" label="Mixed Materials (A0000000075908)" type="box">66</container>
          <container id="02a2b5c557126095698d09ce290041a1" parent="0bd09268e209b269c21c09d8c3e7b1c4" type="folder">1</container>
        </did>
        <accessrestrict id="45e2eef135b65b2a4bc8bfac6895eae6">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="a3e98844edbadfd1126f96dcee9fa072" level="file">
        <did>
          <unittitle>TML, 43-89 - Insulin Aspart - a new rapid-acting insulin</unittitle>
          <unitdate type="inclusive">2001 October 15</unitdate>
          <container id="cfa1f2bae43a99e4e8b00467ac878124" label="Mixed Materials (A0000000075908)" type="box">66</container>
          <container id="803605c2688bd2b7ad9626779b94233d" parent="cfa1f2bae43a99e4e8b00467ac878124" type="folder">2-3</container>
        </did>
        <accessrestrict id="95db9e419544c222951aae12dd139e45">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="2330e815d4bdfd9c12c459306864dcca" level="file">
        <did>
          <unittitle>TML, 43-103 - Drugs for HIV infection</unittitle>
          <unitdate type="inclusive">2001 November 26</unitdate>
          <container id="4afd6cdc63776d166706d96525b5b77b" label="Mixed Materials (A0000000075908)" type="box">66</container>
          <container id="d16be46d0f67fb44c93ccc14ac650834" parent="4afd6cdc63776d166706d96525b5b77b" type="folder">4-7</container>
        </did>
        <accessrestrict id="ba5d1519c239af0bb83357cd9431cc00">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="c9e718e37292bcb43f7c0f24dd8175bb" level="file">
        <did>
          <unittitle>TML, 43-26 - Once-a-Week Alendronate (Fosamaz)</unittitle>
          <unitdate type="inclusive">2001 March 19</unitdate>
          <container id="2e7333cc73b696e4dcceb02c2b3e81fc" label="Mixed Materials (A0000000075908)" type="box">66</container>
          <container id="6adaf6a6f984f3be378f9bf686113088" parent="2e7333cc73b696e4dcceb02c2b3e81fc" type="folder">8</container>
        </did>
        <accessrestrict id="3aaad115d37c1f7c6a8b419cea0284e4">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="ce9f44342b0f523de0bfcb639e0134e8" level="file">
        <did>
          <unittitle>TML - Drugs of Choice - Migraine - Reprints</unittitle>
          <unitdate type="inclusive">2001</unitdate>
          <container id="653c1f4b28667660268422e01f5beb06" label="Mixed Materials (A0000000075908)" type="box">66</container>
          <container id="589199972a5b2a3b478d3cb85e9a72bb" parent="653c1f4b28667660268422e01f5beb06" type="folder">9-10</container>
        </did>
        <accessrestrict id="9d4ad8765f4f79883181f256eb7f9879">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="8c50daa78ebe0875cf14c75e503ea1c1" level="file">
        <did>
          <unittitle>TML, Drugs of Choice - Pain</unittitle>
          <unitdate type="inclusive">2001</unitdate>
          <container id="b5fd3e0079e5a6a1d86500d8bc2db659" label="Mixed Materials (A0000000075908)" type="box">66</container>
          <container id="d48bbebe2a0bcf6815a1c63aacd23948" parent="b5fd3e0079e5a6a1d86500d8bc2db659" type="folder">11</container>
        </did>
        <accessrestrict id="3b2728fff814b6aa47a93b6386e34381">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="468e734f765a9be3853dd86c21c17c5d" level="file">
        <did>
          <unittitle>TML, 43-25 - Direct-to-Consumer advertisements for Glucophage XR</unittitle>
          <unitdate type="inclusive">2001 March 19</unitdate>
          <container id="dd812ab6552e2bb0f590a450690ac78b" label="Mixed Materials (A0000000075908)" type="box">66</container>
          <container id="6d20842fc3858b5b429d5d52f1a98a90" parent="dd812ab6552e2bb0f590a450690ac78b" type="folder">12</container>
        </did>
        <accessrestrict id="82bce5eadd0f640bbbd014ce96f624b7">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="d63b61dd440fbe48748ed3adaaa153a3" level="file">
        <did>
          <unittitle>TML, 43-13 - Palivizumab update</unittitle>
          <unitdate type="inclusive">2001 February 19</unitdate>
          <container id="584c48182361e249b23ebfd73ea9f0ac" label="Mixed Materials (A0000000075908)" type="box">66</container>
          <container id="5baa0adfac4ddb5a9cff6bb7c63fad3f" parent="584c48182361e249b23ebfd73ea9f0ac" type="folder">13-14</container>
        </did>
        <accessrestrict id="a7dd4884d34880dfc26867a2d2428bf1">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="07c5a88addbecee925056539789a95ce" level="file">
        <did>
          <unittitle>TML, 43-14 - Tinzaparin for treatment of deep vein thrombosis</unittitle>
          <unitdate type="inclusive">2001 February 19</unitdate>
          <container id="fec6dbbe514b187723a66b294f049142" label="Mixed Materials (A0000000075908)" type="box">66</container>
          <container id="678fe907b912072cb8601b28512589ba" parent="fec6dbbe514b187723a66b294f049142" type="folder">15-17</container>
        </did>
        <accessrestrict id="e9948bb5cd6966ff6405e6dc4196d47e">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="3c99102c3cbe6573776800745f8ae469" level="file">
        <did>
          <unittitle>TML, 43-39 - Formoterol (Foradil Aerolizer) for asthma</unittitle>
          <unitdate type="inclusive">2001 May 14</unitdate>
          <container id="06057f450f8165e3bebd31724f2258a9" label="Mixed Materials (A0000000075908)" type="box">66</container>
          <container id="618a9a4f11b8adceecb9e0065f052122" parent="06057f450f8165e3bebd31724f2258a9" type="folder">18-20</container>
        </did>
        <accessrestrict id="0e83e8dd8e86709df7f972ac81515598">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="c6baca4f86fe997597684780a50afb04" level="file">
        <did>
          <unittitle>TML, 43-39 - Formoterol (Foradil Aerolizer) for asthma</unittitle>
          <unitdate type="inclusive">2001 May 14</unitdate>
          <container id="cca1c4377fd248a72d6ab9e23f407567" label="Mixed Materials (A0000000075909)" type="box">67</container>
          <container id="2642893d1a91596dbe93074765d72dce" parent="cca1c4377fd248a72d6ab9e23f407567" type="folder">1</container>
        </did>
        <accessrestrict id="a04d9293e94b60a9e39c9b4189abc925">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="21563c371ed6d15964e3cc6b122e8325" level="file">
        <did>
          <unittitle>TML, 43-31 - Advair "Diskus" - A combination of fluticasone and salmeterol for asthma</unittitle>
          <unitdate type="inclusive">2001 April 6</unitdate>
          <container id="82afe73abb7353c0dc5bc5c80a49e934" label="Mixed Materials (A0000000075909)" type="box">67</container>
          <container id="1e20b3b75b761c38262c590b1afc7998" parent="82afe73abb7353c0dc5bc5c80a49e934" type="folder">2-5</container>
        </did>
        <accessrestrict id="591f5ce0464ac805e58c930e1f206114">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="a56fc8ba008f5ec96cb059f94525d216" level="file">
        <did>
          <unittitle>TML, 43-5 - Fluoxetine (Sarafem) for premenstrual dysphoric disorder</unittitle>
          <unitdate type="inclusive">2001 January 22</unitdate>
          <container id="1fe65a4cf658e3afb9f7ef2b79a26e22" label="Mixed Materials (A0000000075909)" type="box">67</container>
          <container id="fd349dffb30f644a88b91ab08e5b86bc" parent="1fe65a4cf658e3afb9f7ef2b79a26e22" type="folder">6-8</container>
        </did>
        <accessrestrict id="516c40c3c42f23a1ef834fac3280423d">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="29dd0d00d8ca1ffa9497a61ade7fcac7" level="file">
        <did>
          <unittitle>TML, 43-57 - Levothyroxine</unittitle>
          <unitdate type="inclusive">2001 July 9</unitdate>
          <container id="6684b04abb41ba78a9609fd26b6cccec" label="Mixed Materials (A0000000075909)" type="box">67</container>
          <container id="0c9e6d8ae7677e428995d844e0ae2cd2" parent="6684b04abb41ba78a9609fd26b6cccec" type="folder">9-11</container>
        </did>
        <accessrestrict id="5e4d50d8e1cee2179d409a4d58ebfe39">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="d2d95b76affb3a4c9b22a381ae08576d" level="file">
        <did>
          <unittitle>TML, 43-28 - Detrol LA and Ditropan XL for overactive bladder</unittitle>
          <unitdate type="inclusive">2001 April 2</unitdate>
          <container id="fbfe8b8fb542d4be478220022c366960" label="Mixed Materials (A0000000075909)" type="box">67</container>
          <container id="abdad57805178a51dbfb7d67d48c1542" parent="fbfe8b8fb542d4be478220022c366960" type="folder">12-13</container>
        </did>
        <accessrestrict id="c2a600b167a1d8ec49922e49f096e4ab">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="bf76f78ab4a4977fe44b60003b8f05f2" level="file">
        <did>
          <unittitle>TML, 43-27 - Prozac Weekly</unittitle>
          <unitdate type="inclusive">2001 April 2</unitdate>
          <container id="108ee417a02088bf7e1fdec1011a4b87" label="Mixed Materials (A0000000075909)" type="box">67</container>
          <container id="d3ed092dfe3623a43ee52fcd7e2be57f" parent="108ee417a02088bf7e1fdec1011a4b87" type="folder">14</container>
        </did>
        <accessrestrict id="154ff78d3302dfb71a0c20f63e7f510f">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="d6b0a2f70273ff0516f8b345cdc4f512" level="file">
        <did>
          <unittitle>TML - Drugs for migraine</unittitle>
          <unitdate type="inclusive">2001</unitdate>
          <container id="642878084d34486867bf3ffbcd34728f" label="Mixed Materials (A0000000075909)" type="box">67</container>
          <container id="f1fb976212f161c5f2d8cb0cd2e22f1c" parent="642878084d34486867bf3ffbcd34728f" type="folder">15-17</container>
        </did>
        <accessrestrict id="81584269571599c2534c39747bee7f6e">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="ab3c9b20ba673d3a09626a2131dfbd70" level="file">
        <did>
          <unittitle>TML - Drugs for migraine</unittitle>
          <unitdate type="inclusive">2001</unitdate>
          <container id="31c77353150238b76e1fcbbcd9138b6d" label="Mixed Materials (A0000000075910)" type="box">68</container>
          <container id="2b550ba73e9dd893ec87ee198c78884f" parent="31c77353150238b76e1fcbbcd9138b6d" type="folder">1</container>
        </did>
        <accessrestrict id="33ca4d5589e42adbdeba4c14888b39e2">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="ce9d0ae7e21eaea0c4687dae309cfee9" level="file">
        <did>
          <unittitle>TML, 43-67 - Twinrix - A combination Hepatitis A and B vaccine</unittitle>
          <unitdate type="inclusive">2001 August 6</unitdate>
          <container id="2f7abb3be815c7045197e642c371ea46" label="Mixed Materials (A0000000075910)" type="box">68</container>
          <container id="ffe4cbf865b26c9a54085a10420bd06f" parent="2f7abb3be815c7045197e642c371ea46" type="folder">2-4</container>
        </did>
        <accessrestrict id="c860c07bca67d0f682cba26ca6577767">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="50348bc86f79794dd7d3880f772dc9fb" level="file">
        <did>
          <unittitle>TML, 43-81 - Influenza prevention 2001-2002</unittitle>
          <unitdate type="inclusive">2001 September 17</unitdate>
          <container id="c5fc2d23ea3b7283eb1f2018f7433ea4" label="Mixed Materials (A0000000075910)" type="box">68</container>
          <container id="5a47074adf55787b3f58237485164bbc" parent="c5fc2d23ea3b7283eb1f2018f7433ea4" type="folder">5-8</container>
        </did>
        <accessrestrict id="1bbd28b63a91d7783c47a3da12aa5197">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="3b16d2ad8da51e66ff96ab39df1d0aac" level="file">
        <did>
          <unittitle>TML, 43-33 - Topical tacrolimus treatment for atopic dermatitis</unittitle>
          <unitdate type="inclusive">2001 April 16</unitdate>
          <container id="8b6bf0e53afa00005c084fdc76bce807" label="Mixed Materials (A0000000075910)" type="box">68</container>
          <container id="30c29cc1a38aa63f2eeade1a19fd75d9" parent="8b6bf0e53afa00005c084fdc76bce807" type="folder">9-12</container>
        </did>
        <accessrestrict id="524857adc52fa0f183b069d3ae7050b5">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="41122ea5a6e7981f0132dc387c47d526" level="file">
        <did>
          <unittitle>TML, 43-42 - Glucowatch Biographer - A noninvasive glucose monitoring device</unittitle>
          <unitdate type="inclusive">2001 May 14</unitdate>
          <container id="228038c022ba514e7d45e8893a93a40d" label="Mixed Materials (A0000000075910)" type="box">68</container>
          <container id="cf2cb68860a913085c9e2dbcdfe009c6" parent="228038c022ba514e7d45e8893a93a40d" type="folder">13-14</container>
        </did>
        <accessrestrict id="8a2f04b8e85fd19c93d31127f994912c">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="1f33fb25dbc24b2e3a9cc4123daa4b4c" level="file">
        <did>
          <unittitle>TML, 43-99 - Cardiovascular Safety of COX-2 Inhibitors</unittitle>
          <unitdate type="inclusive">2001 November 12</unitdate>
          <container id="43a97aef82a0ca7ada440ab2f766c35b" label="Mixed Materials (A0000000075910)" type="box">68</container>
          <container id="55470d6b22f94df9a4f9f7d04ecafeb8" parent="43a97aef82a0ca7ada440ab2f766c35b" type="folder">15-17</container>
        </did>
        <accessrestrict id="ed26092ce8449e46cf63b80b2a291816">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="9c5905505fca4831e512fb2648100be7" level="file">
        <did>
          <unittitle>TML - Drugs of Choice - Hypertension and Heart Failure</unittitle>
          <unitdate type="inclusive">2001</unitdate>
          <container id="31ae547f4f87c859f45afe9821bc7360" label="Mixed Materials (A0000000075910)" type="box">68</container>
          <container id="09665cc803932f91cbb5777ac43c5ec2" parent="31ae547f4f87c859f45afe9821bc7360" type="folder">18</container>
        </did>
        <accessrestrict id="75c6bb282a1bebd46a6a30af50403e35">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="d83158c1d6d2339140e8e837daa705b4" level="file">
        <did>
          <unittitle>TML, 43-23 - Over-the-Counter (OTC) Cough Remedies</unittitle>
          <unitdate type="inclusive">2001 March 19</unitdate>
          <container id="2801693df3962cfce93785c83912cc34" label="Mixed Materials (A0000000075910)" type="box">68</container>
          <container id="e9fbdb5dfbc7774aee6300221e201829" parent="2801693df3962cfce93785c83912cc34" type="folder">19-21</container>
        </did>
        <accessrestrict id="a70ce5ed30190ec1d7686f21b89b6372">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="45a1a372dc6189c488cbf6dbf95adb8d" level="file">
        <did>
          <unittitle>TML, 43-23 - Over-the-Counter (OTC) Cough Remedies</unittitle>
          <unitdate type="inclusive">2001 March 19</unitdate>
          <container id="17b6a9a100c1e7112efe64f777a0af16" label="Mixed Materials (A0000000075911)" type="box">69</container>
          <container id="8b921ed46a506169265857b063028ab3" parent="17b6a9a100c1e7112efe64f777a0af16" type="folder">1</container>
        </did>
        <accessrestrict id="a1903924a041556ee7b26f4c2b26ac5e">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="4cdec89511203afd4fe2dc98bb7107a3" level="file">
        <did>
          <unittitle>TML, 43-3 - Drugs for Vulvovaginal Candidiasis</unittitle>
          <unitdate type="inclusive">2001 January 8</unitdate>
          <container id="a678833da8377a00b88e85a387a65d49" label="Mixed Materials (A0000000075911)" type="box">69</container>
          <container id="d67561f86e127e7323a9b9bffc880764" parent="a678833da8377a00b88e85a387a65d49" type="folder">2-4</container>
        </did>
        <accessrestrict id="721d15062edf16474f8c9615e7343c9b">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="9c93f14bdbe03244367dc9260f841c8a" level="file">
        <did>
          <unittitle>TML, 43-40 - Epoetin - Erythropoietin (Procrit; Epogen) Revisited</unittitle>
          <unitdate type="inclusive">2001 May 14</unitdate>
          <container id="ff4e27e3bbd9e6af17d35cb94eee3a5f" label="Mixed Materials (A0000000075911)" type="box">69</container>
          <container id="8bbe8fb216b9e79a88ee0505218ebc50" parent="ff4e27e3bbd9e6af17d35cb94eee3a5f" type="folder">5-8</container>
        </did>
        <accessrestrict id="0834865471315b83cd87445af0b5d964">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="8c1db8b64ee78c1dea2315fd90476615" level="file">
        <did>
          <unittitle>TML - Drugs of Choice - Epilepsy</unittitle>
          <unitdate type="inclusive">2001</unitdate>
          <container id="0beafe918ae5ed4f141ec43243ae927e" label="Mixed Materials (A0000000075911)" type="box">69</container>
          <container id="1f13c0c8384062158e5de259ad6c60a6" parent="0beafe918ae5ed4f141ec43243ae927e" type="folder">9-12</container>
        </did>
        <accessrestrict id="0b08c7f91d343d75d562eb65c74f54bc">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="42c85fbc002a3352f01a11a7e4a6f54d" level="file">
        <did>
          <unittitle>TML, 43-36 - Esomeprazole (Nexium)</unittitle>
          <unitdate type="inclusive">2001 April 30</unitdate>
          <container id="fb0a6480019f3d35d3f0bdd4ab0f27c5" label="Mixed Materials (A0000000075911)" type="box">69</container>
          <container id="ecee3c2934a4eb574e83a8da1711058a" parent="fb0a6480019f3d35d3f0bdd4ab0f27c5" type="folder">13-14</container>
        </did>
        <accessrestrict id="cc2db5a946dc97445662edf403135cfe">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="dde7a8f4a1c15dd762a0160728804b73" level="file">
        <did>
          <unittitle>TML, 43-111 - Update on glucosamine for osteoarthritis</unittitle>
          <unitdate type="inclusive">2001 December 10</unitdate>
          <container id="526e8e7ab67450db468ca683aca03d5c" label="Mixed Materials (A0000000075911)" type="box">69</container>
          <container id="88568c296c2acdd4110de363ae7b76aa" parent="526e8e7ab67450db468ca683aca03d5c" type="folder">15-17</container>
        </did>
        <accessrestrict id="5b2a4f2cbe109ddd0b02adec46206e8d">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="9666394f9b7e1594ab6d9d740833bf6d" level="file">
        <did>
          <unittitle>TML, 43-53 - Galantamine (Reminyl) for Alzheimer's disease</unittitle>
          <unitdate type="inclusive">2001 June 25</unitdate>
          <container id="411818c8cd197d0fd84219ba1007875b" label="Mixed Materials (A0000000075911)" type="box">69</container>
          <container id="25dbafd7a661f92802d2684b1f93f1b1" parent="411818c8cd197d0fd84219ba1007875b" type="folder">18-20</container>
        </did>
        <accessrestrict id="64351c947d34d22cef39ad4007296824">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="9e514faa1eb026a69873e6b610137535" level="file">
        <did>
          <unittitle>TML, 43-80 - Oxycodone and Oxycontin</unittitle>
          <unitdate type="inclusive">2001 September 17</unitdate>
          <container id="19b63da81a936ef8282030bdb4d8e292" label="Mixed Materials (A0000000075912)" type="box">70</container>
          <container id="777a59e58c535f486077d92468ba9e31" parent="19b63da81a936ef8282030bdb4d8e292" type="folder">1-4</container>
        </did>
        <accessrestrict id="71c26f172f9a9a3876c7b24d11cc0db1">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="9bf44e00458f50d0ecc17dc1d13c078a" level="file">
        <did>
          <unittitle>TML - Drugs of Choice - Asthma - Reprints</unittitle>
          <unitdate type="inclusive">2001</unitdate>
          <container id="26152b4b0bb429303c6b059824a8e182" label="Mixed Materials (A0000000075912)" type="box">70</container>
          <container id="d918cd4e48111394abb4e33ba87f2568" parent="26152b4b0bb429303c6b059824a8e182" type="folder">5-7</container>
        </did>
        <accessrestrict id="753a55d97a80d113ee2476718a3d1661">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="0dc13b68cd4edd9b7be7bd34aad97ff0" level="file">
        <did>
          <unittitle>TML - Drugs of Choice - Hypertension - Reprints</unittitle>
          <unitdate type="inclusive">2001</unitdate>
          <container id="029d686085932b95b5656cb81b507a4d" label="Mixed Materials (A0000000075912)" type="box">70</container>
          <container id="aae16080f22eaf37f054b70d337d241c" parent="029d686085932b95b5656cb81b507a4d" type="folder">8-10</container>
        </did>
        <accessrestrict id="d504ebc62c5421f5e1d907042650019a">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="28985057e383ceb12ff871b5d26e61da" level="file">
        <did>
          <unittitle>TML - Drugs of Choice - Epilepsy - Reprints</unittitle>
          <unitdate type="inclusive">2001</unitdate>
          <container id="bbdab404816538c6a1035ae870125b0a" label="Mixed Materials (A0000000075912)" type="box">70</container>
          <container id="66de88cdfcd8e4c7a64c6c77b1dcff0a" parent="bbdab404816538c6a1035ae870125b0a" type="folder">11-13</container>
        </did>
        <accessrestrict id="22fbfc715602ec37fdf0114b7cb13cbe">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="e9eaa9b717e217af3529d05e6f9fbd9e" level="file">
        <did>
          <unittitle>TML - Drugs of Choice - Arthritis - Reprints</unittitle>
          <unitdate type="inclusive">2001</unitdate>
          <container id="c21c52d84b2ab1ec4e6eafe16bffc6ba" label="Mixed Materials (A0000000075912)" type="box">70</container>
          <container id="2824dff8c9c5cfccc7df51f713d4d200" parent="c21c52d84b2ab1ec4e6eafe16bffc6ba" type="folder">14-15</container>
        </did>
        <accessrestrict id="b5d06faa04330361ca1ca75b21c017fb">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="a8579ee641a8d372e5b92c341780d2f0" level="file">
        <did>
          <unittitle>TML - Drugs of Choice - Depression and Anxiety</unittitle>
          <unitdate type="inclusive">2001</unitdate>
          <container id="6a2e029ed6b355beef84f92073309b84" label="Mixed Materials (A0000000075912)" type="box">70</container>
          <container id="50796d126e49fbcb182d516d24597719" parent="6a2e029ed6b355beef84f92073309b84" type="folder">16-17</container>
        </did>
        <accessrestrict id="85e3914a93c77fea32c035bd079cdf38">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="d1091da187ca03263e9fbe06a0c8e8b9" level="file">
        <did>
          <unittitle>TML, 44-105 - Adefovir (Hespera) for chronic Hepatitis B infection</unittitle>
          <unitdate type="inclusive">2002 December 9</unitdate>
          <container id="40bee5c68e56393708e569201467ecab" label="Mixed Materials (A0000000075913)" type="box">71</container>
          <container id="2ec98e4a2e4e995e7455cd51863be4e9" parent="40bee5c68e56393708e569201467ecab" type="folder">1-4</container>
        </did>
        <accessrestrict id="5e9a358af553725b2b7a0e754e583db4">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="a52ad11ec1e3f4d9273267e959212194" level="file">
        <did>
          <unittitle>TML, 44-67 - Alosetron (Lotronex) revisited</unittitle>
          <unitdate type="inclusive">2002 August 5</unitdate>
          <container id="d2c7c2547d3d15b5390f46633800b9e0" label="Mixed Materials (A0000000075913)" type="box">71</container>
          <container id="a6a82c16de0c000973cf68d07ef5e43b" parent="d2c7c2547d3d15b5390f46633800b9e0" type="folder">5-8</container>
        </did>
        <accessrestrict id="44f937981b03e47fe5b48832e2bc3c06">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="524bcd1ef0983fc228db57fdceccbd8a" level="file">
        <did>
          <unittitle>TML, 44-1 - Prevention and treatment of injury from chemical biological warfare</unittitle>
          <unitdate type="inclusive">2002 January 7</unitdate>
          <container id="3969b157667a4767568474d8c1909d51" label="Mixed Materials (A0000000075913)" type="box">71</container>
          <container id="06837d9d3b5a7369b3838a90a1998074" parent="3969b157667a4767568474d8c1909d51" type="folder">9-11</container>
        </did>
        <accessrestrict id="41a008738c8b0cf8972cf6b24432d838">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="bad1e6f9e4ec0f760e77c31253787c34" level="file">
        <did>
          <unittitle>TML, 44-18 - Anakinra (Kineret) for rheumatoid arthritis</unittitle>
          <unitdate type="inclusive">2002 February 18</unitdate>
          <container id="bb25c076541bd027483fa36ee7a4d492" label="Mixed Materials (A0000000075913)" type="box">71</container>
          <container id="0559da25337fa7e16179222da3caa2b5" parent="bb25c076541bd027483fa36ee7a4d492" type="folder">12-13</container>
        </did>
        <accessrestrict id="5283c1dbc9ae363bd049db90b8c9f8d8">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="ba78803aaafb030f1962308400163490" level="file">
        <did>
          <unittitle>TML, 44-19 - Almotriptan (Axert) and Frovatriptan (Friva) for migraine</unittitle>
          <unitdate type="inclusive">2002 February 18</unitdate>
          <container id="dcf8232aeb0b8cff18465e59583b2173" label="Mixed Materials (A0000000075913)" type="box">71</container>
          <container id="78490676b1981ab89ec3ef6d7c45c469" parent="dcf8232aeb0b8cff18465e59583b2173" type="folder">14-16</container>
        </did>
        <accessrestrict id="261eac7e701cc4253a133eadd4895b0e">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="bb6077375b3a6ffeb4bb53556a4f4c3c" level="file">
        <did>
          <unittitle>TML, 44-110 - Hemolysis from Ceftriaxone</unittitle>
          <unitdate type="inclusive">2002 November 25</unitdate>
          <container id="16afd855242801f3d95f4c05bda570f4" label="Mixed Materials (A0000000075913)" type="box">71</container>
          <container id="ac403eff42a4a65b0b41a956de5e7393" parent="16afd855242801f3d95f4c05bda570f4" type="folder">17-19</container>
        </did>
        <accessrestrict id="06663a53b51c9f32469146874e6a53fd">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="a4e45a144c74f16ab14378047e5576f1" level="file">
        <did>
          <unittitle>TML, 44-6 - Budesonide (Entocort EC) for Crohn's disease</unittitle>
          <unitdate type="inclusive">2002 January 21</unitdate>
          <container id="0eb70aaef3b9940299c49838f52dd3a1" label="Mixed Materials (A0000000075913)" type="box">71</container>
          <container id="cc40dd76da059f2b6517b5b5b94c6afb" parent="0eb70aaef3b9940299c49838f52dd3a1" type="folder">20-21</container>
        </did>
        <accessrestrict id="344623fd522ad204005bd4713a3a7eaa">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="9f13d0adec34e41920a5e68ddd64292c" level="file">
        <did>
          <unittitle>TML, 44-109 - Dustateride (Avodart) for benign prostatic hyperplasia</unittitle>
          <unitdate type="inclusive">2002 December 23</unitdate>
          <container id="def62cacea877cdfc617755d2eb6e60c" label="Mixed Materials (A0000000075914)" type="box">72</container>
          <container id="10a05d55b9185f02191a90ea7b8ece93" parent="def62cacea877cdfc617755d2eb6e60c" type="folder">1</container>
        </did>
        <accessrestrict id="867284bb3e82161ed3ce13cf85bb50cf">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="9263ee3a396996d1f6c92f91c990e8b4" level="file">
        <did>
          <unittitle>TML, 44-55 - Yasmin - an oral contraceptive with a new progestin</unittitle>
          <unitdate type="inclusive">2002 June 24</unitdate>
          <container id="899b75f74972d3ea31374de5e73d8cb2" label="Mixed Materials (A0000000075914)" type="box">72</container>
          <container id="786675d847fb532bffec49faa17baf37" parent="899b75f74972d3ea31374de5e73d8cb2" type="folder">2-7</container>
        </did>
        <accessrestrict id="c400e4bb55cfe7ea165cfb2d2dc99c6b">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="fec2a29720e66cc581b066877ffa632d" level="file">
        <did>
          <unittitle>TML, 44-8 - Othro Evra - A contraceptive patch</unittitle>
          <unitdate type="inclusive">2002 January 21</unitdate>
          <container id="a1fb6e34c9be56720f5ada4b508338dd" label="Mixed Materials (A0000000075914)" type="box">72</container>
          <container id="1d1694983d9ca8511523f775a0d8ce7d" parent="a1fb6e34c9be56720f5ada4b508338dd" type="folder">8-9</container>
        </did>
        <accessrestrict id="f89be5a42a6e7c9142c05161a1bb4330">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="ea19cfea9c41aa789e87a27139849cc9" level="file">
        <did>
          <unittitle>TML, 44-42 - Copyright violations</unittitle>
          <unitdate type="inclusive">2002 April 29</unitdate>
          <container id="528f194d70b25b2917927beb0f974e39" label="Mixed Materials (A0000000075914)" type="box">72</container>
          <container id="9f64cd8b6208d509b491cc5e6a1103b7" parent="528f194d70b25b2917927beb0f974e39" type="folder">10</container>
        </did>
        <accessrestrict id="ec1aa5a5bbffa7071d0ee4e1725ec096">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="573b9aa7949c2b6064549d58f22d1ef4" level="file">
        <did>
          <unittitle>TML, 44-89 - Generic drugs</unittitle>
          <unitdate type="inclusive">2002 October 14</unitdate>
          <container id="d14214640b90d0221846fe3cc3f38e59" label="Mixed Materials (A0000000075914)" type="box">72</container>
          <container id="124c53c83eb5f97e6a0f5bf11e2f4cb7" parent="d14214640b90d0221846fe3cc3f38e59" type="folder">11-13</container>
        </did>
        <accessrestrict id="5b1243a2f3ac837601682945b4ad6a9e">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="eca6e6e8880da77ade266c114c4c3ef8" level="file">
        <did>
          <unittitle>TML, 44-77 - Gefitinib (Iressa) for advanced non-small cell lung cancer</unittitle>
          <unitdate type="inclusive">2002 September 2</unitdate>
          <container id="3caad8da3d9c40d9ac8b3a6070444375" label="Mixed Materials (A0000000075914)" type="box">72</container>
          <container id="759c67209a7b056d09dbeb0f54bce777" parent="3caad8da3d9c40d9ac8b3a6070444375" type="folder">14-16</container>
        </did>
        <accessrestrict id="e52979497dde6f1c31a59d9d3764a403">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="a5125bf7e9b481c9cf3b474c751ee55e" level="file">
        <did>
          <unittitle>TML, 44-103 - GHB for nacolepsy</unittitle>
          <unitdate type="inclusive">2002 December 9</unitdate>
          <container id="a4bafc0467c327d3fdb83cc809d99195" label="Mixed Materials (A0000000075914)" type="box">72</container>
          <container id="a89d21b0c696bf73f1434053fb8b4658" parent="a4bafc0467c327d3fdb83cc809d99195" type="folder">17-19</container>
        </did>
        <accessrestrict id="0fce222a44f0f4d669d6446bfe4d0948">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="5f1f43a60e3a918e61f1524dd78e1670" level="file">
        <did>
          <unittitle>TML - Fungal Infections</unittitle>
          <unitdate type="inclusive">2002</unitdate>
          <container id="2b6d857a9102a25e1294ade08d6453e7" label="Mixed Materials (A0000000075914)" type="box">72</container>
          <container id="72281f65f0c204d83965fb8408248872" parent="2b6d857a9102a25e1294ade08d6453e7" type="folder">20</container>
        </did>
        <accessrestrict id="43b31e9dd0e56b4393c587638541da8a">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="d0277fd8830f2d769496c88f15bb859c" level="file">
        <did>
          <unittitle>TML - Fungal Infections</unittitle>
          <unitdate type="inclusive">2002</unitdate>
          <container id="9151eef7ac495f7ff98bc4af80adb163" label="Mixed Materials (A0000000075915)" type="box">73</container>
          <container id="cc474c3df313c950553c343269b2427e" parent="9151eef7ac495f7ff98bc4af80adb163" type="folder">1</container>
        </did>
        <accessrestrict id="0374c695f899676ae2f0f4ab46c32079">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="38f15317a1ab04ccab7ddf87c59865ca" level="file">
        <did>
          <unittitle>TML, 44-65 - Fulvestrant (Faslodex) for advanced breast cancer</unittitle>
          <unitdate type="inclusive">2002 July 22</unitdate>
          <container id="369f092b317cb03c56d4481b850cef26" label="Mixed Materials (A0000000075915)" type="box">73</container>
          <container id="12d322f3a593b3dff9be43ac4cc56dae" parent="369f092b317cb03c56d4481b850cef26" type="folder">2-4</container>
        </did>
        <accessrestrict id="ce879f9aa1fe59c4646fb8a958d249d1">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="c2dd44962d67176662e4db78dd0a66d1" level="file">
        <did>
          <unittitle>TML, 44-5 - Cefditoren (Spectracef) - A new oral cephalosporin</unittitle>
          <unitdate type="inclusive">2002 January 21</unitdate>
          <container id="8aeb4e81ae3a7be5c4aa7cb071136fd6" label="Mixed Materials (A0000000075915)" type="box">73</container>
          <container id="579706ad0095507e8d92b2d0cb1fece1" parent="8aeb4e81ae3a7be5c4aa7cb071136fd6" type="folder">5-7</container>
        </did>
        <accessrestrict id="a137a040fd97e7017313ae9a82d2fe86">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="70993f6f906adca6d28b7cec87c5cbab" level="file">
        <did>
          <unittitle>TML, 44-93 - Drugs past their expiration date</unittitle>
          <unitdate type="inclusive">2002 October 28</unitdate>
          <container id="024a5c3a462d0859d58aeb2449e62127" label="Mixed Materials (A0000000075915)" type="box">73</container>
          <container id="6b42ca82c964429c3ba3132d3908fbde" parent="024a5c3a462d0859d58aeb2449e62127" type="folder">8-10</container>
        </did>
        <accessrestrict id="e06690c5813977cdcc6c8a5a7653718f">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="f9bc602671296cc3d2de922401f1986e" level="file">
        <did>
          <unittitle>TML, 44-83 - Escitalopram (Lexapro) for depression</unittitle>
          <unitdate type="inclusive">2002 September 30</unitdate>
          <container id="5f46c121c3135db3475e3cca831b943a" label="Mixed Materials (A0000000075915)" type="box">73</container>
          <container id="91029ea5235f5c48ef8b0e241970c728" parent="5f46c121c3135db3475e3cca831b943a" type="folder">11-12</container>
        </did>
        <accessrestrict id="fdb13be24c2193fa8c3289e7d5ad654a">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="88bf2c423e244a87d79645badbf2e9f3" level="file">
        <did>
          <unittitle>TML, 44-43 - Fondaparinux (Arixtra) - a new anticoagulant</unittitle>
          <unitdate type="inclusive">2002 May 13</unitdate>
          <container id="8e3688c31402de9c7c763cc0edd28301" label="Mixed Materials (A0000000075915)" type="box">73</container>
          <container id="1c149d1a84fdc18c0eb2f89afcba932e" parent="8e3688c31402de9c7c763cc0edd28301" type="folder">13-15</container>
        </did>
        <accessrestrict id="bbbdd53df2b8ebd0612902a21d46a748">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="05b64e3022467a23598c9201bc74dfdf" level="file">
        <did>
          <unittitle>TML - Cefepime</unittitle>
          <unitdate type="inclusive">2002</unitdate>
          <container id="f94200a22fb5c7138394eb8d5e95e043" label="Mixed Materials (A0000000075915)" type="box">73</container>
          <container id="8efdf26d8bf68fc6fd1c056136726a51" parent="f94200a22fb5c7138394eb8d5e95e043" type="folder">16-18</container>
        </did>
        <accessrestrict id="394b3115bcff39760eac5c39dc81bdb6">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="0b79a2b45ac5a48beb03988b3255f34c" level="file">
        <did>
          <unittitle>TML, 44-126 - Eratapenem - a new parenteral carbapenem</unittitle>
          <unitdate type="inclusive">2002 March 18</unitdate>
          <container id="4f9937d4e71a271829d8a5639b0c16a8" label="Mixed Materials (A0000000075915)" type="box">73</container>
          <container id="e0b72632469857d32fb0739c68f94c68" parent="4f9937d4e71a271829d8a5639b0c16a8" type="folder">19-21</container>
        </did>
        <accessrestrict id="556a688586b09ef7523a269879e4d606">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="2ab8dcb85ae9ce0ddd2d1fdc51a02ee6" level="file">
        <did>
          <unittitle>TML - Echinacea</unittitle>
          <unitdate type="inclusive">2002</unitdate>
          <container id="0a41d517e36bbba72b9b79836eb530c5" label="Mixed Materials (A0000000075916)" type="box">74</container>
          <container id="291f6b1c5a6514eaa713a6a42d8a5aba" parent="0a41d517e36bbba72b9b79836eb530c5" type="folder">1-3</container>
        </did>
        <accessrestrict id="dc18fb2ef4fb05f2fdaba6355d199ff6">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="af85bd11efe07fd729751c8c218f32d2" level="file">
        <did>
          <unittitle>TML, 44-47 - Botulinum Toxin (Botox Cosmetic) for frown lines</unittitle>
          <unitdate type="inclusive">2002 May 27</unitdate>
          <container id="e2185b44bfe64b445cb4fdeae61baa7e" label="Mixed Materials (A0000000075916)" type="box">74</container>
          <container id="ac728df7890a203d8c3e146bc189b300" parent="e2185b44bfe64b445cb4fdeae61baa7e" type="folder">4-6</container>
        </did>
        <accessrestrict id="e67c688500af00baeca0146003fa4b6f">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="45aa8fe42fd0ddc4536be77350df4b57" level="file">
        <did>
          <unittitle>TML - Fungal Infections - Reprints</unittitle>
          <unitdate type="inclusive">2002</unitdate>
          <container id="c8942e0d215299e9135f636acdac9612" label="Mixed Materials (A0000000075916)" type="box">74</container>
          <container id="97272fe254eba3ba6279b17a60cb32c9" parent="c8942e0d215299e9135f636acdac9612" type="folder">7</container>
        </did>
        <accessrestrict id="1f1099e38699970b363bae0c6975a70b">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="2e47b4ee1607009a90bcdea23b07a404" level="file">
        <did>
          <unittitle>TML - Drugs for Asthma - Treatment Guidelines</unittitle>
          <unitdate type="inclusive">2002</unitdate>
          <container id="4ef3e4fbab23eb38b1fe5e3362fc0125" label="Mixed Materials (A0000000075916)" type="box">74</container>
          <container id="f7cbfb3265dc88bedd974176d48d7f7f" parent="4ef3e4fbab23eb38b1fe5e3362fc0125" type="folder">8-19</container>
        </did>
        <accessrestrict id="831283e78ef78563e6f6b9e3060a60fb">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="f41b47c09c3e11ca72cf6fe9fcfca8b2" level="file">
        <did>
          <unittitle>TML - Drugs for Asthma - Treatment Guidelines</unittitle>
          <unitdate type="inclusive">2002</unitdate>
          <container id="068128f583e68b4034c2b8dc7db45517" label="Mixed Materials (A0000000075917)" type="box">75</container>
          <container id="0da12381c738836d5d10dba3b741ed7f" parent="068128f583e68b4034c2b8dc7db45517" type="folder">1-2</container>
        </did>
        <accessrestrict id="37075cc131616efa32d821ddec70e19a">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="0785dbde88fe25acb019e68e53796851" level="file">
        <did>
          <unittitle>TML, 44-73 - Neotame - a new artificial sweetner</unittitle>
          <unitdate type="inclusive">2002 August 19</unitdate>
          <container id="42c8d99e2477c05195a1f97af2de9877" label="Mixed Materials (A0000000075917)" type="box">75</container>
          <container id="b53909e646e97d892bfb5a787b97c6b7" parent="42c8d99e2477c05195a1f97af2de9877" type="folder">3-4</container>
        </did>
        <accessrestrict id="423a699022dfc41e5a19356b8ede358f">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="daec721a5877ed667e3be025c5b3972b" level="file">
        <did>
          <unittitle>TML, 44-95 - Valacyclovir (Valtrex) for herpes labialis</unittitle>
          <unitdate type="inclusive">2002 November 11</unitdate>
          <container id="54f5d3cb73aa1e2df4b916cffd3c6719" label="Mixed Materials (A0000000075917)" type="box">75</container>
          <container id="a680d5fdefce403df3c66404c0aec9b2" parent="54f5d3cb73aa1e2df4b916cffd3c6719" type="folder">5-6</container>
        </did>
        <accessrestrict id="65275a0edfafc2779f6f3b12b167613d">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="daaa98dacc14a33f7dd8c3607f43fabe" level="file">
        <did>
          <unittitle>TML - Drugs for prevention and treatment of postmenopausal osteoporosis - Treatment Guidelines</unittitle>
          <unitdate type="inclusive">2002 November 1</unitdate>
          <container id="ea913f1bc41b9b00bb450807f259e8b5" label="Mixed Materials (A0000000075917)" type="box">75</container>
          <container id="c05e03603303a5206f1c4b1d6fe43a78" parent="ea913f1bc41b9b00bb450807f259e8b5" type="folder">7-10</container>
        </did>
        <accessrestrict id="66fca14cfc643877b243d938549ef683">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="6c5c80d095e7afd1c721854326e0f8cc" level="file">
        <did>
          <unittitle>TML, 44-9 - Drugs for Non-HIV viral infections</unittitle>
          <unitdate type="inclusive">2002 February 4</unitdate>
          <container id="df5540ad89aacd6118f172b80074f042" label="Mixed Materials (A0000000075917)" type="box">75</container>
          <container id="9888adae6ca28faeae5057202f0ced44" parent="df5540ad89aacd6118f172b80074f042" type="folder">11-17</container>
        </did>
        <accessrestrict id="bdf05fc38d86db9b72f37658b33c4730">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="bcfed60146a9353c15a7810e066eb562" level="file">
        <did>
          <unittitle>TML, 44-39 - Valdecoxib (Bextra) - a new COX2 inhibitor</unittitle>
          <unitdate type="inclusive">2002 April 29</unitdate>
          <container id="7a2775eaab8545b943a2b55df0e43733" label="Mixed Materials (A0000000075917)" type="box">75</container>
          <container id="ff7d7f7477df36120bdeeb9e94c750d8" parent="7a2775eaab8545b943a2b55df0e43733" type="folder">18-19</container>
        </did>
        <accessrestrict id="3f36d4c0ac7dd42dca225464d90a4a7b">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="26f9f680797154013e700d36b1ee02cc" level="file">
        <did>
          <unittitle>TML, 44-39 - Valdecoxib (Bextra) - a new COX2 inhibitor</unittitle>
          <unitdate type="inclusive">2002 April 29</unitdate>
          <container id="5b12d51b590912a619b2a37037685b10" label="Mixed Materials (A0000000075918)" type="box">76</container>
          <container id="1dfbed4ed11c43e79b3159fe57dfea6d" parent="5b12d51b590912a619b2a37037685b10" type="folder">1-2</container>
        </did>
        <accessrestrict id="538e6db36155fc336b5cd7453b267830">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="87edb03339d8ce2c8587c9b08fa0c33c" level="file">
        <did>
          <unittitle>TML, 44-52 - Tazarotene (Tazorac) for acne</unittitle>
          <unitdate type="inclusive">2002 June 10</unitdate>
          <container id="a8528b5b523fd3af50a916bf0242d0b3" label="Mixed Materials (A0000000075918)" type="box">76</container>
          <container id="30d3a699162f5369931e0c1f8d3f4ba2" parent="a8528b5b523fd3af50a916bf0242d0b3" type="folder">3-5</container>
        </did>
        <accessrestrict id="009827e7a43d5b337cbe6459416c7913">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="4e2f11c3afbd278cc01889db51cc3594" level="file">
        <did>
          <unittitle>TML - Safety of antimicrobials in pregnancy</unittitle>
          <unitdate type="inclusive">2002</unitdate>
          <container id="ae01e764c90a7e843045ac6b472d6786" label="Mixed Materials (A0000000075918)" type="box">76</container>
          <container id="6a08672cee345e5a9858263dda7c6d71" parent="ae01e764c90a7e843045ac6b472d6786" type="folder">6-9</container>
        </did>
        <accessrestrict id="4077280e1fc84a55fa2f33342e312820">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="d9af5da201c75753edd17152b98006c9" level="file">
        <did>
          <unittitle>TML, 44-63 - Voriconazole</unittitle>
          <unitdate type="inclusive">2002 July 22</unitdate>
          <container id="19c4a9b5397f7bdb7fe3433a6398e910" label="Mixed Materials (A0000000075918)" type="box">76</container>
          <container id="cbbeb4e1c946dddb2d561e31bc9e1c7c" parent="19c4a9b5397f7bdb7fe3433a6398e910" type="folder">10-14</container>
        </did>
        <accessrestrict id="7f7313cf1c86daf164b8b5b1d2c47390">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="f449d0ea0cb02a16dc4bb161afd0e8e1" level="file">
        <did>
          <unittitle>TML - Cardiovascular drugs in the ICU - Treatment Guidelines</unittitle>
          <unitdate type="inclusive">2002 December</unitdate>
          <container id="f00305ec15204a43aced17dab3f7df0e" label="Mixed Materials (A0000000075918)" type="box">76</container>
          <container id="ab1edef2fc74588812e63dcbd77712e3" parent="f00305ec15204a43aced17dab3f7df0e" type="folder">15-20</container>
        </did>
        <accessrestrict id="d78727a12815fb45316cee4c1bb66369">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="4536f53d88709a34f9764f238002f522" level="file">
        <did>
          <unittitle>TML, 44-51 - Triptorelin Pamoate (Trelstar)</unittitle>
          <unitdate type="inclusive">2002 June 10</unitdate>
          <container id="e470b23f2a67edf7d62157f950ccd85e" label="Mixed Materials (A0000000075919)" type="box">77</container>
          <container id="05033badd1c820aae3663a416034dd06" parent="e470b23f2a67edf7d62157f950ccd85e" type="folder">1-4</container>
        </did>
        <accessrestrict id="3f564956f49faf84f827624973a86572">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="8319ac1e74f3772c55f953d49d1fe802" level="file">
        <did>
          <unittitle>TML - Drugs for Tuberculosis</unittitle>
          <unitdate type="inclusive">2002</unitdate>
          <container id="6fe5c9456e322f70219629be84dbda98" label="Mixed Materials (A0000000075919)" type="box">77</container>
          <container id="65ecaa29aba0a089ef6d12afdd508b53" parent="6fe5c9456e322f70219629be84dbda98" type="folder">5-8</container>
        </did>
        <accessrestrict id="6e3e6b2b8bab0f3a6559d5327bba741c">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="c61123a9a767eb2a2f0665b7e710f056" level="file">
        <did>
          <unittitle>TML, 44-80 - Tepostinil (Remodulin) for pulmonary arterial hypertension</unittitle>
          <unitdate type="inclusive">2002 September 16</unitdate>
          <container id="68ae52f0551ff47238af1032542d5b2d" label="Mixed Materials (A0000000075919)" type="box">77</container>
          <container id="5139b49380658b37f58b69c1e1bd8ea8" parent="68ae52f0551ff47238af1032542d5b2d" type="folder">9-11</container>
        </did>
        <accessrestrict id="96d0a14409c624606417824206c572f4">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="9c1edb72ecb57f4a5cf544ab8a33f1ca" level="file">
        <did>
          <unittitle>TML, 44-59 - Drugs that may cause psychiatric symptoms</unittitle>
          <unitdate type="inclusive">2002 July 8</unitdate>
          <container id="d4958d7d944af193d6e1def53c42e886" label="Mixed Materials (A0000000075919)" type="box">77</container>
          <container id="636527a388cb550599690d8ef80d7f93" parent="d4958d7d944af193d6e1def53c42e886" type="folder">12-16</container>
        </did>
        <accessrestrict id="049b266831555277c80bf92411b09f0b">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="83c1e0a1fb9e3488cec1e298480b45b9" level="file">
        <did>
          <unittitle>TML, 44-79 - Tegaserod Maleate (Zelnom) for IBS with constipation</unittitle>
          <unitdate type="inclusive">2002 September 16</unitdate>
          <container id="d2cd6c98ea78961ae2067066e6e7d48c" label="Mixed Materials (A0000000075919)" type="box">77</container>
          <container id="3742049696ec84d6ff1d33c0e256cef3" parent="d2cd6c98ea78961ae2067066e6e7d48c" type="folder">17-19</container>
        </did>
        <accessrestrict id="6b6e7ca2998642d620f912e4ae273e58">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="702df7b3933e28f25249b7010b1efc23" level="file">
        <did>
          <unittitle>TML - HAT</unittitle>
          <unitdate type="inclusive">2002</unitdate>
          <container id="ab3a9abd8418de0d4a0e1b1593915871" label="Mixed Materials (A0000000075919)" type="box">77</container>
          <container id="2b746436efa2a2b44d4353819c8b403c" parent="ab3a9abd8418de0d4a0e1b1593915871" type="folder">20</container>
        </did>
        <accessrestrict id="21f8d786633e1a74c8baaec02b6e69c6">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="fbd9f3d2b393e963f637e86d90ca6f0c" level="file">
        <did>
          <unittitle>TML - Drugs for sexually transmitted infections</unittitle>
          <unitdate type="inclusive">2002</unitdate>
          <container id="74d705a8b77e397888233078f52239ce" label="Mixed Materials (A0000000075919)" type="box">77</container>
          <container id="f3a13bf62aa9702b84ca0fbe0e4b8e87" parent="74d705a8b77e397888233078f52239ce" type="folder">21</container>
        </did>
        <accessrestrict id="8c19ab74e7734be86d15ccfc2ffd8632">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="3238875c71befee0c843bfb578b0af6f" level="file">
        <did>
          <unittitle>TML - Drugs for sexually transmitted infections</unittitle>
          <unitdate type="inclusive">2002</unitdate>
          <container id="2cfaebcefda337668643b30e028dfe67" label="Mixed Materials (A0000000075920)" type="box">78</container>
          <container id="a228593d927d58c44f70f8c48243cb57" parent="2cfaebcefda337668643b30e028dfe67" type="folder">1-3</container>
        </did>
        <accessrestrict id="f07baa851539686de763d2f786c2177e">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="0f73f901dbd4ead91b01d80ceed67c30" level="file">
        <did>
          <unittitle>TML, 44-75 - Influenza prevention 2002-2003</unittitle>
          <unitdate type="inclusive">2002 September 2</unitdate>
          <container id="271131508df95649ef6a5d546363d3c8" label="Mixed Materials (A0000000075920)" type="box">78</container>
          <container id="a812ba24b2f1959d7d277836ce421670" parent="271131508df95649ef6a5d546363d3c8" type="folder">4-6</container>
        </did>
        <accessrestrict id="f979eb1f784b0838d5a64de4d9ac9da1">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="23ee674858aa228c8597cb11a5363b5d" level="file">
        <did>
          <unittitle>TML, 44-33 - Advice for travelers</unittitle>
          <unitdate type="inclusive">2002</unitdate>
          <container id="905e65c67d0fd734505580bcd5a03552" label="Mixed Materials (A0000000075920)" type="box">78</container>
          <container id="d6e7c5906cf75553492a541e42172ae3" parent="905e65c67d0fd734505580bcd5a03552" type="folder">7-9</container>
        </did>
        <accessrestrict id="687d9c16855007cc90b89408873e9116">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="c3ff86733b644974c019ea29b403f49f" level="file">
        <did>
          <unittitle>TML, 44-97 - Potassium Iodine for thyroid protection in a nuclear accident or attack</unittitle>
          <unitdate type="inclusive">2002 November 11</unitdate>
          <container id="a945f5f91c6bc4e5a58c5263cd135ff7" label="Mixed Materials (A0000000075920)" type="box">78</container>
          <container id="4cbcda144c2142bfa69b5ccc0753d3d1" parent="a945f5f91c6bc4e5a58c5263cd135ff7" type="folder">10-11</container>
        </did>
        <accessrestrict id="ae3d1b9904d63ec7a442b7bf1ecd8dc5">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="24af9a9128ef19b87942303f71c93a4b" level="file">
        <did>
          <unittitle>TML, 44-91 - Acetaminophen safety</unittitle>
          <unitdate type="inclusive">2002 October 28</unitdate>
          <container id="351810d06355956421afed7542266f49" label="Mixed Materials (A0000000075920)" type="box">78</container>
          <container id="141eccc9a79f0ad9b38e245d5b5fadf6" parent="351810d06355956421afed7542266f49" type="folder">12-16</container>
        </did>
        <accessrestrict id="7768a5d75ddf57469eb3bbdfec0f20af">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="b3aae1ba9f482e9eeee3c33251fd33f7" level="file">
        <did>
          <unittitle>TML, 44-57 - New treatments for actinic keratoses</unittitle>
          <unitdate type="inclusive">2002 June 24</unitdate>
          <container id="ae6c6039951d2897d3dd100e195dd606" label="Mixed Materials (A0000000075920)" type="box">78</container>
          <container id="0a6776b5d899e43515e6097a6aaa00f4" parent="ae6c6039951d2897d3dd100e195dd606" type="folder">17-19</container>
        </did>
        <accessrestrict id="afa4af3e07bce4f2fa04d79ed2a8e09b">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="8104e8da1a3aff8455ce0008f38fee5a" level="file">
        <did>
          <unittitle>TML, 44-57 - New treatments for actinic keratoses</unittitle>
          <unitdate type="inclusive">2002 June 24</unitdate>
          <container id="b9a43e027899eee1f0005e700364b1c8" label="Mixed Materials (A0000000075921)" type="box">79</container>
          <container id="bdd1ae347a1fe4a98d581926d3482c84" parent="b9a43e027899eee1f0005e700364b1c8" type="folder">1-2</container>
        </did>
        <accessrestrict id="aca0e4a78b7223c626fd6a43994f5d31">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="02479e2c1173076c05f34aa17007ba49" level="file">
        <did>
          <unittitle>TML, 44-21 - Acute reactions of drug abuse</unittitle>
          <unitdate type="inclusive">2002 March 4</unitdate>
          <container id="18c454b24bc80c0181c603453b14d900" label="Mixed Materials (A0000000075921)" type="box">79</container>
          <container id="3edf8acef19929169b9b8d43ebf00170" parent="18c454b24bc80c0181c603453b14d900" type="folder">3-6</container>
        </did>
        <accessrestrict id="c95f7f827b4be73752d104280c14ae0c">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="d1098818233489d81f3ee9a35c491fda" level="file">
        <did>
          <unittitle>TML, 44-71 - Tests for drug abuse</unittitle>
          <unitdate type="inclusive">2002 August 19</unitdate>
          <container id="c7d34d9c186d4e5327468295d4bcf2af" label="Mixed Materials (A0000000075921)" type="box">79</container>
          <container id="85aa90fae7a740affec22516e4000fb5" parent="c7d34d9c186d4e5327468295d4bcf2af" type="folder">7-10</container>
        </did>
        <accessrestrict id="6b5deed194656d7a78e4584eaf23da1c">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="a2d97df9926c22348169dc85fc2da466" level="file">
        <did>
          <unittitle>TML, 44-82 - Accutane</unittitle>
          <unitdate type="inclusive">2002 September</unitdate>
          <container id="a5177adc71180a5f463c482947b846ef" label="Mixed Materials (A0000000075921)" type="box">79</container>
          <container id="bbb561ad330cfadf0ca91a68959d1fc8" parent="a5177adc71180a5f463c482947b846ef" type="folder">11-12</container>
        </did>
        <accessrestrict id="811a73112a0f3db0c61460c6f50c3a83">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="77f6dda8f57e4d024c751d9255cb8084" level="file">
        <did>
          <unittitle>TML, 44-50 - Spinal Manipulation</unittitle>
          <unitdate type="inclusive">2002 May 22</unitdate>
          <container id="918e90048bf3908fc8505c1fe432b18a" label="Mixed Materials (A0000000075921)" type="box">79</container>
          <container id="cf4e380b998f51e23f16d6cc5593c69b" parent="918e90048bf3908fc8505c1fe432b18a" type="folder">13-15</container>
        </did>
        <accessrestrict id="c6a5678b6a97ed4390bd98a720535a47">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="09411c4ec2cd0e10526be529fdbb7c1d" level="file">
        <did>
          <unittitle>TML, 44-101 - Irbritumomab tiuxetan (Zevalin) for non-hodgkins lymphoma</unittitle>
          <unitdate type="inclusive">2002 November 25</unitdate>
          <container id="90a938a975b9303c36c3c1611c32b730" label="Mixed Materials (A0000000075921)" type="box">79</container>
          <container id="6b816a8b2e4c1c32bbdab11b54372c8e" parent="90a938a975b9303c36c3c1611c32b730" type="folder">16-17</container>
        </did>
        <accessrestrict id="1fde5116b8525bf37872775d4c998b9e">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="2af7784d4333e1386ceb5387b0141573" level="file">
        <did>
          <unittitle>TML, 44-101 - Irbritumomab tiuxetan (Zevalin) for non-hodgkins lymphoma</unittitle>
          <unitdate type="inclusive">2002 November 25</unitdate>
          <container id="11a61fc32c71dd1744bb8fb0b1fcefa9" label="Mixed Materials (A0000000075922)" type="box">80</container>
          <container id="25c8f1f54980abe8ab1b69db9087b1f6" parent="11a61fc32c71dd1744bb8fb0b1fcefa9" type="folder">1-2</container>
        </did>
        <accessrestrict id="b2d240752dac7c5d6b161365b06fbe2d">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="45b86f5c46903225f479639e02061c91" level="file">
        <did>
          <unittitle>TML, 44-17 - Drotecogin - Activated Protein C (Xigris) for Severe Sepsis</unittitle>
          <unitdate type="inclusive">2002 February 18</unitdate>
          <container id="ca24c12c44e7d9ab76df0e43f1c0736c" label="Mixed Materials (A0000000075922)" type="box">80</container>
          <container id="4d5ffc88d8ace778637ba1d71fbdef34" parent="ca24c12c44e7d9ab76df0e43f1c0736c" type="folder">3-7</container>
        </did>
        <accessrestrict id="c6644b7dd17dbfbedd1d1af2963340f4">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="2df9fa1b1dadedbd80d056c6d1eb7e1b" level="file">
        <did>
          <unittitle>TML, 44-78 - Hormone replacement therapy</unittitle>
          <unitdate type="inclusive">2002 September 2</unitdate>
          <container id="f4b29b0d91e674c9ee6354ae004d83d2" label="Mixed Materials (A0000000075922)" type="box">80</container>
          <container id="41cf54e844352aff7169beb8f93f34d5" parent="f4b29b0d91e674c9ee6354ae004d83d2" type="folder">8-9</container>
        </did>
        <accessrestrict id="25fbac45d92806e8263c700a8600b817">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="79ecc959704f5a99033f6383c71d5e2b" level="file">
        <did>
          <unittitle>TML, 44-30 -Bosentan (Tracleer) for pulmonary arterial hypertension</unittitle>
          <unitdate type="inclusive">2002 April 11</unitdate>
          <container id="2c5f083f55f08fc324f1fead2f94e102" label="Mixed Materials (A0000000075922)" type="box">80</container>
          <container id="28dae905de1805e58c00906483aeb7a1" parent="2c5f083f55f08fc324f1fead2f94e102" type="folder">10-12</container>
        </did>
        <accessrestrict id="c218a513a6535a5ceb72241f53f1083c">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="ebeb0b87fb29433a1b670b6a4d5aa5fc" level="file">
        <did>
          <unittitle>TML, 44-45 - Dexmethylphenidate (Focalin) for ADHD</unittitle>
          <unitdate type="inclusive">2002 May 13</unitdate>
          <container id="e0df7e66cf847fdfe03555ef602b71e1" label="Mixed Materials (A0000000075922)" type="box">80</container>
          <container id="cb594975600e81dbcb18070498b6b6c3" parent="e0df7e66cf847fdfe03555ef602b71e1" type="folder">13-14</container>
        </did>
        <accessrestrict id="daa9fc43588271721e9668e6387b1ecc">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="9cf28c7502d38a3253794dc0aff81d12" level="file">
        <did>
          <unittitle>TML, 44-53 - Droperidol Risk - Arrhythmias</unittitle>
          <unitdate type="inclusive">2002 June 10</unitdate>
          <container id="c21914eefe51169f565df59cdb301d58" label="Mixed Materials (A0000000075922)" type="box">80</container>
          <container id="1c36efb8f9f000d015d9ac03b8ece631" parent="c21914eefe51169f565df59cdb301d58" type="folder">15-16</container>
        </did>
        <accessrestrict id="9343665bbaab14cdc391de9fbda39aab">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="037a4523e063f09b403c4b86b056b0b9" level="file">
        <did>
          <unittitle>TML, 44-84 - Herbal Products - Problems with dietary supplements</unittitle>
          <unitdate type="inclusive">2002 September 30</unitdate>
          <container id="fad039a350d0939ec81bb610cac00f03" label="Mixed Materials (A0000000075922)" type="box">80</container>
          <container id="68fadf526a27a15db7c9fa6ad12da309" parent="fad039a350d0939ec81bb610cac00f03" type="folder">17-19</container>
        </did>
        <accessrestrict id="2fdc328774c9f82ce8ebb61aee7387a6">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="606c2c7591fb4c21ba3d38fc6c7462b0" level="file">
        <did>
          <unittitle>TML, 44-96 - Rasburicase</unittitle>
          <unitdate type="inclusive">2002 November 11</unitdate>
          <container id="f4ddc7a5e11e248b0e9c78c1704faea3" label="Mixed Materials (A0000000075923)" type="box">81</container>
          <container id="3e77eaddfd7211c8ec5698efc2fc4d8b" parent="f4ddc7a5e11e248b0e9c78c1704faea3" type="folder">1-2</container>
        </did>
        <accessrestrict id="6dd42fdac95221294c398b8dad4d3a7e">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="b3d8e525fd2c6ceabdefb1c16c80e100" level="file">
        <did>
          <unittitle>TML, 44-88 - Three beta-interferons for MS</unittitle>
          <unitdate type="inclusive">2002 October 14</unitdate>
          <container id="f447a5668805dedc89b1192c572fcb33" label="Mixed Materials (A0000000075923)" type="box">81</container>
          <container id="a6c41add2be86e97d1a77be8f56be3e6" parent="f447a5668805dedc89b1192c572fcb33" type="folder">3-6</container>
        </did>
        <accessrestrict id="de5073ebce08ff223cdc3bac4b44096d">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="cd35b74adb66fbee3caa77d502914319" level="file">
        <did>
          <unittitle>TML, 44-99 - Indications for an implantable cardioverter defibrillator</unittitle>
          <unitdate type="inclusive">2002 November 25</unitdate>
          <container id="eeb90b3d412828a942e4416602af9eb4" label="Mixed Materials (A0000000075923)" type="box">81</container>
          <container id="4ea9a734d06ab989e5bd14b4ac5e8e2a" parent="eeb90b3d412828a942e4416602af9eb4" type="folder">7-9</container>
        </did>
        <accessrestrict id="44a756d7626a6484624c170f3c9fe601">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="caba3d20cbb6ac2bcf0fffb6486cd172" level="file">
        <did>
          <unittitle>TML - Drugs for Diabetes - Treatment Guidelines</unittitle>
          <unitdate type="inclusive">2002 September</unitdate>
          <container id="491d164fe014fb01f7e32b429a1ca1ee" label="Mixed Materials (A0000000075923)" type="box">81</container>
          <container id="596637a5f1c99e1bc7e2926ef15a3cb5" parent="491d164fe014fb01f7e32b429a1ca1ee" type="folder">10-13</container>
        </did>
        <accessrestrict id="27fb92f6dcd523eaebbcb18be6a423a5">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="0cdc8024ee854934a00a2e6cc658127c" level="file">
        <did>
          <unittitle>TML, 44-87 - Once-a-Week risedronate (Actonel)</unittitle>
          <unitdate type="inclusive">2002 October 14</unitdate>
          <container id="f15d6a17f2dfb44742e05aae5f77af4f" label="Mixed Materials (A0000000075923)" type="box">81</container>
          <container id="b2fa3dea61e5b8dd3fb1a4350f3e365a" parent="f15d6a17f2dfb44742e05aae5f77af4f" type="folder">14-15</container>
        </did>
        <accessrestrict id="3c69c2eda4cf5e33f151894a6dae98fa">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="6373e1ea574b03380381b604f8f317ea" level="file">
        <did>
          <unittitle>TML, 44-48 - Topical Primecrolimus (Elidel) for treatment of atopic dermatitis</unittitle>
          <unitdate type="inclusive">2002 May 27</unitdate>
          <container id="915a75664d7417a2a686335cf67f763e" label="Mixed Materials (A0000000075923)" type="box">81</container>
          <container id="0392ac1fb08a00ab924eb7807a139b23" parent="915a75664d7417a2a686335cf67f763e" type="folder">16-17</container>
        </did>
        <accessrestrict id="c8982cc8907e5273994dc146b1a74168">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="0a43de1bea99678d0bd3f43b5c8e3aab" level="file">
        <did>
          <unittitle>TML, 44-107 - Metaglip and Avandamet for type 2 diabetes</unittitle>
          <unitdate type="inclusive">2002 December 23</unitdate>
          <container id="db25ef40798c7e82d998280d0d0fb9fc" label="Mixed Materials (A0000000075924)" type="box">82</container>
          <container id="e1dd48090475ca5b2bb8389532f62f3b" parent="db25ef40798c7e82d998280d0d0fb9fc" type="folder">1-3</container>
        </did>
        <accessrestrict id="77f5cb2d5690ac4fb8b1401da5ce42c3">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="0ad024dbe91f78abe8bfbef002c6b1ff" level="file">
        <did>
          <unittitle>TML, 44-27 - Desloratadine</unittitle>
          <unitdate type="inclusive">2002 March 18</unitdate>
          <container id="f74fec20b8bcb21586956db0d7498090" label="Mixed Materials (A0000000075924)" type="box">82</container>
          <container id="1a05c571c9b6d4b074b48891c8fdfda5" parent="f74fec20b8bcb21586956db0d7498090" type="folder">4-6</container>
        </did>
        <accessrestrict id="36a5c8671473d8ebde644f9ea2a482bc">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="b7991b9a56fe105d30e6587c04553698" level="file">
        <did>
          <unittitle>TML, 44-41 - Pantoprazole (Protonix IV)</unittitle>
          <unitdate type="inclusive">2002 April 29</unitdate>
          <container id="0f2fb197c97821097013f88df513034a" label="Mixed Materials (A0000000075924)" type="box">82</container>
          <container id="f9edea95db891fa47a5dc56bf22d9688" parent="0f2fb197c97821097013f88df513034a" type="folder">7-8</container>
        </did>
        <accessrestrict id="ecf59515bb41f3b93d8d69d9976e28b0">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="e886d7140f04a51e798f5685595d8a64" level="file">
        <did>
          <unittitle>TML, 44-69 - Olmesartan (Benicar) for hypertension</unittitle>
          <unitdate type="inclusive">2002 August 5</unitdate>
          <container id="74df3e0f853bb1f34addeeffed60714e" label="Mixed Materials (A0000000075924)" type="box">82</container>
          <container id="0e4ef3d5b6f72a0ab10427e07b5b311d" parent="74df3e0f853bb1f34addeeffed60714e" type="folder">9-12</container>
        </did>
        <accessrestrict id="74dedc4bdd750d18fabe19b677cbe4fb">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="a62ab234ffcd38be2c7ecb1b5105a478" level="file">
        <did>
          <unittitle>TML - Drugs for Parasitic Infections</unittitle>
          <unitdate type="inclusive">2002</unitdate>
          <container id="ec0b67bb0a7315ca0f3121ec26f6c6d5" label="Mixed Materials (A0000000075924)" type="box">82</container>
          <container id="a826059e527b059d147c02f2d4692a61" parent="ec0b67bb0a7315ca0f3121ec26f6c6d5" type="folder">13-16</container>
        </did>
        <accessrestrict id="a1761f494a6aadd735240b5f6234da0c">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="334f7d2fdf7bebf0df4dbded68f76c8d" level="file">
        <did>
          <unittitle>TML, 44-44 - Pegfilgrastin (Neulasta) for prevention of febrile neutropenia</unittitle>
          <unitdate type="inclusive">2002 May 13</unitdate>
          <container id="0ff1a402ecb676315aa7a839793b4571" label="Mixed Materials (A0000000075924)" type="box">82</container>
          <container id="4ea1d6b44606ab337bccb5a36ed28cbb" parent="0ff1a402ecb676315aa7a839793b4571" type="folder">17-19</container>
        </did>
        <accessrestrict id="a69e5af2889f08c295264781d0dc1080">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="f777550cceb72905734014265970ba2d" level="file">
        <did>
          <unittitle>TML, 45-25 - Adalimumab (Humira) for rheumatoid arthritis</unittitle>
          <unitdate type="inclusive">2003 March 31</unitdate>
          <container id="bd6da5f1f0a3fc3c8226bdace534d56f" label="Mixed Materials (A0000000075925)" type="box">83</container>
          <container id="17881caf356aa9c7faf496a464f4f6c7" parent="bd6da5f1f0a3fc3c8226bdace534d56f" type="folder">1-3</container>
        </did>
        <accessrestrict id="843488d272c7cd2629b6cfaf3ea233ef">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="755a5cb278c5674c278d62217583d0dc" level="file">
        <did>
          <unittitle>TML, 45-31 - Alefacept (Amevive) for treatment of psoriasis</unittitle>
          <unitdate type="inclusive">2003 April 14</unitdate>
          <container id="ffc259388d9d3b3c7022b7cff0beb3e2" label="Mixed Materials (A0000000075925)" type="box">83</container>
          <container id="3e257fb12b43f6d93ac7379015c91c95" parent="ffc259388d9d3b3c7022b7cff0beb3e2" type="folder">4-6</container>
        </did>
        <accessrestrict id="a72cbce0a6c64d80126a119167b5dc50">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="9a2ad2a43a1bd9b6c3ff840aca327639" level="file">
        <did>
          <unittitle>TML, 45-43 - Alprazolam XR for panic disorder</unittitle>
          <unitdate type="inclusive">2003 May 26</unitdate>
          <container id="34fd6832a56397709d9656b5f87ea6d5" label="Mixed Materials (A0000000075925)" type="box">83</container>
          <container id="e59e208f16aac18762174eaf4c928eba" parent="34fd6832a56397709d9656b5f87ea6d5" type="folder">7</container>
        </did>
        <accessrestrict id="7facc30ebfc92bd3e698021dbdeb21fe">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="32827b05df08c432fb2cbb3d952c316a" level="file">
        <did>
          <unittitle>TML, 45-15 - Aripiprazole (Abilify) for schizophrenia</unittitle>
          <unitdate type="inclusive">2003 February 17</unitdate>
          <container id="c12c6750d0588e697e724d36ffad3a08" label="Mixed Materials (A0000000075925)" type="box">83</container>
          <container id="99878d4c28110fd99af032d9126e08f6" parent="c12c6750d0588e697e724d36ffad3a08" type="folder">8-10</container>
        </did>
        <accessrestrict id="e9db4aba5feb72c13178e46e3f2599e5">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="2dcb5260bf184933786c79514811276a" level="file">
        <did>
          <unittitle>TML, 45-5 - Augmentin XR</unittitle>
          <unitdate type="inclusive">2003 January 20</unitdate>
          <container id="0d114d8956af32a844576f7782026721" label="Mixed Materials (A0000000075925)" type="box">83</container>
          <container id="9a588f404a28895fb79a9dcdb30a05b4" parent="0d114d8956af32a844576f7782026721" type="folder">11-13</container>
        </did>
        <accessrestrict id="352c7f8bef5faa523d50be8830568d03">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="6719542efa0dd7e6ff2199fb0fc45784" level="file">
        <did>
          <unittitle>TML, 45-50 - Blue Light (Clearlight) for acne vulgaris</unittitle>
          <unitdate type="inclusive">2003 June 23</unitdate>
          <container id="9599222dd5619bfe4b02958ea5009cad" label="Mixed Materials (A0000000075925)" type="box">83</container>
          <container id="84d3c35299c08207f77936223940e037" parent="9599222dd5619bfe4b02958ea5009cad" type="folder">14-15</container>
        </did>
        <accessrestrict id="dd3798d0577bb9e1fc29332ed3c1ed16">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="face99254c656f96b64bf580e5f85bcf" level="file">
        <did>
          <unittitle>TML, 45-57 - Bortezomib for multiple myeloma</unittitle>
          <unitdate type="inclusive">2003 July 21</unitdate>
          <container id="7674d73a95c215aae0436d8953aa5a85" label="Mixed Materials (A0000000075925)" type="box">83</container>
          <container id="e620e0c50b0ea83b06b91c2c5a86f9eb" parent="7674d73a95c215aae0436d8953aa5a85" type="folder">16-18</container>
        </did>
        <accessrestrict id="5b737b9395121e3828a6f6fa407666da">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="9ec231ed3611900061caae3128c95513" level="file">
        <did>
          <unittitle>TML, 45-102 - Choice of an Antipsychotic</unittitle>
          <unitdate type="inclusive">2003 December 22</unitdate>
          <container id="4d9295b63ee6971702110440356ddf3c" label="Mixed Materials (A0000000075925)" type="box">83</container>
          <container id="759ecb89733430407f67ad5fc35241c8" parent="4d9295b63ee6971702110440356ddf3c" type="folder">19</container>
        </did>
        <accessrestrict id="e0dca88a43ebdabbfbf835cde2da0a4f">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="c6404194bb02ecf2496bacd146a0cc60" level="file">
        <did>
          <unittitle>TML, 45-102 - Choice of an Antipsychotic</unittitle>
          <unitdate type="inclusive">2003 December 22</unitdate>
          <container id="ec3fbf76fbf4e00894d015b432ef3a95" label="Mixed Materials (A0000000075926)" type="box">84</container>
          <container id="5481ff671ea8a58e9982ab623eab5137" parent="ec3fbf76fbf4e00894d015b432ef3a95" type="folder">1-3</container>
        </did>
        <accessrestrict id="ff3d2237bfc8f29c4712b54bf885e9be">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="2ddbc741772355d7dce54b4b63ef6749" level="file">
        <did>
          <unittitle>TML, 45-97 - Efalizumabe (Raptiva) for treatment of psoriasis</unittitle>
          <unitdate type="inclusive">2003 December 8</unitdate>
          <container id="e3f352ad9c39dbebd1f65467ebada7fa" label="Mixed Materials (A0000000075926)" type="box">84</container>
          <container id="54ab7b510723b9806b9f7fa8b07713f1" parent="e3f352ad9c39dbebd1f65467ebada7fa" type="folder">4-5</container>
        </did>
        <accessrestrict id="6eb237f5b70a5174ed44b4dc845e1439">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="0f45b082b3a08c7cce74229a00644b02" level="file">
        <did>
          <unittitle>TML, 45-97 (45-333) - Eletriptan (Replax) for migraine</unittitle>
          <unitdate type="inclusive">2003 April 28</unitdate>
          <container id="95b075012a1ea18d9270a71613379ecc" label="Mixed Materials (A0000000075926)" type="box">84</container>
          <container id="1614ac711831fb1383f9e3c6a16227f6" parent="95b075012a1ea18d9270a71613379ecc" type="folder">6-8</container>
        </did>
        <accessrestrict id="f517a35e209156fcce5cddbc43b68b14">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="94948e6e42424f89ec840de91511a768" level="file">
        <did>
          <unittitle>TML, 45-49 - Enfuvirtide (Fuzeon) for HIV infection</unittitle>
          <unitdate type="inclusive">2003 June 23</unitdate>
          <container id="0de383844c8c4fd283bf33156255368b" label="Mixed Materials (A0000000075926)" type="box">84</container>
          <container id="4348b798fd181fe0cefb3a815b47adb8" parent="0de383844c8c4fd283bf33156255368b" type="folder">9-11</container>
        </did>
        <accessrestrict id="a3551a188d335a0b903727fcd2a48fa4">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="48f4b3c522fa705a3ae202735e45ac3b" level="file">
        <did>
          <unittitle>TML, 45-89 - Growth hormone for normal short children</unittitle>
          <unitdate type="inclusive">2003 November 10</unitdate>
          <container id="e60aec02b918a08c2be50d43897e5eec" label="Mixed Materials (A0000000075926)" type="box">84</container>
          <container id="47183ca83defb7a6085e62a4c10ade93" parent="e60aec02b918a08c2be50d43897e5eec" type="folder">12-14</container>
        </did>
        <accessrestrict id="3229644ce53e8795f97a65d5d61f18e8">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="780d425bdbd53ceafd83133223d279a7" level="file">
        <did>
          <unittitle>TML, 45-67 - Omalizumab (Xolair) for Asthma</unittitle>
          <unitdate type="inclusive">2003 August 18</unitdate>
          <container id="26dc6b6a550ca627303b6672efc9b679" label="Mixed Materials (A0000000075926)" type="box">84</container>
          <container id="c268b362979569fa4f68961f7073d78a" parent="26dc6b6a550ca627303b6672efc9b679" type="folder">15-18</container>
        </did>
        <accessrestrict id="12994eea68e1f09108df54e255ae8cff">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="3e27a4c127b0269848618ade1805962f" level="file">
        <did>
          <unittitle>TML, 45-7 - Oxalipatin</unittitle>
          <unitdate type="inclusive">2003 January 20</unitdate>
          <container id="3a1d1988c2cddda797825dba864e7939" label="Mixed Materials (A0000000075926)" type="box">84</container>
          <container id="21767e55142c4f157a35ef0105222967" parent="3a1d1988c2cddda797825dba864e7939" type="folder">19</container>
        </did>
        <accessrestrict id="319e1cb1c4d5a539efc2e6af94af005a">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="732aaf61ce82ace45c4354ea0038b752" level="file">
        <did>
          <unittitle>TML, 45-7 - Oxalipatin</unittitle>
          <unitdate type="inclusive">2003 January 20</unitdate>
          <container id="ef359e9f02879a484dc38ac904bf249d" label="Mixed Materials (A0000000075927)" type="box">85</container>
          <container id="287925e4783ae2a27a501caa53a94c2f" parent="ef359e9f02879a484dc38ac904bf249d" type="folder">1-2</container>
        </did>
        <accessrestrict id="c716c8d0ab4facf419cf7e7c4082202e">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="c4617feb74a721aa21a7112babed977f" level="file">
        <did>
          <unittitle>TML, 45-38 - Oxbutynin trandermal (Oxytrol) for overactive bladder</unittitle>
          <unitdate type="inclusive">2003 May 12</unitdate>
          <container id="d09e250b3c3fad8f8e98a4da0a3bdca7" label="Mixed Materials (A0000000075927)" type="box">85</container>
          <container id="257e90f221186878e3bee8ae312924a3" parent="d09e250b3c3fad8f8e98a4da0a3bdca7" type="folder">3-4</container>
        </did>
        <accessrestrict id="09ded828b852ae6c86297bc23c88adc0">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="8486f3e9d9968bc9f1dce0df7483cd4b" level="file">
        <did>
          <unittitle>TML, 45-54 - Rapid tests for HIV infection</unittitle>
          <unitdate type="inclusive">2003 July 7</unitdate>
          <container id="f157e388f3a9e95a45d998ebfed84be8" label="Mixed Materials (A0000000075927)" type="box">85</container>
          <container id="f817659f99f91e1b2155961c9372c82d" parent="f157e388f3a9e95a45d998ebfed84be8" type="folder">5-8</container>
        </did>
        <accessrestrict id="9d74192e21e6502b4dff990dec4cbb50">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="e54b07dbb6cb8e75aad0e568c11cae0a" level="file">
        <did>
          <unittitle>TML, 45-77 - Vardenafil (Levitra) for erectile dysfunction</unittitle>
          <unitdate type="inclusive">2003 September 29</unitdate>
          <container id="585d351ed4cca4893dd14930803c62db" label="Mixed Materials (A0000000075927)" type="box">85</container>
          <container id="8be4dc1c6e114d983f2a80ee0f46fa0a" parent="585d351ed4cca4893dd14930803c62db" type="folder">9-12</container>
        </did>
        <accessrestrict id="f6350ccd6ef35a9adb3c39e7c7bf3a3c">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="fdd62d893c6f422fd7c183e65efa7835" level="file">
        <did>
          <unittitle>TML, 45-11 - Atomoxetine (Strattera)</unittitle>
          <unitdate type="inclusive">2003 February 3</unitdate>
          <container id="3dd52701c036803746eaf6695e2b9353" label="Mixed Materials (A0000000075927)" type="box">85</container>
          <container id="1d4b42c00a8583954aa99e9796cf9f68" parent="3dd52701c036803746eaf6695e2b9353" type="folder">13-15</container>
        </did>
        <accessrestrict id="36610a7149adbc1f92cfdc7751128db1">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="35402d0a4356ba61f6f491a96f89217a" level="file">
        <did>
          <unittitle>TML, 45-15 - Buprenorphine - an alternative to methadone</unittitle>
          <unitdate type="inclusive">2013 February 17</unitdate>
          <container id="82dc98be4cbddae9474ea9979dcaa03b" label="Mixed Materials (A0000000075927)" type="box">85</container>
          <container id="19677909ab2ebc243c55b7e010a77adb" parent="82dc98be4cbddae9474ea9979dcaa03b" type="folder">16-20</container>
        </did>
        <accessrestrict id="136a1315a2303fa111e5d01cb0517e7d">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="3fc7a0238f453d851bcf8a694afaf2ab" level="file">
        <did>
          <unittitle>TML, 45-74 - Agalsidase beta (Fabrazyme) for Fabry disease</unittitle>
          <unitdate type="inclusive">2003 September 15</unitdate>
          <container id="4b5b982cbda979a7eed3df836fe625c7" label="Mixed Materials (A0000000075928)" type="box">86</container>
          <container id="9adaea46e7a86ed57a8500eb18e8e8d0" parent="4b5b982cbda979a7eed3df836fe625c7" type="folder">1-3</container>
        </did>
        <accessrestrict id="aab1089a7327f8fc78a2fc319190599a">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="5569c52b23e7d7eeddf53f7c2b84a996" level="file">
        <did>
          <unittitle>TML, 45-39 - Eplerenone (Inspra)</unittitle>
          <unitdate type="inclusive">2003 May 12</unitdate>
          <container id="4f6e9b38b329a45ff4076a33f39d3b3e" label="Mixed Materials (A0000000075928)" type="box">86</container>
          <container id="442ac23397857076546273cf10506388" parent="4f6e9b38b329a45ff4076a33f39d3b3e" type="folder">4-6</container>
        </did>
        <accessrestrict id="4fc1e68dd96cabb133f171a2e6a52471">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="19fc064c09e3806caaddbb51b70e4090" level="file">
        <did>
          <unittitle>TML, 45-98 - New Glucose-Monitoring Devices</unittitle>
          <unitdate type="inclusive">2003 December 8</unitdate>
          <container id="b91cf5871d5cb856d1b200aa8e82b745" label="Mixed Materials (A0000000075928)" type="box">86</container>
          <container id="130deac35052ab233fd0ba0b6ea1f351" parent="b91cf5871d5cb856d1b200aa8e82b745" type="folder">5A-6A</container>
        </did>
        <accessrestrict id="60b6213d43e89633056c4a067f8c54e8">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="f0a8b264973dfe8db5fe8da9b49f6e58" level="file">
        <did>
          <unittitle>TML, 45-98 - New Glucose-Monitoring Devices</unittitle>
          <unitdate type="inclusive">2003 December 8</unitdate>
          <container id="02bff6be77ee3d0c6dde6bc6f6934591" label="Mixed Materials (A0000000075928)" type="box">86</container>
          <container id="5dbdda6970eb7db757717ca9c4d1f7e3" parent="02bff6be77ee3d0c6dde6bc6f6934591" type="folder">7-9</container>
        </did>
        <accessrestrict id="7a45da012d9d8375ab9c62d057d20b13">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="d1e93fdc68ebf64e073b0d53c908f073" level="file">
        <did>
          <unittitle>TML, 45-101 - Tadalafil (Cialis) for Erectile dysfunction</unittitle>
          <unitdate type="inclusive">2003 December 22</unitdate>
          <container id="83723ef9c12df64778ea28767b9a90e1" label="Mixed Materials (A0000000075928)" type="box">86</container>
          <container id="ba2d4a21342b101c709c5ba41547e641" parent="83723ef9c12df64778ea28767b9a90e1" type="folder">10-11</container>
        </did>
        <accessrestrict id="a187e298156d35ecb24bf62acbaa2162">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="bf6ed6095bb9e6efdcac9a21b49e00e9" level="file">
        <did>
          <unittitle>TML, 45-95 - Tattoo Removal</unittitle>
          <unitdate type="inclusive">2003 November 24</unitdate>
          <container id="52e4cb85b91c8446f0f756147285d8be" label="Mixed Materials (A0000000075928)" type="box">86</container>
          <container id="b35143274bb75be711024294dd87039c" parent="52e4cb85b91c8446f0f756147285d8be" type="folder">12-13</container>
        </did>
        <accessrestrict id="1cb8774dfbec0195c1be0234b77205c6">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="a857cbd537b23d5351b0c89499d70d8e" level="file">
        <did>
          <unittitle>TML, 45-51 - Priloscec, Nexium and stereoisomers</unittitle>
          <unitdate type="inclusive">2003 June 23</unitdate>
          <container id="6033b2cb8d11eb9e93a3e52c76554af0" label="Mixed Materials (A0000000075928)" type="box">86</container>
          <container id="425f1afdc933728090d371f9afd45b37" parent="6033b2cb8d11eb9e93a3e52c76554af0" type="folder">14</container>
        </did>
        <accessrestrict id="4b2308536bb701384ee28edb8995985a">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="1ed11b7c73752bdb0689383a30c1baf5" level="file">
        <did>
          <unittitle>TML, 45-65 - Immunization, Influenza, Flumist</unittitle>
          <unitdate type="inclusive">2003 August 18</unitdate>
          <container id="eb5132ca3fd365cd48e74041e03c7563" label="Mixed Materials (A0000000075928)" type="box">86</container>
          <container id="0fab7bbea0f3110fe2885803104d0963" parent="eb5132ca3fd365cd48e74041e03c7563" type="folder">15-16</container>
        </did>
        <accessrestrict id="4ae7a8a3386cf59e0586622b1db28e61">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="c48f05a528d95bdfee4855de30cb54e2" level="file">
        <did>
          <unittitle>TML, 45-65 - Immunization, Influenza, Flumist</unittitle>
          <unitdate type="inclusive">2003 August 18</unitdate>
          <container id="ac658627b46276ff322eaffe6e9c7530" label="Mixed Materials (A0000000075929)" type="box">87</container>
          <container id="6e452523368251a4810517ff91e0479a" parent="ac658627b46276ff322eaffe6e9c7530" type="folder">1</container>
        </did>
        <accessrestrict id="d1a19b29c41ed450efa6dd0a35b030ad">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="3e6aff84359c7cdd06669d9d72f8c12a" level="file">
        <did>
          <unittitle>TML, 45-21 - Montelukast (Singulair) for allergic rhinitis</unittitle>
          <unitdate type="inclusive">2003 March 17</unitdate>
          <container id="30118b5660e9903345bccabca878c507" label="Mixed Materials (A0000000075929)" type="box">87</container>
          <container id="c918c7f1b1bdea6d7cf31ed3a6e9f07b" parent="30118b5660e9903345bccabca878c507" type="folder">2-4</container>
        </did>
        <accessrestrict id="2b573db89b3a7e7ffb7bbe4571d64e85">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="7d40fbe976113721e79b64dd1d00e27d" level="file">
        <did>
          <unittitle>TML, 45-3 - OTC Loratadine</unittitle>
          <unitdate type="inclusive">2003 January 6</unitdate>
          <container id="98f290f4073a8e7803e257d64201a597" label="Mixed Materials (A0000000075929)" type="box">87</container>
          <container id="4f09cf5c56e254c5813a16e099c7e836" parent="98f290f4073a8e7803e257d64201a597" type="folder">5</container>
        </did>
        <accessrestrict id="68d83db5324a44659c1dd3f51c2e2864">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="1823eedc9d0074c8a4265ac61efdfda5" level="file">
        <did>
          <unittitle>TML, 45-41 - Insect repellents</unittitle>
          <unitdate type="inclusive">2003 May 26</unitdate>
          <container id="52b9f9b7fd907fe298ce84cdcecff835" label="Mixed Materials (A0000000075929)" type="box">87</container>
          <container id="393464bf00f9169991a41bcea629ac62" parent="52b9f9b7fd907fe298ce84cdcecff835" type="folder">6-8</container>
        </did>
        <accessrestrict id="fd9f974ca565c85df29a51348d8fb4a7">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="2f3bcea3a484b983f63233e648e58d71" level="file">
        <did>
          <unittitle>TML, 45-81 - Rosuvastatin - a new lipid-lowering drug</unittitle>
          <unitdate type="inclusive">2003 October 13</unitdate>
          <container id="02b52e5427763bc86e6e9b1c2baf79e1" label="Mixed Materials (A0000000075929)" type="box">87</container>
          <container id="a4518dfba581c3adcb45a4ff1b5fe792" parent="02b52e5427763bc86e6e9b1c2baf79e1" type="folder">9-12</container>
        </did>
        <accessrestrict id="43bf4f6f81d3fbdf04c68bbc454e9040">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="ba56ad48c3bef0d702fff7fdda72fa22" level="file">
        <did>
          <unittitle>TML, 45-35 - Insulin-sensitizing drugs for polycystic ovary syndrome</unittitle>
          <unitdate type="inclusive">2003 April 28</unitdate>
          <container id="b9cc75393844aeb94dfd2ccece07cd69" label="Mixed Materials (A0000000075929)" type="box">87</container>
          <container id="9b564aeea189447da5a5c5c1b4a1d6a5" parent="b9cc75393844aeb94dfd2ccece07cd69" type="folder">13-15</container>
        </did>
        <accessrestrict id="68c074ca5c7b85d99e37109be8f03f26">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="3d9fbb15ae7446c6c645d70bd47fbf3b" level="file">
        <did>
          <unittitle>TML, 45-73 - Memantine for Alzheimer's disease</unittitle>
          <unitdate type="inclusive">2003 September 15</unitdate>
          <container id="6d0ade87a93de76027467fba7f6ed109" label="Mixed Materials (A0000000075929)" type="box">87</container>
          <container id="2f54b48ed06a479c604ab49580c3440a" parent="6d0ade87a93de76027467fba7f6ed109" type="folder">16-18</container>
        </did>
        <accessrestrict id="349dea74056b705fe12a6e58b6be4a61">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="11bdec471c430a38763f1ea9a86eab38" level="file">
        <did>
          <unittitle>TML, 45-58 - Treatment of heat injury</unittitle>
          <unitdate type="inclusive">2003 July 21</unitdate>
          <container id="6c65994ff45bc48da4ae08a4d62e0406" label="Mixed Materials (A0000000075930)" type="box">88</container>
          <container id="19ce8b21a4be4228be920c75b5ed37c7" parent="6c65994ff45bc48da4ae08a4d62e0406" type="folder">1-2</container>
        </did>
        <accessrestrict id="b32e89185eafe8ec72db09448de5ce28">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="806d8942533d66de734e65e88b3304ee" level="file">
        <did>
          <unittitle>TML, 45-90 - Atazanavir (Reyataz) and Emtricitabine (Emtriva) for HIV infection</unittitle>
          <unitdate type="inclusive">2003 November 10</unitdate>
          <container id="044deec909d9d74b89f8ece2e7a4dd60" label="Mixed Materials (A0000000075930)" type="box">88</container>
          <container id="5f2905c07af9e4ac0ba18b9b9eb9db76" parent="044deec909d9d74b89f8ece2e7a4dd60" type="folder">3-6</container>
        </did>
        <accessrestrict id="d90cbf0a7351c28f0b2d1347edc27949">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="04dee614a81cacb32c43ef5b0a88af03" level="file">
        <did>
          <unittitle>TML, 45-88 - Aldurazyme (Laronidase)</unittitle>
          <unitdate type="inclusive">2003 October 27</unitdate>
          <container id="75a2c669e418ff3f06ee39a2e9d810de" label="Mixed Materials (A0000000075930)" type="box">88</container>
          <container id="cd6a9172ec3801c0b0c68c7efac331ee" parent="75a2c669e418ff3f06ee39a2e9d810de" type="folder">7-8</container>
        </did>
        <accessrestrict id="b53a56596e6cd54c520d93ec764edd68">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="9233509af152396c7a0be4f4a4690cec" level="file">
        <did>
          <unittitle>TML, 45-46 - Drug Interactions</unittitle>
          <unitdate type="inclusive">2003 June 9</unitdate>
          <container id="e76347240747d2b4e7ffe50913da79b2" label="Mixed Materials (A0000000075930)" type="box">88</container>
          <container id="d57367a8a16d31b80cb08940033c8c4d" parent="e76347240747d2b4e7ffe50913da79b2" type="folder">9-12</container>
        </did>
        <accessrestrict id="7b355cfd23bf5faae7008b6d8dfcd613">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="95a2b9eb73be12648888070a03ead474" level="file">
        <did>
          <unittitle>TML, 45-85 - Lowering Plasma Homocystein</unittitle>
          <unitdate type="inclusive">2003 October 27</unitdate>
          <container id="45f4ae1f0797020fe6144dc4830b2b18" label="Mixed Materials (A0000000075930)" type="box">88</container>
          <container id="9beca77c2fdbb21a9147f47c03312039" parent="45f4ae1f0797020fe6144dc4830b2b18" type="folder">13-17</container>
        </did>
        <accessrestrict id="150bc9e4636bdbb6ef444d31120758f6">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="dad27947e40b662edd3cc5a90a0be625" level="file">
        <did>
          <unittitle>TML, 45-83 - Lp-Pla2 - A new marker of Vasular Risk</unittitle>
          <unitdate type="inclusive">2003 October 13</unitdate>
          <container id="bc0f71e7eb5ae7593055db92b5e4a8bd" label="Mixed Materials (A0000000075930)" type="box">88</container>
          <container id="85abf55e18ef26d01bd4305be8dc2d22" parent="bc0f71e7eb5ae7593055db92b5e4a8bd" type="folder">18-19</container>
        </did>
        <accessrestrict id="7bacb749d5cace7b77c6d20686088469">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="e617e6eea5f9996628c705dd200e1ffa" level="file">
        <did>
          <unittitle>TML, 45-17 - Three new drugs for hyperlipidemia</unittitle>
          <unitdate type="inclusive">2003 March 3</unitdate>
          <container id="ea7847fcdede14aae579cb0e1a7d35f7" label="Mixed Materials (A0000000075930)" type="box">88</container>
          <container id="1f26b2b7a0036cb04a586a14b5fd3a71" parent="ea7847fcdede14aae579cb0e1a7d35f7" type="folder">20</container>
        </did>
        <accessrestrict id="8c291adc86b1ece8d63fe68ecf028b3e">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="9fd8a0d9db61f711e261afe6ec4c49ea" level="file">
        <did>
          <unittitle>TML, 45-17 - Three new drugs for hyperlipidemia</unittitle>
          <unitdate type="inclusive">2003 March 3</unitdate>
          <container id="c760f83f22be71df522deffe5a69f005" label="Mixed Materials (A0000000075931)" type="box">89</container>
          <container id="8c6a7239986de1a472eb6a5ebc452e38" parent="c760f83f22be71df522deffe5a69f005" type="folder">1-4</container>
        </did>
        <accessrestrict id="bce92c80f15ffaccbaa401c6170b83ed">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="edaf8bc319227fe95dce9ce1973f3621" level="file">
        <did>
          <unittitle>TML, 45-86 - Iodine-131 - Tositumomab (Bexxar) for treatment of Lymphoma</unittitle>
          <unitdate type="inclusive">2003 October 27</unitdate>
          <container id="79b0f4a1e21e2266a77b5d64f791b8fd" label="Mixed Materials (A0000000075931)" type="box">89</container>
          <container id="2b5b3077c8e996839124222dda168628" parent="79b0f4a1e21e2266a77b5d64f791b8fd" type="folder">5-9</container>
        </did>
        <accessrestrict id="a9e5f083314a82f3692a841eac51a5ca">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="f8dc69e4bf109c9986cc722051633070" level="file">
        <did>
          <unittitle>TML, 45-27 - Pneumococcal Conjugate Vaccine</unittitle>
          <unitdate type="inclusive">2003 March 31</unitdate>
          <container id="92cc508bdc1410d4f0bbad6146cfa9d3" label="Mixed Materials (A0000000075931)" type="box">89</container>
          <container id="71be74ea1f35de8b2e8c3dc0042f2c68" parent="92cc508bdc1410d4f0bbad6146cfa9d3" type="folder">10-11</container>
        </did>
        <accessrestrict id="e59f218612780c21cd1831f3c38ec08e">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="cc9f06be346fedef1f6102477bee9cb2" level="file">
        <did>
          <unittitle>TML, 45-78 - Influenza Prevention</unittitle>
          <unitdate type="inclusive">2003 September 29</unitdate>
          <container id="5c682bb869a54cb0d742488a4119ef1c" label="Mixed Materials (A0000000075931)" type="box">89</container>
          <container id="48f4629fd499a489042d5f7d2c0cbb42" parent="5c682bb869a54cb0d742488a4119ef1c" type="folder">12-14</container>
        </did>
        <accessrestrict id="cc6daf505d9a0ea7ee4c3ea324aa8478">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="39d9d76dedec7d6057d3eb65d8744ded" level="file">
        <did>
          <unittitle>TML, 45-19 - Peginterferon alfa (Pegasys) for Chronic Hepatitis C</unittitle>
          <unitdate type="inclusive">2003 March 3</unitdate>
          <container id="21b6537add944aba30c3a66963b4a814" label="Mixed Materials (A0000000075931)" type="box">89</container>
          <container id="d13f42cd98d33c380dee534cc89da335" parent="21b6537add944aba30c3a66963b4a814" type="folder">15-16</container>
        </did>
        <accessrestrict id="4cfe15ffe7bdd2742771ed54d3c1d07c">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="efd0e7eb3789a0bc30a68f63ca9b430c" level="file">
        <did>
          <unittitle>TML, 45-55 - Pegvisomant (Somavert) for Acromegly</unittitle>
          <unitdate type="inclusive">2003 July 7</unitdate>
          <container id="7b2657e5b5b461cc13156c91d0124c34" label="Mixed Materials (A0000000075931)" type="box">89</container>
          <container id="1180a256ef11e35e34f5566be824fee8" parent="7b2657e5b5b461cc13156c91d0124c34" type="folder">17-20</container>
        </did>
        <accessrestrict id="565dbbbdc9cf527d50ca1536a406a58f">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="e809ce901af88811ad1fd0cb5bc5882c" level="file">
        <did>
          <unittitle>TML, 45-9 - Teriparatide for Osteoporosis</unittitle>
          <unitdate type="inclusive">2003 February 3</unitdate>
          <container id="c2c743736a5a83793dc7427cb30a5cee" label="Mixed Materials (A0000000075932)" type="box">90</container>
          <container id="cc41591b8c46e649ec0d3437975ca49e" parent="c2c743736a5a83793dc7427cb30a5cee" type="folder">1-4</container>
        </did>
        <accessrestrict id="662bdc9f7dbb54b08b4950ea34c176c4">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="acd944256fa6e191f50b1c636b7b7bf4" level="file">
        <did>
          <unittitle>TML, 45-70 - Testim and Striant - two new testosterone products</unittitle>
          <unitdate type="inclusive">2003 September 1</unitdate>
          <container id="3d46807bfeb48d578cd5eb1bda383d6c" label="Mixed Materials (A0000000075932)" type="box">90</container>
          <container id="401da1ef5f561dc19213da0290e22792" parent="3d46807bfeb48d578cd5eb1bda383d6c" type="folder">5-8</container>
        </did>
        <accessrestrict id="56655a641344d4055a005097ec27c5cb">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="fbdf4b7f30d77eaf33b84599e0a5e6e6" level="file">
        <did>
          <unittitle>TML, 45-1 - Smallpox vaccine</unittitle>
          <unitdate type="inclusive">2003 January 6</unitdate>
          <container id="1914c09fabf1313e47a3c86e652f8620" label="Mixed Materials (A0000000075932)" type="box">90</container>
          <container id="29859ec9c6cf2e18c50fde3314ea43e4" parent="1914c09fabf1313e47a3c86e652f8620" type="folder">9-12</container>
        </did>
        <accessrestrict id="df814d1bfcebe53223f1d57c2a6776e2">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="d9642438ec124cd82d8e135b0198ede7" level="file">
        <did>
          <unittitle>TML, 45-69 - Minimal surgery for treatment of GERD</unittitle>
          <unitdate type="inclusive">2003 September 1</unitdate>
          <container id="7c066ae2e5fa338ddfa0418bafa235e1" label="Mixed Materials (A0000000075932)" type="box">90</container>
          <container id="4caa6a3a84a6957f626386663230cb87" parent="7c066ae2e5fa338ddfa0418bafa235e1" type="folder">13-16</container>
        </did>
        <accessrestrict id="572b2a0e74e3c89c9169b31576cc0b55">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="0e7f3c8cc41ff780e30caa2e1cd3c245" level="file">
        <did>
          <unittitle>TML, 45-23 - Drug-eluting Stents</unittitle>
          <unitdate type="inclusive">2003 March 17</unitdate>
          <container id="e9a06a9641aa2221ee2b3c3c8ba2c3c5" label="Mixed Materials (A0000000075932)" type="box">90</container>
          <container id="a0a18a47412d4f2832ad51e919ecffa1" parent="e9a06a9641aa2221ee2b3c3c8ba2c3c5" type="folder">17-19</container>
        </did>
        <accessrestrict id="91472bcb765db5980f76960bca69f7bb">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="4cbcc7808efc65afe1e68d84b33f1bea" level="file">
        <did>
          <unittitle>TML, 45-23 - Drug-eluting Stents</unittitle>
          <unitdate type="inclusive">2003 March 17</unitdate>
          <container id="a257dcfa8c1f9641a377d0ba9823d7f3" label="Mixed Materials (A0000000075933)" type="box">91</container>
          <container id="1aee4abbe3227e6966a02862aae3d263" parent="a257dcfa8c1f9641a377d0ba9823d7f3" type="folder">1</container>
        </did>
        <accessrestrict id="ad37cdcd99a2044624e749e1cd39779d">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="f9a9c4fc1896553a888be142b1758016" level="file">
        <did>
          <unittitle>TML, 45-61 - Omeprazole (Prilosec) (OTC)</unittitle>
          <unitdate type="inclusive">2003 August 4</unitdate>
          <container id="3b74968f6572ee827ff733aafabe528c" label="Mixed Materials (A0000000075933)" type="box">91</container>
          <container id="8f613278381ec7048cf3b494c488fa94" parent="3b74968f6572ee827ff733aafabe528c" type="folder">2-3</container>
        </did>
        <accessrestrict id="d9a5d8493c3334bb1cda4ff7afb8a52c">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="839fb8691411f959bd1aac5c4ebf7d26" level="file">
        <did>
          <unittitle>TML, 45-29 - Nitazoxanide (Alina) - a new anti-protozoal agent</unittitle>
          <unitdate type="inclusive">2003 April 14</unitdate>
          <container id="0cc7d77b5d000f5dde5c212657a89048" label="Mixed Materials (A0000000075933)" type="box">91</container>
          <container id="be9dd86584505273ca9efaab294a12df" parent="0cc7d77b5d000f5dde5c212657a89048" type="folder">4-5</container>
        </did>
        <accessrestrict id="ba825ee552c2bf91acd8b458e0a15d2d">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="55365ce4b3ea2d58db64e9416965cb4e" level="file">
        <did>
          <unittitle>TML - Drug of Choice for Cancer - Treatment Guidelines</unittitle>
          <unitdate type="inclusive">2003 March</unitdate>
          <container id="7f166a97e7cc4b5b83b192fc797a7aa8" label="Mixed Materials (A0000000075933)" type="box">91</container>
          <container id="c136451d0ef7b83aa243cc6f1b84c3d3" parent="7f166a97e7cc4b5b83b192fc797a7aa8" type="folder">6-17</container>
        </did>
        <accessrestrict id="0ed20f41fac45d1a638a3740752cb703">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="668d7e7e07b5750eb2c823e11c095964" level="file">
        <did>
          <unittitle>TML - Drug of Choice for Cancer - Treatment Guidelines</unittitle>
          <unitdate type="inclusive">2003 March</unitdate>
          <container id="4f89565070c07f6d8f0a7de9153aa085" label="Mixed Materials (A0000000075934)" type="box">92</container>
          <container id="ba111484d4e0f3ca1205b8a004c830a7" parent="4f89565070c07f6d8f0a7de9153aa085" type="folder">1-4</container>
        </did>
        <accessrestrict id="c2b71f78c735a86ad9547e6e3d24546c">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="c171f13c04b5ef1cf3b3fe5e96a9ef03" level="file">
        <did>
          <unittitle>TML - Weight Loss - Treatment Guidelines</unittitle>
          <unitdate type="inclusive">2003 December</unitdate>
          <container id="91d82658cf52144a52104c0a37fdc730" label="Mixed Materials (A0000000075934)" type="box">92</container>
          <container id="f45023c087e0e2bca2de05befa15f206" parent="91d82658cf52144a52104c0a37fdc730" type="folder">5-13</container>
        </did>
        <accessrestrict id="6dd9eece4a3c89e40bca2442781a600d">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="ee60c4bf66a25475983425024da14c39" level="file">
        <did>
          <unittitle>TML - Heart Failure - Treatment Guidelines</unittitle>
          <unitdate type="inclusive">2003 April</unitdate>
          <container id="1a9fdaaf3664e767ef49f06dfeb41b75" label="Mixed Materials (A0000000075934)" type="box">92</container>
          <container id="3d422d71706a274e7d65904b8c6a88f5" parent="1a9fdaaf3664e767ef49f06dfeb41b75" type="folder">14-18</container>
        </did>
        <accessrestrict id="957488be5b6a3b3f5fb3aca8638e23b6">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="0be1e684fc9e69b20bc9867cc0b7288f" level="file">
        <did>
          <unittitle>TML - Drugs for rheumatoid arthritis - Treatment Guidelines</unittitle>
          <unitdate type="inclusive">2003 January</unitdate>
          <container id="0380d6eee5a6dfa86bb85cc56d06638f" label="Mixed Materials (A0000000075935)" type="box">93</container>
          <container id="2fcef7abfdc83c76b87aad30f6bb9f50" parent="0380d6eee5a6dfa86bb85cc56d06638f" type="folder">1-7</container>
        </did>
        <accessrestrict id="fea0a477360238ce0c79c9e79ad6d39a">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="c0978c508033828e366f1d55950a308e" level="file">
        <did>
          <unittitle>TML - Drugs for Psychiatric Disorders</unittitle>
          <unitdate type="inclusive">2003 July</unitdate>
          <container id="755527762fe895155cdb1aceeb766aef" label="Mixed Materials (A0000000075935)" type="box">93</container>
          <container id="d61e0d4403d36c3c37f077c25deb0285" parent="755527762fe895155cdb1aceeb766aef" type="folder">8-18</container>
        </did>
        <accessrestrict id="03781a219ff982acf63e0290b3b87f0e">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="a9906d72f32382fa1bb39c1ccd388091" level="file">
        <did>
          <unittitle>TML - Rheumatoid Arthritis - Treatment Guidelines - Reprints</unittitle>
          <unitdate type="inclusive">2003 January</unitdate>
          <container id="9a2b9be3729a48ab3593522c3dc7740c" label="Mixed Materials (A0000000075935)" type="box">93</container>
          <container id="9550be85583ba733901ac224fb0dd3db" parent="9a2b9be3729a48ab3593522c3dc7740c" type="folder">19</container>
        </did>
        <accessrestrict id="a19ba7012ef7e238dc26e208ad0c53df">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="9d1257d4a4ba512b1aa0bb0a4c07fdcd" level="file">
        <did>
          <unittitle>TML - Rheumatoid Arthritis - Treatment Guidelines - Reprints</unittitle>
          <unitdate type="inclusive">2003 January</unitdate>
          <container id="2bbeebcfcf32954a86fb482aaefd7a23" label="Mixed Materials (A0000000075936)" type="box">94</container>
          <container id="b9dcb7dfee19fdf0e974b4bdaa06c441" parent="2bbeebcfcf32954a86fb482aaefd7a23" type="folder">1-4</container>
        </did>
        <accessrestrict id="2097ee7f9bd39cd5ea6f974d3df6ff1f">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="380c664090534851fbc806e0558fde2f" level="file">
        <did>
          <unittitle>TML - Assisted Reproduction - Treatment Guidelines</unittitle>
          <unitdate type="inclusive">2003 October</unitdate>
          <container id="0a474dedd73a8f3894bf5bddde1c91ef" label="Mixed Materials (A0000000075936)" type="box">94</container>
          <container id="049c8e949f3325d782d0f9f6994b48e0" parent="0a474dedd73a8f3894bf5bddde1c91ef" type="folder">5-13</container>
        </did>
        <accessrestrict id="69fb416fcc934ed0c8b1f96140cd08e2">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="dfe820ca0d9eb165533f652cbc41ee32" level="file">
        <did>
          <unittitle>TML - Drugs for Hypertension - Treatment Guidelines</unittitle>
          <unitdate type="inclusive">2003 February</unitdate>
          <container id="733754ce13df6dba90daeada29f34f23" label="Mixed Materials (A0000000075936)" type="box">94</container>
          <container id="724e2d3fc99a9484080b14f51282d706" parent="733754ce13df6dba90daeada29f34f23" type="folder">14-17</container>
        </did>
        <accessrestrict id="5a63fa0917343ef8eb141521fcb9e24e">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="3ce9ce08c457fba44042e2deea5066f7" level="file">
        <did>
          <unittitle>TML - Tobacco Addiction - Treatment Guidelines</unittitle>
          <unitdate type="inclusive">2003 March</unitdate>
          <container id="370586df9f3ef66efeef1ff5e41f9720" label="Mixed Materials (A0000000075936)" type="box">94</container>
          <container id="0b82baf61da6000af592fb7c5cd947da" parent="370586df9f3ef66efeef1ff5e41f9720" type="folder">18</container>
        </did>
        <accessrestrict id="43bc17de19e0d00f4e7031362b3b3efc">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="d475b54c5095880adce7b8263966fe2d" level="file">
        <did>
          <unittitle>TML - Tobacco Addiction - Treatment Guidelines</unittitle>
          <unitdate type="inclusive">2003 March</unitdate>
          <container id="d6b2626635dd5283579f0696b2dc2a68" label="Mixed Materials (A0000000075937)" type="box">95</container>
          <container id="44944e9034e213369de703980918a5a0" parent="d6b2626635dd5283579f0696b2dc2a68" type="folder">1-8</container>
        </did>
        <accessrestrict id="d727ecc0d3636f553591f418559bc721">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="a6efb00d5c63c6a2ccedf6563ae43110" level="file">
        <did>
          <unittitle>TML - Drugs for Epilepsy - Treatment Guidelines</unittitle>
          <unitdate type="inclusive">2003 May</unitdate>
          <container id="5d914235e78bed2081712227c58bfd3f" label="Mixed Materials (A0000000075937)" type="box">95</container>
          <container id="afcc8e13e0e31a1373ed0cb19a318ec8" parent="5d914235e78bed2081712227c58bfd3f" type="folder">9-14</container>
        </did>
        <accessrestrict id="ae7bd45c44b6a19a25f101af3b5a211a">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="5a5ba60bec4d0b97fddcd00799fd7626" level="file">
        <did>
          <unittitle>TML - Drugs for Lipid Disorders - Treatment Guidelines</unittitle>
          <unitdate type="inclusive">2003 August</unitdate>
          <container id="094606d5b31720c75fa7d766904e26a6" label="Mixed Materials (A0000000075937)" type="box">95</container>
          <container id="742f51e702d5cd6906f0d8d54ee1baa0" parent="094606d5b31720c75fa7d766904e26a6" type="folder">15-18</container>
        </did>
        <accessrestrict id="334e64660b4fc298f4d1c26e9a76a343">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="3c1aea5febbafdf8b5e437a8e97b9218" level="file">
        <did>
          <unittitle>TML, 49-53 - SSRIs Safe for Children</unittitle>
          <unitdate type="inclusive">2003 July 7</unitdate>
          <container id="0ad7dde3f40e3e68e6ad0911af384df2" label="Mixed Materials (A0000000075937)" type="box">95</container>
          <container id="9a0c78cee55a2ca78854475ef15b1810" parent="0ad7dde3f40e3e68e6ad0911af384df2" type="folder">19</container>
        </did>
        <accessrestrict id="7cdf942787e0cbed8326189a2020f299">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="ddf6b73987ce0637989f66584610c6ea" level="file">
        <did>
          <unittitle>TML, 49-53 - SSRIs Safe for Children</unittitle>
          <unitdate type="inclusive">2003 July 7</unitdate>
          <container id="0261d9453df2bad79bbcd4c5e1a62511" label="Mixed Materials (A0000000075938)" type="box">96</container>
          <container id="d3ede9977371feac325162c8eb2f2ac9" parent="0261d9453df2bad79bbcd4c5e1a62511" type="folder">1</container>
        </did>
        <accessrestrict id="2b960cecbba771988110df8a9cd33742">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="0ca468433bcdc6006e7fb9b0ef21814e" level="file">
        <did>
          <unittitle>TML, 45-93 - Which SSRI</unittitle>
          <unitdate type="inclusive">2003 November 24</unitdate>
          <container id="78f9bebef232916a3646bfc48cfa5f0d" label="Mixed Materials (A0000000075938)" type="box">96</container>
          <container id="2a38b4f150717376ab80e2d174b8b63c" parent="78f9bebef232916a3646bfc48cfa5f0d" type="folder">2-5</container>
        </did>
        <accessrestrict id="72e10bfbf01df945876de61f8480a08b">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="1e5a72f232d4e116685aff32e9ed9f87" level="file">
        <did>
          <unittitle>TML - Drugs for Allergic Disorders - Treatment Guidelines</unittitle>
          <unitdate type="inclusive">2003 November</unitdate>
          <container id="d040fbde0ee2533e4e9164dfc232e31f" label="Mixed Materials (A0000000075938)" type="box">96</container>
          <container id="56d422ad77ecb540be94b619e282b9b8" parent="d040fbde0ee2533e4e9164dfc232e31f" type="folder">6-9</container>
        </did>
        <accessrestrict id="ce922dcf8bde445758a34a54106e0ec6">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="7621ca9e85272fb03e367f6102650bf9" level="file">
        <did>
          <unittitle>TML - Drugs for Pneumonia - Treatment Guidelines</unittitle>
          <unitdate type="inclusive">2003 September</unitdate>
          <container id="dcb0b014647d512e34db3b9608c7cfbd" label="Mixed Materials (A0000000075938)" type="box">96</container>
          <container id="645f4d1b584fc55671728e9431d91d67" parent="dcb0b014647d512e34db3b9608c7cfbd" type="folder">10-17</container>
        </did>
        <accessrestrict id="429d1928e15342d8a9639e6b6a92e6d4">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="68e729c691bb49c8be35f332fbb1e32b" level="file">
        <did>
          <unittitle>TML - Antimicrobial Prophylaxis for Surgery - Treatment Guidelines</unittitle>
          <unitdate type="inclusive">2004</unitdate>
          <container id="6f13429e80d16030443e5cecfc2552ab" label="Mixed Materials (A0000000075939)" type="box">97</container>
          <container id="555de4478f584de35e8c691669d1136f" parent="6f13429e80d16030443e5cecfc2552ab" type="folder">1-10</container>
        </did>
        <accessrestrict id="084a4278da0f4581918db07f8eb825b4">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2030</p>
        </accessrestrict>
      </c>
      <c id="07f19737b5f6d3009e9e85a8b0528533" level="file">
        <did>
          <unittitle>TML - Drugs for Cardiac Arrhythmias - Treatment Guidelines</unittitle>
          <unitdate type="inclusive">2004</unitdate>
          <container id="911f8c118a532ac7dda698ea68fff76e" label="Mixed Materials (A0000000075939)" type="box">97</container>
          <container id="c3f62f0ce4017a2d5c9cbb116c0d3a93" parent="911f8c118a532ac7dda698ea68fff76e" type="folder">11-18</container>
        </did>
        <accessrestrict id="8f26a61c71898392ee05f246c39c61b0">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2030</p>
        </accessrestrict>
      </c>
      <c id="c099bb967206188345dcdbf9c2975e6d" level="file">
        <did>
          <unittitle>TML - Advice for Travelers - Treatment Guidelines</unittitle>
          <unitdate type="inclusive">2004</unitdate>
          <container id="5aaeafad59890cbc31d7baca25a4a739" label="Mixed Materials (A0000000075940)" type="box">98</container>
          <container id="f7cd00ab014a374d32df4ca438070246" parent="5aaeafad59890cbc31d7baca25a4a739" type="folder">1-9</container>
        </did>
        <accessrestrict id="e0b7814bc924716eb27275e9522cf9ae">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2030</p>
        </accessrestrict>
      </c>
      <c id="237497500e700200226282634e319af9" level="file">
        <did>
          <unittitle>TML - Drugs for Migraine - Treatment Guidelines</unittitle>
          <unitdate type="inclusive">2004</unitdate>
          <container id="d83fabc7fa43727f1a6d53e50f35e43e" label="Mixed Materials (A0000000075940)" type="box">98</container>
          <container id="0472158e95e106a3b67684e706fc15e1" parent="d83fabc7fa43727f1a6d53e50f35e43e" type="folder">10-15</container>
        </did>
        <accessrestrict id="00d75b64dab2398628516bc88ce53406">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2030</p>
        </accessrestrict>
      </c>
      <c id="423b8c383be805c9a485a8fecfe9ddb1" level="file">
        <did>
          <unittitle>TML - Tuberculosis - Treatment Guidelines</unittitle>
          <unitdate type="inclusive">2004 December</unitdate>
          <container id="4eca14041d2898370882dbd2dce02ee3" label="Mixed Materials (A0000000075940)" type="box">98</container>
          <container id="08e4a214a9e25e1df5a48c352b525658" parent="4eca14041d2898370882dbd2dce02ee3" type="folder">16</container>
        </did>
        <accessrestrict id="98f8b37e529ccb193a51c645e7d19af9">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2030</p>
        </accessrestrict>
      </c>
      <c id="26700edc7d4dff9bb83e29c005e8dedd" level="file">
        <did>
          <unittitle>TML - Tuberculosis - Treatment Guidelines</unittitle>
          <unitdate type="inclusive">2004 December</unitdate>
          <container id="3ae116f85d049045b9431fea94008c5d" label="Mixed Materials (A0000000075941)" type="box">99</container>
          <container id="b8bf823e2a5b37c06b70bec6bb7c9319" parent="3ae116f85d049045b9431fea94008c5d" type="folder">1-5</container>
        </did>
        <accessrestrict id="ff906c4305f7b289ec47141f34c41d10">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2030</p>
        </accessrestrict>
      </c>
      <c id="bef1ef630d26c3d4f70cc63b2da9dbfa" level="file">
        <did>
          <unittitle>TML - Drugs for Sexually transmitted infections - Treatment Guidelines</unittitle>
          <unitdate type="inclusive">2004 October</unitdate>
          <container id="e825af04ab7cf229cd025cd004e68bd5" label="Mixed Materials (A0000000075941)" type="box">99</container>
          <container id="972df23a2eecb9695d4792d337ff25f2" parent="e825af04ab7cf229cd025cd004e68bd5" type="folder">6-12</container>
        </did>
        <accessrestrict id="6db6900a0738aa418a1db1239ba995f3">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2030</p>
        </accessrestrict>
      </c>
      <c id="ef8b77a4a9168df66dbaa1d35328f051" level="file">
        <did>
          <unittitle>TML - Drugs for Parkinson's disease - Treatment Guidelines</unittitle>
          <unitdate type="inclusive">2004 June</unitdate>
          <container id="7528eeffbda4a19bcb9c6aed8f59749b" label="Mixed Materials (A0000000075941)" type="box">99</container>
          <container id="f7198a1d74a8a3170d1a0121e40fcc20" parent="7528eeffbda4a19bcb9c6aed8f59749b" type="folder">13-18</container>
        </did>
        <accessrestrict id="d4257f7e3e2891eb7db697e7bd0a7fc7">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2030</p>
        </accessrestrict>
      </c>
      <c id="4122c98e47eb1d53ed958233e91ca5d6" level="file">
        <did>
          <unittitle>TML - Drugs for Parkinson's disease - Treatment Guidelines</unittitle>
          <unitdate type="inclusive">2004 June</unitdate>
          <container id="a1972eb1595f687cf3023d406048f0a9" label="Mixed Materials (A0000000075942)" type="box">100</container>
          <container id="8da542e6692c17db163e32bf122a2a28" parent="a1972eb1595f687cf3023d406048f0a9" type="folder">1-3</container>
        </did>
        <accessrestrict id="4ac25a41ad51ce40a2b44624b0c6f458">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2030</p>
        </accessrestrict>
      </c>
      <c id="1db0c21858cc9e616d5906c203e6860d" level="file">
        <did>
          <unittitle>TML, 46-22 - Abarelix (Plenaxis) for advanced prostrate cancer</unittitle>
          <unitdate type="inclusive">2004 March 15</unitdate>
          <container id="36874511334dcb530812df99ab97b59c" label="Mixed Materials (A0000000075942)" type="box">100</container>
          <container id="d71b65d32fdb52b12bc5468d17a0240f" parent="36874511334dcb530812df99ab97b59c" type="folder">4-5</container>
        </did>
        <accessrestrict id="d7dfc37db7d6c404c6134b6250ab6400">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2030</p>
        </accessrestrict>
      </c>
      <c id="7f8aea6a2a9125acc397a2b721ccebdb" level="file">
        <did>
          <unittitle>TML, 46-9 - Daptomycin (Cubicin) for skin and soft tissue infections</unittitle>
          <unitdate type="inclusive">2004 February 2</unitdate>
          <container id="36f939e9569ee9bae1d101845360575a" label="Mixed Materials (A0000000075942)" type="box">100</container>
          <container id="3509b95fa43ce28fc7d60a27f7854810" parent="36f939e9569ee9bae1d101845360575a" type="folder">6-8</container>
        </did>
        <accessrestrict id="8b64bb10092754b7b8a4c90c8deb7337">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2030</p>
        </accessrestrict>
      </c>
      <c id="08fbdaa8a0871e1576f4bafb794f57f9" level="file">
        <did>
          <unittitle>TML, 46-10 - Emergency Contraception OTC</unittitle>
          <unitdate type="inclusive">2004 February 2</unitdate>
          <container id="287a8c9d1fc2792cf7a20e06b1749523" label="Mixed Materials (A0000000075942)" type="box">100</container>
          <container id="80af23be8307c2c76bfb4b5757285627" parent="287a8c9d1fc2792cf7a20e06b1749523" type="folder">9-10</container>
        </did>
        <accessrestrict id="00f05ef1f3a72bb3da4ce317cb793c27">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2030</p>
        </accessrestrict>
      </c>
      <c id="9ea3892837eec8429d01fe1dc14e6b41" level="file">
        <did>
          <unittitle>TML, 46-5 - Lasik and its alternatives - an update</unittitle>
          <unitdate type="inclusive">2004 January 19</unitdate>
          <container id="5f7e4f081ed4a914ee4d89b4b66f7ab9" label="Mixed Materials (A0000000075942)" type="box">100</container>
          <container id="cdf2396549234315c2c040a00c375c00" parent="5f7e4f081ed4a914ee4d89b4b66f7ab9" type="folder">11-14</container>
        </did>
        <accessrestrict id="7815c3c9e1b402b4a02ed5022e168609">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2030</p>
        </accessrestrict>
      </c>
      <c id="f1703fc66140060139d86d70ac0c3846" level="file">
        <did>
          <unittitle>TML, 46-15 - Effexor vs. SSRI</unittitle>
          <unitdate type="inclusive">2004 February 16</unitdate>
          <container id="4136646f3855b8e71cda617b1369a7ea" label="Mixed Materials (A0000000075942)" type="box">100</container>
          <container id="6655666c8fdec54934a1a8b223ed5fdf" parent="4136646f3855b8e71cda617b1369a7ea" type="folder">15-18</container>
        </did>
        <accessrestrict id="dc0cf1e8ca62aefc4f65bdca678ea19e">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2030</p>
        </accessrestrict>
      </c>
      <c id="e8f33c13c32daa15598a2e144e9f900f" level="file">
        <did>
          <unittitle>TML, 46-15 - Effexor vs. SSRI</unittitle>
          <unitdate type="inclusive">2004 February 16</unitdate>
          <container id="9a0c43d51ef97f73fa2f2f458564ca11" label="Mixed Materials (A0000000075943)" type="box">101</container>
          <container id="8b5f5fcb8f06150370afc6d59970ef0b" parent="9a0c43d51ef97f73fa2f2f458564ca11" type="folder">1</container>
        </did>
        <accessrestrict id="81a1621d7a2a2452c30a530869fc9bea">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2030</p>
        </accessrestrict>
      </c>
      <c id="f1258ee39d7e2cce0fa124be57ed0634" level="file">
        <did>
          <unittitle>TML - Choice of Antibacterial Drugs - Treatment Guidelines</unittitle>
          <unitdate type="inclusive">2004 March</unitdate>
          <container id="61a36fe9860c4b7ea27d124cbc100264" label="Mixed Materials (A0000000075943)" type="box">101</container>
          <container id="03f08b3a7bada157b6d84bf4ddc56158" parent="61a36fe9860c4b7ea27d124cbc100264" type="folder">2-8</container>
        </did>
        <accessrestrict id="d14f31516858f5ff1d6ab38316a1acdf">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2030</p>
        </accessrestrict>
      </c>
      <c id="dcf6c003359f1d37afb6b89504a47763" level="file">
        <did>
          <unittitle>TML - Drugs for Peptic Ulcers - Treatment Guidelines</unittitle>
          <unitdate type="inclusive">2004 February</unitdate>
          <container id="70c47d70553fd879ff223ea7090485b2" label="Mixed Materials (A0000000075943)" type="box">101</container>
          <container id="37379fb2c4673053a416dedf74046589" parent="70c47d70553fd879ff223ea7090485b2" type="folder">9-17</container>
        </did>
        <accessrestrict id="ee022307e7bb1d19942f259293477255">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2030</p>
        </accessrestrict>
      </c>
      <c id="0ba4f3a6cf74e6af72c13dc1e491dbd6" level="file">
        <did>
          <unittitle>TML - Drugs for HIV Infection - Treatment Guidelines</unittitle>
          <unitdate type="inclusive">2004 January</unitdate>
          <container id="018cb606aecac9dce458a95b12e92c35" label="Mixed Materials (A0000000075943)" type="box">101</container>
          <container id="0ae4ff73a7341eeafe0df23cf4a4d453" parent="018cb606aecac9dce458a95b12e92c35" type="folder">18-19</container>
        </did>
        <accessrestrict id="cae76792326d54b966f74999980f0522">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2030</p>
        </accessrestrict>
      </c>
      <c id="499346d5020cece037a74d774986c858" level="file">
        <did>
          <unittitle>TML - Drugs for HIV Infection - Treatment Guidelines</unittitle>
          <unitdate type="inclusive">2004 January</unitdate>
          <container id="cf4dcaf85212ce8543c41a69aa54c213" label="Mixed Materials (A0000000075944)" type="box">102</container>
          <container id="322b0b4931b1168ac2058433767e5553" parent="cf4dcaf85212ce8543c41a69aa54c213" type="folder">1-4</container>
        </did>
        <accessrestrict id="78b76f282a6087796d952eea7ca3851b">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2030</p>
        </accessrestrict>
      </c>
      <c id="e2ff3268992aa759f09a842e60822ffb" level="file">
        <did>
          <unittitle>TML - Drugs for Pain - Treatment Guidelines</unittitle>
          <unitdate type="inclusive">2004 July</unitdate>
          <container id="ece479fd20bf489799f09c6063550603" label="Mixed Materials (A0000000075944)" type="box">102</container>
          <container id="42844d12326ececccc683e05c80f3c5b" parent="ece479fd20bf489799f09c6063550603" type="folder">5-14</container>
        </did>
        <accessrestrict id="04e11af6b467a1e7c10d7574675c44fb">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2030</p>
        </accessrestrict>
      </c>
    </dsc>
  </archdesc>
</ead>
